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ABSTRACT

It is recognized that nonintentional, automatic processing shapes physical health and well-being
in critical ways. Conditioning––or priming––has been shown to influence attitude, beliefs,
agency, behavior, and medical outcomes. Although expectations and beliefs correlate strongly
with physical health, research in clinical application is needed, and studies on hope, as related to
agency, in chronic pain are rare. The purpose of this study was to investigate whether, in a
chronic pain sample (N = 154), hope could be primed via a Pain Neuroscience Educational
(PNE) tutorial. A pre- and post-test intervention study consisting of two randomized parallel
groups was designed to answer these research questions: What effect does a primed PNE have on
hope in a chronic pain sample? Does exposure to a primed PNE affect pain at the present
moment? What is the relationship between hope, stress-hardiness, and the perception of pain in
this sample? After completing a pain inventory and obtaining baseline measures of hope, pain at
the present moment, typical pain throughout the last year, and the trait of stress-hardiness, two
parallel groups (n = 122) of chronic pain participants were exposed to either a primed or neutral
condition and reassessed for hope and pain. After analyzing results, a third group (n = 32) was
recruited and exposed to the primed condition but without the hardiness scale. A significant gain
in hope at p = 0.001 was found in all three groups (N = 154), with medium effect sizes (Cohen’s
d), p = 0.05. There was no change in pain at the present moment. Statistically significant
Pearson’s correlations were found among hope, typical pain, and hardiness, p = 0.05. Broadly,
the statistically significant elevation in hope across all groups suggests that unconscious
exposure can prime or condition implicit attitudes apart from conscious goal setting, although the
mechanism is unclear (i.e., tutorials and/or the Hope scale). By utilizing a novel priming method
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in a chronic pain sample, this study contributes to the field of health priming and its findings
advance the basis for the clinical application of nonconscious methods in health and medicine.
Keywords: Subliminal priming, placebo, hope, agency, stress-hardiness, chronic pain
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TABLES AND FIGURES
Table 1
Comparative Table of T-Test Results and Effect Size of Hope, Before and After, in Primed,
Neutral and Primed Without Hardiness Groups

Group

Hope
T1/T2
Hope T1

Mean

T-Value

P-Value

Cohens d
Effect Size

0.416

4.01

<0.001

0.546

0.352

3.50

<0.001

0.425

0.351

3.80

<0.001

0.672

4.57

Neutral (n=54)
Hope T2

4.99

Hope T1

4.31

Primed (n=68)

Primed w/o
Hardiness (n=32)

Mean of
Hope T2-T1

Hope T2

4.67

Hope T1

4.42

Hope T2

4.77
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CHAPTER ONE: INTRODUCTION
It is recognized that nonintentional, automatic processing shapes health and well-being in
critical ways. Mindsets or beliefs have downstream effects (i.e., physiological enhancements)
and can be influenced by environmental triggers or subtle cues (i.e., priming) without conscious
awareness. Although nonconscious methods are believed to be more effective than conscious
methods in changing beliefs and health behavior, research in clinical application is rare (Bargh,
2016; Girgis et al., 2018; Papies, 2016; Phillips & Pagnini, 2016). This investigation examines
the effect of priming on hope, as linked to agency (e.g., see definition of terms), which is
associated with lower morbidity, all-cause mortality, and the experience of pain (Long et al.,
2020). Therefore, this investigation examined whether hope can be primed in a chronic pain
sample.
This dissertation contains five chapters: an introduction, a literature review, the
methodology, research findings and a concluding discussion followed by references and
appendices. This chapter, the introduction, consists of the following sections and is organized in
the order listed: the background and statement of the problem; the purpose of the study; guiding
research questions; definition of terms; contributions to the field; limitations and delimitations of
the study; overview of the literature and methods, followed by an outline of the dissertation.
Health Priming: A Call for Research
Intriguing cases led to an interest in priming (i.e., the process of environmental cueing) as
I observed its impact on well-being and physical health. For example, when Susie was diagnosed
with cardiomyopathy her ejection fraction (i.e., a measure of heart function) was so low that
surgery for a pacemaker was scheduled. Shortness of breath and the fear of surgery contributed
to panic attacks, so she was referred to me for counseling prior to the procedure. While our work
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together alleviated her anxiety, an echocardiogram showed that there had been no change in the
condition, and surgery was scheduled for the following week. Almost as an after-thought, during
our last session prior to the procedure, I asked Susie to describe the room she and her husband
spent the most time in. There, on the mantle, on either side of the television, were two urns: one
for her mother and one for her mother-in-law. After discussing environmental cueing, Susie
chose to relocate the urns, and a few days later when she arrived for the procedure her ejection
fraction had improved so that she no longer needed a pacemaker. Without further intervention
her cardiac function gradually normalized.
Although the basis of Susie’s remarkable outcome cannot be ascertained with certainty,
presenting this case at a medical conference kindled several discussions around the nature of
priming (i.e., environmental cueing), and stimulated a desire to investigate the topic further.
While it is recognized that attitudes and beliefs (i.e., mindsets) modulate physiological measures
and well-being in significant ways (Stockdale, 2009; 2011), recent findings indicate that
nonconscious (i.e., priming) interventions are more effective than conscious methods in changing
mindsets and health behavior (Elgendi et al., 2018; Papies, 2016; Sheeran et al., 2013).
The psychobiological phenomenon of priming is “widely recognized as having a potent
impact upon treatment outcomes in both medical and psychological interventions” (Sliwinski &
Elkins, 2013, p. 1) and is believed to play a “crucial role in determining clinical outcomes”
(Crum et al., 2017, p. 1). Beliefs and meanings, such as mindsets, “can be stored in memory and
activated by subtle cues” (Savary et al., 2014, p. 4), profoundly impacting motivation, physical
health, and will to live (Girgis et al., 2018; Jaremka et al., 2014; Levy et al., 2012; Marques et
al., 2014; Wurm et al., 2013).
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Although “belief systems are a robust predictor of well-being and related health
outcomes” (Van Tongeren & Bernette, 2018, p. 102), and priming interventions can effectively
stimulate adaptive mindsets, “most of these insights have not been translated into effective
intervention tools” (Papies, 2016, p. 2). This study is, in part, a response to a collective call for
action to identify effective clinical methods that can modify implicitly held beliefs and attitudes.
As the loss of hope in chronic conditions has been shown to negatively affect quality of life and
contribute to morbidity and mortality, this project was designed to explore whether hope can be
primed in chronic pain, a population particularly vulnerable to the loss of hope (Serbic et al.,
2016).
Statement of the Problem
When pain becomes chronic, structural remodeling of pain pathways in the brain
contribute to its persistence, rendering it particularly challenging to treat (Kuner & Flor, 2017).
Such effects are evident in phantom limb pain: A diseased limb may be amputated but the
perception of pain persists in the missing limb. Likewise, spinal defects, when surgically
corrected, only eliminate pain in a minority of patients, as sensitized pain pathways are
operational even when the injury or structural abnormality has been corrected (Hanscom, 2017).
Furthermore, glia––a set of nervous system cells––can chronically and independently send pain
signals, without physiological cause (i.e., damaged tissue) (Donnelly et al., 2020). In this way,
pain can become its own primary condition, arising after an injury or on its own. Over time the
effectiveness of opioids and analgesics decrease, contributing to the syndrome (KleineBorgmann et al., 2019).
These challenges can lead to hopelessness, an identified factor contributing to disability
and comorbidities in chronic conditions. In chronic pain specifically, the loss of hope is
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associated with passive coping, amplified pain, increased comorbidities, and lower quality of
life; whereas hope is linked to agency, pro-health behaviors, and positive outcome in chronic
pain (Baliki & Apkarian, 2015; DuPont et al., 2020; France et al., 2020; Jaremka et al., 2014).
Nevertheless, chronic pain is seldom studied in clinical practice (Brascher et al., 2018).
Recent findings, however, show that new learning can change not only the perception of
pain, but the connectivity of the brain (Seminowicz et al., 2011). Pain neuroscience education
(PNE), or learning about the neurobiology of pain, is a recognized treatment reimbursed by
Medicare, and has been found, in some cases, to decrease the perception of pain and improve
physical function (Puentedura & Flynn, 2016). In contrast, a systematic review and metaanalysis failed to show long-term benefits of PNE, due to nonadherence (Wood & Hendrick,
2020; 2018). In chronic conditions, acting in one’s best interest is fundamental to lasting
behavioral change. As such, the actionable quality of hope––associated with perseverance
toward goals––is critical (Long et al., 2020). Even so, this author was unable to locate studies
investigating the impact of PNE on hope; furthermore, “hope has rarely been considered in
discussions of expectancy and the placebo response” (Eaves et al., 2016, p. 3).
Expectations about one’s health have been found to be predictive of well-being and
physical health (Levy, 2009; Van Tongeren & Bernette, 2018). Upending self-limiting beliefs,
however, demands more than data, as learning––in the sense of drawing conclusions about one’s
prognosis––may occur outside of one’s awareness, as expectations (i.e., belief systems or
mindsets) may be “activated via unconscious exposure [i.e., priming]” (Papies, 2016, p. 22;
Crum & Zuckerman, 2017). As such, nonconscious processes are considered more effective than
conscious methods in changing implicit attitudes and health behavior, yet research in clinical
application is scarce (Papies, 2016; Elgendi et al., 2018; Sheeran et al., 2013).
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In summary, while recent findings in neuroscience show the brain can learn to change the
course of pain, research is needed to develop targeted clinical interventions aimed at instilling
adaptive mindsets (Zion, 2019). Therefore, this project focused on the possibility of priming
hope (i.e., outside of conscious awareness) in a chronic pain population.
Historical Context & Complicating Factors
Contributing directly to morbidity and mortality are personal beliefs and attitudes,
recognized in the late 1970s as key factors in the development of long-term pain. As a challenge
to Cartesian dualism, a biopsychosocial model was proposed (Engel, 1977) and defined as a
“multidimensional, dynamic interaction among physiological, psychological, and social factors
that reciprocally influence each other” (Edwards, et al., 2016, p. 5). Interventions based on this
model––evidenced by more than four decades of research––not only modulate pain perception
and improve quality of life but reduce morbidity and mortality as well (Puentedura & Flynn,
2016).
Despite evidence to the contrary, the prevailing biomedical model (i.e., linear, cause and
effect) attributes pain solely to injured or damaged tissue. This view about the nature of chronic
pain can result in undue patient dependence on the medical system, contributing to helplessness
which, in turn, is associated with passive coping, hopelessness, amplified pain, increased
comorbidities and lower quality of life (Gatchel, et al., 2011; Long et al., 2020;
Vanhaudenhuyse, et al., 2017).
Biobehavioral (i.e., biopsychosocial) interventions, on the other hand, are demonstrated
to enhance outcome, improve well-being, and significantly reduce health costs (Wilson et al.,
2019). To illustrate, in one investigation subjects with chronic back pain were trained in
individual sessions to disassociate pain as a threatening condition, leading to hypoalgesia or pain
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reduction (Ashar et al., 2021). Although compelling, health practitioners are increasingly time
pressured and may not have the resources to teach behavioral medicine methods or communicate
these in a way that addresses or inspires hope/agency. Consequently, a lack of motivation along
with a high drop-out rate has proved problematic in behavioral medicine programs for chronic
pain (Kerns et al., 2014; Stockdale, 2019).
Priming, on the other hand, does not require a significant time investment. Given that
nonintentional, automatic processing shapes health in critical ways (Wryobeck & Chen, 2003),
Crum and Zuckerman (2017) propose that priming methods be implemented in all
physician/patient interactions. Yet, even in a biopsychosocial context, many health professionals
are unaware of the value and efficacy of priming for better health outcomes, and such methods
are seldom studied in a clinical context. To encourage utilization, research on practical,
economical delivery methods is needed (Elgendi et al., 2018; Sheeran et al., 2013).
Although hope, as related to agency, is associated with pain reduction (i.e., hypoalgesia),
less functional disability, pro-health behaviors, and lower morbidity and all-cause mortality, it
has received less attention in chronic pain and is often incorrectly conflated with optimism
(Goodin & Bulls, 2013; Long, et al., 2020).
Therefore, a primary question addressed by this project is whether such hope can be
primed via a brief, written PNE tutorial. A secondary question is whether pain perception is
affected by reading positively primed pain information (i.e., PNE). And lastly, this research
project explored the relationship among pain, hope and the quality of stress-hardiness.
The High Cost of Losing Hope
At least twenty percent of individuals in the U.S. are reported to be suffering from
unresolved, chronic pain; and for the majority, there is no identified cause (Jaremka et al., 2014;
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Serbic et al., 2016). Unresolved pain symptoms “cost the U.S. health-care system roughly $256
billion in . . . direct costs per year” (Ewart et al., 2014, p. 977). Chronic back pain alone is
considered “a major global health problem, while its treatment is hampered by a lack of efficacy
and restricted safety profile of common frontline therapies” (Kleine-Borgmann et al., 2019,
Abstract, para. 1).
Although chronic pain is acknowledged as “an enormous health care issue . . . its science
has remained rudimentary” (Baliki & Apkarian, 2015, p. 23); and when the medical system is
unable to ease suffering or identify the cause of pain, anger, frustration, and hopelessness may
ensue (Kerns et al., 2014). In addition, downstream effects such as job loss and frayed familial
relationships contribute to isolation and despair (Jaremka et al., 2014).
Since an increased risk of comorbidities and all-cause mortality is associated with
hopelessness, there is a particular need for high fidelity, economical and time-saving methods
that elevate hope. As a construct, hope has been measured in psychological and behavioral
studies as a mediator of coping, recovery, and resilience (Coughlin, 2006). For example, in a
longitudinal epidemiological study of more than twelve-thousand individuals, hope-fueled
agency was associated with a reduction in pain, morbidities and all-cause mortality (Long et al.,
2020). Consequently, this investigation examined whether hope could be primed in a chronic
pain sample.
Related to agency and resilience, the trait of stress-hardiness (Kobassa, 1979) has been
associated with improved immunity and cardiovascular stress response, lower inflammatory
markers, and enhanced parasympathetic activation (Zerach et al., 2020), yet is seldom studied in
chronic pain. Investigating the association among the trait factor of hardiness, hope and pain was
an additional goal of this study.
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Purpose of the Study
Considering hope’s cardinal role in health and well-being, this study investigated whether
hope could be primed via a brief PNE tutorial in a chronic pain sample. While hope has been
defined in various ways, Long et al.’s (2020) definition––which distinguishes hope from
optimism––is preferred (e.g., see definition of terms), and will be explored further in Chapter
Three. The purpose of this study, then, was to examine the effect of a priming intervention on
hope, related to agency, in chronic pain.
Guiding Research Questions
The objective of this research project was to examine the effect(s) of a priming
intervention, modeled after PNE, on hope and the perception of pain, and to explore the
relationship among hope, hardiness, and pain perception. The primary question guiding this
project was: Does exposure to a positively primed Pain Neuroscience Educational (PNE) tutorial
promote hope in respondents experiencing chronic pain? (Or: Can hope be primed via brief,
written communication among participants experiencing chronic pain?) A second question was:
Does exposure to a positively primed PNE tutorial influence the experience of pain as perceived
in the present moment? The third query explored the relationship between hope and pain. For
example, this project addressed the question: If hope increases, does pain in the moment
decrease? This investigation also measured the trait of stress-hardiness. By evaluating hardiness
in the sample population, it was possible to gauge this particular trait and examine its association
to hope and pain.
Definition of Terms
Beliefs or Mindsets are a construct of implicit-theories that can be described as
“transparent patterns or templates” (VanTongeren & Burnette, 2018, p. 101), or “lenses or
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frames of mind that orient an individual to a particular set of associations and expectations”
(Crum & Zuckerman, 2017, p. 1). Such mindsets, or attitudes, have neurobiological correlates
that modulate physiology, and even outcome in medical treatment (Girgis et al., 2018).
The biopsychosocial model has been defined as a “multidimensional, dynamic interaction
among physiological, psychological, and social factors that reciprocally influence each other”
(Edwards, et al., 2016, p. 5).
Hardiness is more discreetly defined than the broad construct of resilience, which is
interpreted in multiple ways by numerous researchers. Hardiness is a “multidimensional
personality disposition which encompasses three basic facets: commitment, control and
challenge,” (Zerach et al., 2020, p. 1008) and is associated with improved immunity and
cardiovascular stress response, lower inflammatory markers, enhanced parasympathetic
activation, and is inversely associated with post-traumatic stress (2020).
Hope, as defined herein, is “understood to be a positive motivational state that enables
people to persevere towards goals and pathways” (Long et al., 2020, p. 1). Hopefulness has been
“conceptualized as a cognitive set involving both agency (i.e., the belief in one’s ability to
initiate and sustain actions) and pathways (i.e., the belief in one’s ability to generate routes to
achieve desired goals)” (Goodin & Bulls, 2013, p. 3). As such, hope is strongly linked to agency,
and distinguished from optimism, in that believing the future will be good is very different from
acting on one’s own behalf (Long et al., 2020).
Optimism, as defined in this proposal “may be understood as a disposition towards having
expectations that the future will be good (which may be with or without reasons)” (Long et al.,
2020, p. 1). As noted, optimism is distinguished from hope in that believing the future will be
good is different from acting (i.e., an expression of agency) on one’s own behalf.
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Pain Neuroscience Education (PNE), also known as Therapeutic Neuroscience
Education, is education about the neural basis, or neurophysiology of pain and the nervous
system. PNE refers to learning about the neurobiology of pain in a productive way that can
contribute toward the development of positive expectations for pain reduction (Rondon-Ramos et
al., 2020).
A Placebo is a mechanism which includes words and rituals, symbols, and beliefs such as
the meaning an individual ascribes to their illness that produces measurable, physiological
change (Benedetti, 2011; Eaves et al., 2016). The placebo effect has been defined as “the robust
and measurable effect of three components: the body’s natural ability to heal, the patient
mindset, and the social context” (Shashkevich, 2017, para. 1). Likewise, the nocebo effect can be
elicited when a disadvantageous process or outcome is suggested which produces a measurable
change for the worse (Phillips & Pagnini, 2016). In general, the term placebo is used for both
positive and negative effects:
Due to their capacity to improve or worsen symptoms and well-being, placebo and
nocebo effects are highly relevant not only in research but also in clinical practice. They
contribute to most therapeutic effects, occur regularly in doctor-patient interactions, and
are assumed to play a role in the development and maintenance of chronic pain and other
diseases. (Brascher et al., 2018, Significance of Classical Conditioning, para. 4).
Priming, or conditioning, refers to the role of the subconscious and influence of the
physical environment, or subtle cues, on mindsets, behavior, and physiology. Like placebos and
nocebos, primes can be positive or negative, and while they generally imply a lack of awareness
of the exposure or influence, in some cases the priming can be consciously determined and no
less effective. In other cases, the term subliminal priming, indicates that the word or image has
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been masked or occluded. Supraliminal priming also aims to influence behavior unconsciously,
but the image or phrase is not occluded. Distinctions between the two are most often seen in
market research, while health priming research appears to prefer the term subliminal under both
conditions.
Priming interventions aim to influence behavior outside of deliberate planning, and “refer
to an increased sensitivity to certain stimuli, resulting from prior exposure to related visual or
audio messages” (Eglendi et al., 2018, p. 1). Priming is the experimental manipulation in this
study. Such methods are often subtle and unobtrusive, yet they activate “relevant mental
representations by external, environmental stimulus” (Sheeran et al., 2013, p. 465). These
representations include words and objects in the environment that can be leveraged to various
effects on behavior and health (Wryobeck & Chen, 2003).
Contributions to the Field
By utilizing a novel priming method in a chronic pain sample, this study contributes to
the field of health priming, and its findings advance the basis for the clinical application of
nonconscious methods in health and medicine. Although fully discussed in Chapter Five, this
section briefly considers a few of the ways this project contributes to priming literature.
Although nonconscious processes “profoundly affect health and well-being” (Crum &
Zuckerman, 2017, p. 1), and appear to be more effective than conscious methods in changing
health behavior and outcome (Elgendi et al., 2018; Sheeran et al., 2013; Wryobeck & Chen,
2003), in clinical practice they remain largely untested (Hollands, et al., 2016; Wegesin et al.,
2004). Moreover, although researchers advocate that priming be implemented in all
physician/patient interactions (Crum and Zuckerman, 2017), many health professionals are
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unaware of the value and efficacy of priming for better health outcomes, further justifying the
need for evidence-based intervention tools (Papies, 2016, p. 2; Sheeran et al., 2012).
Therefore, in response to these deficits, this study examined a feasible, targeted priming
intervention in a notably hard-to-treat population, the results of which contribute to the
biopsychosocial model of chronic pain treatment in unique ways. Despite its determining role in
health and well-being, the role of hope in physical health, expectancy and the placebo response,
is seldom studied (Eaves et al., 2016; Long et al., 2020), yet “is central to how people living with
pain . . . adjust their expectations to find meaning in individual treatment narratives” (Eaves et
al., 2016, p. 3). This investigation, then, contributes to the field of health priming and the
psychological study of hope and its relationship to chronic pain.
Surprisingly, although pain-related beliefs “are better predictors of health-related quality
of life outcomes than pain intensity outcomes” (France et al., 2020, p. 577), few studies
“investigate pain patients and even less focus on clinical pain” (Brascher et al., 2018, Clinical
Context, para. 1). Therefore, this study also contributes to a call for research investigating
clinical pain and pain-related beliefs (France et al., 2020).
This investigation also evaluated the trait factor of stress-hardiness––characterized by the
three facets of control, commitment, and challenge––which is seldom studied in chronic pain
(Zerach et al., 2020). The inclusion of this distinctive measure of resilience and agency
contributes to the store of knowledge and a nuanced understanding of the relationship among
pain perception, hope and stress-hardiness. Furthermore, this study also allowed for a
comparison of hope and hardiness outcomes, verifying the adapted Hope scale (Long et al.,
2020) in assessing agency. Further details and additional facets that contribute to the literature
are discussed in the concluding section of Chapter Five.
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In summary, this investigation is a response to a call for clinical application in the field of
health priming and a need for research in clinical pain and pain-related beliefs. It also addresses a
scarcity of research in hope and chronic pain. This cross-sectional study (i.e., medical, and
psychological) of hope and its relationship to chronic pain fills a need in biobehavioral health.
This study also allowed for a novel comparison of hope and stress-hardiness outcomes,
supporting the use of the adapted Hope scale (Long et al., 2020) in assessing hope related to
agency. Therefore, this project contributes to the broad arena of biobehavioral health, chronic
pain, and priming research, while its findings can inform clinical practice and serve as a
stepping-stone for future research.
Delimitations/Limitations of the Study
Delimitations
Given the long-term effects of chronic pain on neural pathways, participation was limited
to adults experiencing chronic pain for at least one-year, as they are more representative of the
chronic pain population, as opposed to those experiencing pain for a shorter duration. To
complete the online survey, a computer or cellular device was necessary, therefore a bias in
terms of computer literacy is assumed. While libraries, prior to SARS-CoV2, provided computer
access, these were not uniformly available in May of 2021. This delimitation (e.g., email survey)
skewed the sample toward individuals with access to technology and English fluency.
Whereas Long et al.’s (2020) longitudinal investigation considered detailed medical
histories, the primary focus in this study was on hope, pain perception, and the trait of stresshardiness, not the source or type of chronic pain. Suggestions for future research could include
relevant medical histories, including analgesic use, that could be correlated to hope and pain

CAN HOPE BE PRIMED IN CHRONIC PAIN

14

perception, although MD Anderson found such data to be of little help in analyzing pain (MD
Anderson’s Brief Pain Inventory Guide).
Further, due to ethical constraints, a delimitation of this project is that it did not assess the
difference in hope (i.e., pre- and post-intervention) utilizing a negative prime. The application
submitted to the Institutional Review Board (IRB) for human subjects research emphasized the
importance of avoiding a negative prime in terms of hopelessness and pain, while acknowledging
that the Hope scale itself could act as a positive prime. Likewise, to avoid the potential harm
resulting from a standard biomedical tutorial (Claessen et al., 2015), a relatively neutral
adaptation on pain was used for the control group. Barring ethical considerations, future research
could include a negatively primed group as did Claessen et al. (2015).
Limitations
Since hopelessness can inhibit motivation (Jaremka et al., 2014), it is possible that the
self-selection process and response bias attracted individuals inclined toward hope, resulting in a
group skewed toward hope. On the other hand, it is possible that high functioning individuals
with chronic pain were not inclined to spend time taking the survey, biasing the sample toward
more debilitated individuals.
Additionally, to control for Type 1 errors rigorous alpha levels were adopted which could
have increased the likelihood of Type II errors. Each of these issues will be discussed in more
detail in Chapter Five under Limitations. Future research, with a sample size of several hundred
(e.g., patients in a pain clinic), could correct for some of these limitations.
Overview of the Literature
In this brief overview of the literature, findings about the influence of automatic
processes in attitudinal and goal formation are contrasted with a lack of clinical research in
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health priming methods. This body of literature captures the impact of unconscious processes in
attitudinal change and health outcomes, and collectively, provides the necessary foundation from
which to explore the rationale for investigating hope-priming in a vulnerable population, such as
chronic pain. A more comprehensive literature review can be found in Chapter Two, but an
overview of each section is provided below.
Memory Systems: The Priming of Memory
It is recognized that nonintentional, automatic processing affects health in critical ways
(Wryobeck & Chen, 2003). Elgendi et al. (2018) argue that “the influence of subliminal priming
(behavior outside of awareness) . . . can impact behavior, choices, and actions” (p. 1). Given the
“limited effects of intentions on behaviour . . . novel methods . . . are needed that do not rely on
conscious intentions” (Papies, 2016, p. 1). As such, priming, or cueing interventions, aim to
influence behavior outside of deliberate planning.
This sensitivity (i.e., conditioning) “involves complex interactions of specialized memory
systems mediated by distinct cerebral networks” (Layton & Krikorian, 2002, p. 255). Implicit
and explicit memory systems are pivotal to understanding the neuroscience of conditioned
responses (2002) and their relevance to biobehavioral health. By considering the nature of
memory, and the physiological implications of automatic processing, the sources reviewed
clarify how unconscious exposure can prime or condition health behavior apart from conscious
goal setting. This section of the literature review (i.e., presented in Chapter Two) contributes to
an understanding of the impact of subliminal priming on health and well-being and provides the
necessary foundation from which to appreciate the need for, and the importance of, this
investigation and others like it.
A Primer on Priming
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Priming’s relatively recent history is complex. To better appreciate the need for more
research, the broad context of priming is considered, along with the limitations imposed on
health priming by the sectarian nature of the field.
Although priming’s influence on attitudes and behavior is undisputed by researchers, the
mechanisms by which it operates, and variations in defining terms, are intensely debated. Despite
rapid growth, the field is hampered by the absence of an overarching rubric, and a central,
unified (i.e., standardized) vocabulary tying research sectors together. More than semantics, the
problem of terminology has become a defining one in priming research, contributing to
confusion (Bargh, 2016), and hindering advancement in the field (Hollands et al., 2013).
The lack of conceptual clarity among researchers, and between disciplines, makes a
cross-sectional review of priming on health and well-being challenging (Hollands et al., 2013).
In the literature review presented in the following chapter, these conceptual conflicts are
acknowledged and addressed. This understanding provides the necessary groundwork to locate
the current state of health priming research as it relates to this investigation.
Placebo, Mindset & Belief
This intriguing portion of the literature review explores how beliefs or mindsets function
as potent medicinal primes, with notable downstream effects (i.e., physiological enhancements)
on well-being and health (Levy, 2009; Van Tongeren & Burnette, 2018). Such mindsets, or
attitudes, can become actualized by means of subtle environmental cues (Savary et al., 2014),
modulating physiology, and medical treatment outcomes (Girgis et al., 2018). A thorough
presentation of these conceptualizations and the supporting research (e.g., the trickle-down
effects of hopelessness on physiology) anchors this project in an essential way.
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Emblematic of priming in health and medicine is the placebo effect. This
psychobiological phenomenon is recognized as having a profound impact upon medical and
psychological outcomes (Sliwinski & Elkins, 2013), and is believed to underlie virtually every
treatment effect (Crum & Zuckerman, 2017). Although priming and placebo research are two
parts of the same whole, due to the general separation of the psychological and the medical,
placebo research is rarely included in psychological priming studies, and vice versa (Rosen et al.,
2017).
In summary, the sources cited in this section explore the connections among mindset,
beliefs, and placebo research, as related to physical health, in conditioned (i.e., primed)
responses. However, research investigating clinical applications is scarce, leading to the
following discussion of hope and chronic pain.
Hope & Chronic Pain
This section reviews evidence supporting the current investigation, arguing the need for
methods that foster hope in chronic pain populations as an essential nutriment in positive health
outcomes.
Whereas hope and hopelessness are well-represented in depression literature, the role of
hope, as related to agency, in physical health has received less attention (Long et al., 2020). Even
so, when studied in biopsychosocial models this active form of hope has been linked to
reductions in pain and less functional disability (Goodin & Bulls, 2013). The studies reviewed in
this section contrast the effects of hope and hopelessness on morbidity, mortality, agency, and
quality of life, particularly as seen in a chronic pain population. In Long et al.’s (2020)
longitudinal study of more than 12,000 individuals, hope, linked to agency, was found to be
significantly protective.
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Although priming methods (i.e., nonconscious processes) “profoundly affect health and
well-being” (Crum & Zuckerman, 2017, p. 1), and are purported to be more effective than
conscious methods in changing health behavior and outcome (Elgendi et al., 2018; Sheeran et al.,
2013; Wryobeck & Chen, 2003), in clinical practice they remain largely untested (Hollands, et
al., 2016; Wegesin et al., 2004). An exception is a recent investigation using positively primed,
neutral, and negatively primed questionnaires in a pain clinic. Those answering the positively
primed questionnaire reported less functional disability than those responding to the neutral, or
the negatively primed questionnaire (Claessen et al., 2015).
Inspiring this study, Claessen et al.’s (2015) investigation raised the possibility of
priming a mindset such as hope in a chronic pain sample. Accordingly, this research project was
designed to answer the primary question: Can hope be primed in chronic pain? Or, more
specifically, can hope be primed among participants experiencing chronic pain via brief, written
communication? To best answer this guiding question a quantitative, randomized experiment
was conducted. The following section discusses the rationale for the study’s design.
Overview of the Methods
A complete description of the instrument selection and methodology can be found in
Chapter Three, whereas this section provides a brief overview of the methods. After discussing
the study design and its rationale, the process of recruitment and participation is summarized,
followed by the setting for the study, and concluding with the selection of instrumentation.
This pre-and post-test, randomized interventional study investigated whether the critical
quality of hope could be primed in a chronic pain population. It also incorporated methods,
scales and analytics that would contribute to a nuanced understanding of the relationship among
hope, pain, and stress-hardiness. In parallel groups, approximately fifty percent of participants
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were exposed to the primed intervention (i.e., hope manipulation) and fifty percent received a
traditional tutorial on pain (i.e., control manipulation). Analyses were carried out in both
independent groups. In the first analysis, the effect of the intervention was isolated by controlling
for the baseline measure of hope and calculating the difference. In a second analysis, the
outcome of pain in the present moment was assessed in the same manner.
The survey also evaluated the trait of stress-hardiness which was used to examine the
association among hope, stress-hardiness, and pain. Specifically, correlational analyses
compared the baseline measure of hope to the mean of hardiness and average pain throughout the
year. Typical pain experienced throughout the year and the mean of hardiness were also assessed
in the same manner.
The primed tutorial was modeled after PNE concepts reflecting advances in the
neuroscience of pain (Ashar et al., 2021). The development of a neutral tutorial presented a
challenge, as a strictly neutral tutorial (e.g., organic gardening) selects against a pain focus and
would not enable an adequate comparison of the two groups as the experimental group (i.e., hope
manipulation) was required to focus on pain throughout the survey. An organic gardening
tutorial, by way of example, side steps that condition while introducing another variable:
distraction from pain, thereby obfuscating the objective of the study. Nor could the neutral
tutorial include negative pain conceptualizations and risk inducing a nocebo effect. Thus, the
condition for both groups was exposure to information on pain but in somewhat different ways––
one in a primed capacity and one in a relatively neutral condition. In this way, by requiring all
subjects to focus on pain, results are more applicable to clinical practice, in that, patients are
focused on pain when seeking treatment or participating in PNE.
This design helped the researcher answer the following questions:
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What effect does exposure to a positively primed Pain Neuroscience Educational (PNE)
tutorial have on the quality of hope in respondents experiencing chronic pain?
Is there an effect on the perception of pain after reading either traditional or positively
primed information on pain (i.e., do pain levels fluctuate)?
What is the relationship among hope, hardiness, and the perception of pain?
Participants: Recruitment, Consent & Privacy
An ongoing criticism of research in social psychology and priming is that of inadequate
sample sizes. To avoid this pitfall and draw meaningful conclusions from the data, an a priori
power analysis was performed. Since the adapted Hope scale is a novel instrument, there was no
empirical precedent upon which to calculate a sample size to ensure adequate power. Likewise,
the author could not locate a similar study in extant literature to compare the hope difference and
pain difference as outcomes in two randomly assigned independent, parallel groups. Therefore,
to estimate the sample size, Cohen’s (1988) Power Table was consulted. Assuming a medium
effect size, with alpha probability of .05 and .10, it was established that each group needed either
36 or 38 participants respectively (i.e., at least 75 participants total). Despite the current SARSCoV2 pandemic, more than 200-participants were recruited and 154 qualified.
The recruitment announcement invited adults experiencing chronic pain (e.g., chronic
migraine, etc.) for at least one-year to participate in an online survey titled “understanding pain”
and offered subjects the opportunity to help researchers learn more about the relationship
between pain and well-being. To protect the nature of the investigation, the title of the
announcement differed from that of the study, since disclosing the topic of hope could alter
perception and be counter-productive in terms of subliminal priming research. Therefore, wellbeing was the preferred term for the announcement (see Appendix A).
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To maximize participation, the web link was posted on social media and sent to email
subscribers, associates, colleagues, physicians, physical therapists, and chiropractors (i.e.,
snowballing). Permission was granted to place cards with a QR code linking to the study in the
waiting areas of a general practitioner, two private physical therapy offices, a hospital pain
clinic, and two chiropractic offices. The researcher was not present so there was no interviewer
bias and respondents chose when and where to participate. An incentive was a 30-minute
relaxation audio available via a link that could be accessed upon qualifying to participate in the
survey.
The Setting
The setting for the study was a designated website containing a link to the survey so that
participants could complete the survey at a convenient time and place. The Likert scale
questionnaires, instruments, and consent were developed and tested using Survey Monkey
software before being embedded into the site. Participants clicked on the link provided to take
the survey. Anonymity was ensured at every step: Tracking was disabled via Survey Monkey
software, and no identifiers were collected at any time.
Instrumentation
Standardized scales, noted for their reliability and validity, were selected for their ability
to address the research questions posed within this paper while strengthening the methodology
and reducing complications. Short-form scales were preferred, and in some cases adapted, to
reduce negative priming and survey completion time. Although this section presents the scales
based on their qualities for inclusion, a complete discussion of instruments and their adaptations
can be found in Chapter Three. A copy of each instrument can be found in Appendices C, D, E
and F.
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For clarity, the instruments are listed briefly, and then discussed individually, and
collectively, as to their appropriateness and measurement characteristics. The primed and neutral
tutorials (i.e., interventions) are discussed under the section titled, The Neutral and Primed
Tutorials. The scales are as follows: the Five-Item Pain inventory; the Hope scale; and the
Adapted Short-form Hardiness scale.
The Five-Item Pain Inventory
To establish the nature of an individual’s perception of pain (i.e., severity) and its effects
(i.e., interference), the first scale is an adaptation of MD Anderson’s Brief Pain inventory (BPI
Short-form). The BPI Short-form is a widely used, 13-item (Yes, No, numerical rating scale, and
0-10 Likert scale) self-report instrument that has been validated and shown to be reliable over
time in terms of pain, as well as functional ability or disability (Correll, 2007; JelsnessJorgensen, et al., 2016). Its internal consistency (Chronbach alpha) ranges from .80 to .92. The
test-retest reliability is highest for short-term pain and average pain ratings (.93 to .78). Testretest reliability for current (i.e., “now”) pain ratings is naturally lower (.59) due to the changing
nature of pain (Cleeland, 1991).
For the purpose of this investigation, the BPI Short-form was adapted in several ways.
For example, it is designed to be completed on paper and includes a diagram on which
individuals are asked to shade in the areas where they experience pain. Since the area affected by
pain (e.g., neck, arm, leg, etc.) was not evaluated in this investigation, this item was eliminated.
Additionally, an open-ended question asking that respondents list the medications and treatments
they are receiving was eliminated. Not only were these not evaluated in this project, but the item
was found to be of little value in assessing pain (Cleeland, 1991).
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Finally, instructions for the paper and pencil version ask participants to circle the number
that best answers the question. As indicative of online surveys, individuals clicked on the number
indicating the best answer rather than circling the number. Redundant questions that could
unnecessarily fatigue participants were also eliminated, leaving five questions assessing current
pain, typical pain throughout the year, and pain interference in three domains: general activity,
walking and life enjoyment. The adapted version of the BPI Short-form––the Five-Item Pain
inventory––can be found in Appendix C.
The Hope Scale
Although there are several hope/hopelessness scales from which to choose, the recently
adapted Hope scale (Long et al., 2020) uniquely reflects the conceptualization of hope examined
within this investigation:
Empirical and philosophical work suggests that hope is distinct from optimism despite
the continued conflation of the two terms in both popular and academic discussion. Some
of the conflation may have emerged from the fact that agency and pathways are likely
sources of hope, but also sources of optimism. In returning to more classical
understandings of hope, hope may be distinguished from optimism in that hope may be
understood as a disposition towards having an attentional focus on the possibility that the
future will be good, characteristically in the face of difficulty. Optimism, on the other
hand, may be understood as a disposition towards having expectations that the future will
be good (which may be with or without reasons). (Long et al. 2020, p. 1.)
Therefore, in a novel adaptation, Long et al. (2020) reverse coded items derived from two
other measures (Everson et al., 1996; Beck et al., 1974) to construct a scale of hope rather than
hopelessness, which will be discussed further in Chapter Three. The self-report scale consists of
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four statements rated from one to six (Strongly Disagree to Strongly Agree): “It is possible for
me to reach goals; the future seems hopeful to me; I do expect to get what I really want; There is
use in trying” (Long et al., 2020 p. 1).
While empirical evidence supports the health promoting effects of hope, both mentally
and physically, previous Hope scales (Everson et al., 1996; Beck et al., 1974) could be gauging a
lack of depressive symptoms which is not the same as the actionable quality of hope and the
perseverance toward goals (Long et al., 2020). Further, the chronic pain population is not
classified as psychiatric which also argues for the use of this revised scale.
Therefore, Long et al.’s (2020) revised Hope scale captures a distinct aspect of hope that
makes it possible to conceptualize the relationship between chronic pain and hope inspired
agency, and was, therefore, the preferred Hope scale for use in this study. For ease of
comparison, Appendix C includes the original negatively phrased items derived from Everson et
al. (1996) and Beck et al. (1974).
The Adapted Short-form Hardiness Scale (DRS-II, Short-form)
The concept of stress resistance, or hardiness, was established by Kobasa (1979) as a
protective personality trait that is stable over time. Kobasa (1979) found that––despite high
scores on the Rahe and Holmes Life Event Checklist (LEC) which proved predictive of serious
illness––individuals with high levels of hardiness did not become seriously ill. Since then, the
concept of hardiness has been empirically demonstrated to be a moderator in illness (Gebhardt et
al., 2001), and has also been found to correlate to the Big 5 Personality inventory (Kardum, et
al., 2012).
Although the inverse relationship between hardiness and chronic illness is wellestablished in the literature, very little has been published examining the relationship between
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hardiness (i.e., control, commitment, and challenge) and chronic pain (Zerach et al., 2020).
Various resilience scales have been used in chronic pain, but they are frequently conflated with
optimism (Goodin & Bulls, 2013); therefore, comparing and contrasting Kobassa’s findings
(1979) with the actionable quality of hope was a goal of this study.
Unfortunately, among hardiness scales, there is no “gold standard” (Windle et al., 2011),
with various scales measuring different properties or attributes of stress-hardiness, and few
having strong test-retest reliability. For example, some hardiness or resilience scales have been
found to measure either an individual’s ability to bounce back or seek support from outside
sources, neither of which adequately captures the nature of hardiness as defined by Kobasa
(1979). Yet, the DRS-II short-form (Sinclair et al., 2003), based on Bartone’s (1991) earlier
work, uses language that directly relates to an individual’s capacity to take personal
responsibility (i.e., control) despite challenges.
After reviewing a number of these scales, the DRS-II was found to have good overall
internal consistency (Chronbach’s alpha .83), but test-retest reliability has been difficult to
establish for this instrument. However, the DRS-II is based on the Dispositional Resilience scale
(DRS), which was found to have a coefficient measured at .78 across numerous populations
(Bartone, 2007). The DRS, though, seems to be more relevant for language groups other than
English (Bartone, 2013), so, for this investigation the DRS-II short-form is preferred (Sinclair et
al. 2013).
The Short-form Hardiness scale contains 18-items, rated on a five-point scale from one
(Definitely False) to six (Definitely True). This instrument evaluates six subscales: control or
self-efficacy; powerlessness and/or fatalism; commitment, which is defined as being interested in
and fully engaged with life; alienation, which refers to a sense of meaninglessness and isolation;
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challenge, which is the “tendency to view stressors as challenges rather than threats;” and
rigidity which is gauged by a lack of flexibility and resistance to change. (Sinclair et al., 2003, p.
11).
The internal reliability of the six subscales is as follows: Control (.79); Powerlessness
(.93); Commitment (.79); Alienation (.88); Challenge (.77); and Rigidity (.66) (Sinclair et al.,
2003, p. 13).
The ways in which the Short-form Hardiness scale was adapted for the purposes of this
investigation are discussed in Chapter Three. The adapted scale and guide to interpretation can
be found in Appendix E.
The Neutral and Primed Tutorials
Participants were randomized to either a control (i.e., neutral manipulation) or
experimental group (i.e., hope manipulation). The experimental group (n = 68) reviewed a
primed 219-word tutorial on the advances in the neuroscience of pain and the control group (n =
54) reviewed a 219-word supportively written tutorial on the nature of pain (see Appendix F).
Later, a third group (n = 32) was exposed to the primed tutorial but without the hardiness scale.
In designing the primed tutorial, every effort was made to present the essential, but
potentially disruptive data, in a supportive way. For some, new information, albeit positively
presented, could trigger a conflict of authority with treating physicians, surgeons, or the medical
system (Knowles et al., 2015). So, although pain re-education suggests that individuals can
diminish pain by learning to perceive their pain in a non-threatening manner (Ashar et al. 2021),
this idea was not stated to minimize conflict. As a result, the primed tutorial reflects PNE content
with an emphasis on new findings in pain neuroscience, along with references for interested
individuals.
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Although the control group was still required to focus on pain-related content, care was
taken to construct a relatively neutral tutorial to avoid the nocebo effect. Thus, the control group
reviewed a 219-word tutorial on the unique nature of pain (see Appendix F).
Procedure
After qualifying (e.g., adults experiencing chronic pain for more than one year) and
establishing consent, participants completed a brief demographic survey followed by the FiveItem Pain scale, the Hope scale, and the Adapted Short-form Hardiness scale, before being
exposed to either the Primed or Neutral tutorials consisting of 219-words each. Upon reviewing
either the primed or neutral tutorial, both groups again completed the Hope scale, and rated pain
experienced at the present moment from 0-10.
The order of instrumentation was structured in such a way as to best answer the research
questions. In the pre-test, participants focused on the nature of their pain immediately prior to
completing the Hope scale. Since the Hope scale also assessed agency it segues into hardiness, a
measurement of self-mastery. The post-test was designed to assess hope immediately after the
intervention, concluding with a single-question pain assessment.
This pre-and post-intervention survey (with an experimental group and a control group)
addressed these research questions:
What effect does exposure to a positively primed Pain Neuroscience Educational (PNE)
tutorial have on the quality of hope in respondents experiencing chronic pain?
What do participants report on the perception of pain after reading either neutral or
positively primed information on pain (i.e., do pain levels fluctuate)?
What is the relationship among hope, pain, and hardiness in this sample?
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The following section delineates the procedure followed by participants and the data
collection process.
Data Collection Procedures & Tools
The procedure for participants was as follows: On a designated website,
www.UnderstandingPainStudy.com, participants clicked on the link provided and established
qualifiers (i.e., age and chronic pain duration of at least one-year). After reading the consent
form, subjects selected “continue” to agree to the terms of participation (see Appendix B). After
consenting, a brief demographic survey was completed (e.g., age, gender, country of origin), and
individuals were able to download a 30-minute relaxation audio using psychoacoustics as an
incentive, whether completing the study or not.
After completing the above, administration of the first wave of instruments began.
Participants completed the Five-Item Pain scale (see Appendix D), the four-item Hope scale (see
Appendix C), and the 10-item Adapted Short-form Hardiness scale (see Appendix E). The
experimental group then reviewed a primed PNE tutorial of 219-words, while the control group
was exposed to a relatively neutral pain tutorial, with the same word count. See Appendix F to
compare the two tutorials. After reviewing either the primed or neutral tutorial, post-test
measures began. Both groups again completed the four-item Hope scale and rated the level of
pain or discomfort in the present moment on a scale of 0-10.
Data collection began when target participation goals were reached. After 84-participants
completed the survey using the Primed tutorial, data was collected and uploaded into Excel and
IBM’s Statistical Package for the Social Sciences (SPSS). The primed tutorial was then replaced
with the neutral (i.e., control) tutorial. After 77-participants completed the Neutral survey, data
was collected and uploaded into Excel and SPSS software. Of the 161-respondents, 122
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qualified. Findings then indicated the need for a third group (n = 32). This group reviewed the
primed tutorial, and all measures were equal except this group was not exposed to the Hardiness
scale.
Confidentiality & Anonymity
As indicated, the survey was administered online via a link on a designated website, and
no identifiers were collected ensuring anonymity throughout the process. All participants were
treated equally.
The methodology is discussed in detail in Chapter Three, and the result of each
corresponding measure is analyzed in Chapter Four and interpreted in Chapter Five. To
summarize this section, the strengths of the investigation are sample size, randomization,
standardized instrumentation adapted to the purposes of the investigation, and a unique priming
method. The following and final section of this chapter concludes with an outline of the
dissertation.
Chapter Outline
In this introductory chapter, the primacy of non-conscious methods in modifying implicit
attitudes and beliefs affecting health and well-being was discussed. The context and statement of
the problem, the significance and purpose of the study, the guiding research questions,
limitations, and definitions of terms were all covered herein.
The second chapter reviews the broad literature on priming, mindset, attention bias and
placebo research, as well as conflicting definitions and sectarian limitations, with a focus on
health and concomitant well-being. This chapter concludes by assessing the current state of
health priming research and advocates for a more inclusive framework to advance the field. It
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also sets the stage for the study by examining extant literature on the effects of hope and
hopelessness on physiology.
Chapter Three provides an overview of the experiment: the pre-and post-intervention
design and methodology selected to best answer the research questions. The instrumentation,
setting, participant recruitment, and data collection process are all clearly detailed therein.
The fourth chapter presents the findings as they relate to each research question, while
the final section, Chapter Five, interprets the data accordingly. The strengths and limitations of
the study are discussed in detail along with directions for future research and clinical application.
The final sections of Chapter Five analyze conclusions that can be drawn from the data and how
the project contributes to health priming research and biobehavioral medicine, while furthering a
nuanced understanding of the relationship among hope, pain, and hardiness.
To better appreciate the need for research in clinical application, the next chapter will
consider the historical context of priming, its interdisciplinary foundations and the limitations
imposed on health priming by the sectarian nature of intersecting fields.
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CHAPTER TWO: LITERATURE REVIEW
As thoughts, feelings and behaviors have downstream effects on physiology, and can be
influenced by environmental triggers without conscious awareness (Bargh, 2016; Phillips &
Pagnini, 2016), the literature reviewed in this chapter provides the necessary framework from
which to evaluate the study’s purpose, design, and its contribution to clinical application. To that
end, this chapter offers an interdisciplinary review of priming (i.e., non-conscious methods) on
well-being and concomitant physical health. Each section contributes to an overview of the
current state of health priming research, supporting the need and rationale for this investigation.
To highlight the impact of subliminal priming on physical health and well-being,
divergent and intersecting tracks of research are included, such as: implicit and explicit memory,
attention bias modification, supraliminal and subliminal priming, and placebo/nocebo research,
each of which will be defined herein. This understanding provides the necessary framework in
which the guiding research questions are conceptualized; namely, can the critical quality of hope
be primed in respondents experiencing chronic pain for at least one-year?
Running parallel to a discussion of health priming is the problem of terminology. More
than semantics, the issue has become a defining one in priming research, contributing to
confusion among students and researchers (Bargh, 2016). The lack of conceptual clarity among
researchers, and between disciplines, is a significant factor limiting progress in the field
(Hollands et al., 2013). This appears to have inhibited a cross-sectional review of priming on
health and well-being, as this author could not locate such a compendium.
To appreciate the challenges of an interdisciplinary review, and in the interest of clarity,
the first two sections of this chapter provide relevant foundational concepts. The first explores
the nature of memory, which is fundamental to priming. The second section offers a brief history
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of priming research. In these two sections, terms are defined as they arise in context, but it is the
third section that addresses conflicting terminology associated with research findings leading to
the rationale for the terminology used herein. The remaining sections review priming research,
including key concepts such as placebo/nocebo effects, mindset, and attention bias. The literature
reviewed is relevant to adults in general, but the final section focuses on disparities in health and
aging that appear to be mitigated by certain priming interventions. Despite the growth of priming
literature over the last two decades research investigating practical application is scarce, leading
to the rationale for this project.
Consequently, every effort has been made to limit the discussion (i.e., definitions,
viewpoints, examples, etc.) to closely adhere to health priming concerns. Each section compares
and contrasts conflicting viewpoints, and where possible, identifies areas for further
investigation. Examples are cited throughout the paper to illustrate concepts and capture the
nature of the content. Unless stated otherwise, these are simplified to advance the discussion, and
are not derived from a particular source. Definitions are stated as simply and briefly as possible,
so as not to distract from the flow of argument. With that in mind, the literature selected reflects
a wide swath of peer reviewed articles in medical, behavioral, and psychological journals.
Multiple databases were used including Google and Google Scholar, PubMed, and Lesley
Library. More than 150 journal articles and book chapters were determined to be relevant to this
paper, and far more were reviewed. It should be noted, however, that this paper is not intended to
be a complete discussion of each of the defined constructs, nor provide an exhaustive review of
the literature; it is, rather, a selective, thematic review of the therapeutic potential of health
priming.
How We Know: The Priming of Memory
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Simply put, health education is geared toward motivating individuals to adopt patterns of
behavior that improve both physical and psychosocial well-being––a subjective quality of life
shown to reduce risk of morbidity and mortality. Despite such a straightforward endeavor,
“recent research has shown the limited effects of intentions on behaviour, so that novel methods
to facilitate behaviour change are needed that do not rely on conscious intentions” (Papies, 2016,
p. 1). Since priming impacts behavior, choices, and actions, priming, or cueing interventions, aim
to influence behavior outside of deliberate planning. Priming effects, or automatic responses,
result from this conditioning.
To appreciate this sensitivity (i.e., conditioning), and how it emerges from experience, it
is useful to understand two specialized memory systems: the explicit (i.e., declarative, or
conscious) memory system, and the implicit (i.e., nondeclarative) system (Layton & Krikorian,
2002). Implicit learning occurs in the absence of conscious or deliberate awareness. Although
there are several forms of implicit learning (Squire, 2004), only two will be discussed here:
procedural and emotional. Procedural learning, often referred to as muscle memory, occurs
through repetitive motor actions such as riding a bike or typing that can be acquired and
eventually performed without conscious attention to the motor actions. Emotional learning
occurs during emotive experiences, such as feelings associated with particular songs. Explicit
memory, on the other hand, is available to conscious awareness and consists of semantic
memory––the store of facts and knowledge––and autobiographical memory, a subset of episodic
memory which contains the details––the who, what and when––of personal events and
experience (Hine & Tsushima, 2018).
There are different models of the processes by which the learning and memories from
different systems are activated, and how conflicting schemas affect behavior. Sheeran et al.
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(2013) argue that such conflicts have largely overtaken what should be the primary point: the
“appreciation of how nonconscious processes can promote as well as compromise health” (pp.
460-461).
Although semantic, autobiographical, procedural, and emotional memory are mediated by
and operate in separate neurobiological systems they can, and do, interact. To illustrate how
implicit and explicit memory are involved in a conditioned, or primed response, consider the
example of biting into a lemon. After the initial experience, when exposed to photos of lemons or
even the word lemon, one may automatically salivate. Recognition of the word requires explicit
(i.e., semantic) memory, but the recollection of the sour taste is an implicit, automatic response
of salivation. Simply put, exposure to the sour taste could cause a conditioned or nonconscious
response to the word or an image of a lemon.
Processes such as these, that are not directed by an individual’s conscious intention, are
considered automatic. If, for example, lemons provoke an allergic response, the conditioned
body memory could be aversive, and, among other things, trigger a physiological state associated
with anxiety. Such conditioned associations involve implicit learning and represent nonconscious
learning or implicit priming (Payne et al., 2016).
Extending the example of the lemon, previous experience and cultural influence are
powerful examples of how “priming is closely related to top-down processing” (Hardin, 2018,
Day 1, para. 10). Top-down processing is thought to occur without conscious awareness and is
primed or conditioned not only by experience, but via expectations (Gaspelin & Luck, 2018). An
often-cited investigation by Bornstein et al. (1987) found that frequent exposure to a stimulus
resulted in a preference for that stimulus, even though the individuals were unaware of the
exposure (i.e., “the exposure effect,” p. 1070). Whether or not one is aware of the experience:
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once such a situated conceptualisation has been stored, activating any of its elements on
later occasions can re-activate its other elements, with those elements then more likely to
be enacted. In other words, an action previously performed in a certain context can be
triggered automatically by a contextual cue, leading to nonconscious effects on behavior.
(Papies, 2016, p. 6)
Therefore, “to promote behavioral change, it may thus be beneficial or even necessary to
develop intervention strategies that allow for a change of implicit evaluations” (Vanaelst et al.,
2016, Introduction, para. 1). Considering the implicit, or:
nonintentional effects on health behaviour, such as the effects of habits, impulses, and
nonconscious goals . . . through the activation of cognitive structures by specific
situations . . . [i]nterventions should therefore be situated to change these effects, either
by changing the critical cognitive structures (training interventions), or by . . . priming as
a cueing intervention tool to activate health goals. (Papies, 2016, p. 1)
In sum, the nature of memory, and the physiological implications of automatic processing
clarify an important component of this project: how unconscious exposure can prime or
condition attitudes or health behavior apart from conscious goal setting. In experimental and
other branches of psychology, such conditioned responses often form the basis of cueing or
priming research; therefore, to aid in locating the current state of health priming research, a brief
history of priming is discussed in the following section.
A Primer on Priming
Priming, then, is a form of implicit learning (Claessen et al., 2015; Sliwinski & Elkins,
2013), and has been referred to as “pre-programming of the mind” (Friedman, 2013, p. 559).
Although priming techniques are often subtle and unobtrusive, they nonetheless activate
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“relevant mental representations by external, environmental stimulus” (Sheeran et al., 2013, p.
465). As with placebos, these representations include words, rituals, symbols, and beliefs as well
as objects that can be leveraged to various effects on behavior and health (Eaves et al., 2016;
Wryobeck & Chen, 2003).
In the previous example, salivating to the idea of a lemon illustrates a conditioned,
nonconscious response. That such a response could be primed to influence behavior, came to the
fore in the 1950s when subliminal messages (i.e., presented for brief periods below the threshold
of awareness), in movie theatres encouraged the consumption of Coca-Cola and popcorn.
Despite conflicting viewpoints on whether the increase in consumption was statistically
significant, two decades later the Federal Communications Commission banned subliminal
advertising from television (Bergland, 2015).
However, in both marketing and psychological sectors, the study of environmental cueing
is a relatively recent one. Less than one-hundred-years ago, “it was a radical thing in
experimental psychology to suggest that one’s experience of the outside world was determined
by anything other than the stimulation ‘out there’” (Bargh & Chartrand, 2000, p. 312). The early
foundations of what is known today as priming, and perceptual neuroscience, can be found in the
“study of visual illusions . . . [that illustrate individual differences in] perception of size,
distance, and brightness” (p. 312), such as the well-known, ambiguous image of Rubin’s vase.
Nevertheless, for decades individual variability in perception was largely ignored (Phillips &
Pagnini, 2016), and treated as “error variance” (Bargh & Chartrand, 2000, p. 313).
Eventually in the 1950s, these perceptual variations became known as priming. If a
snapshot of a lemon was flashed below the threshold of perception during a lecture, and
observers noted the rate of water consumption before and after, the process was termed as
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passive priming. As an aside, priming effects in medical and psychobiological research increased
in the 1950s as well, but due to the prevailing biomedical model––separating mind and body––
such research is incorporated in placebo literature but does not appear to be included in priming
history literature. These effects are concerned with physiology––how alterations in perception
can impact measures such as heart rate, blood pressure and insulin levels––and will be further
considered in the section on placebo. As such, this section concerns itself with the history of
priming as presented by the cited texts.
While passive priming refers to a lack of awareness of the exposure, this term was largely
replaced as distinctions were made between subliminal and supraliminal priming which are
discussed in the following section. In the 1970s a novel series of experiments showed that
priming could alter one’s views of, or assumptions about, other people outside of intentional
awareness (Fatemi, 2016). Findings in the following decades paved the way for the current
distinctions between implicit and explicit memory (Bargh & Chartrand, 2000). But it wasn’t until
the 1990s that priming research began to probe behavioral and motivational effects in a systemic
way (2000).
In market research, and within various branches of psychology––applied, cognitive and
experimental, to name a few––a variety of priming or conditioning methods have been evaluated.
Although it is beyond the scope of this paper to deconstruct priming methodologies, the few
examples that follow illustrate how closely related they can be, and why it is not always
necessary to many health investigations to distinguish the technique.
Semantic and visual priming refer to words and visual cues, respectively (Friedman,
2013). Context priming “is said to occur when a word is used to accelerate the processing of
stimuli that are likely to occur within the given context” (Elgendi et al., 2018), such as when
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“table” triggers the word “chair.” Evaluative conditioning is often used to prime implicit
attitudes and refers to pairing a positive stimulus to a negative one to reduce the negative effect
of the aversive stimulus (Claessen et al., 2015). For example, in one evaluative conditioning
study images of obesity were paired with various types of snacks to determine the effect on food
choice (Sheeran, et al., 2013). Conceptual priming can be somewhat difficult to distinguish from
mindset priming, as both can refer to stereotypes that may influence non-conscious goals
(Friedman, 2013). For example, participants might be exposed to either optimistic or depressing
scenes, and then asked to complete a problem-solving question. Sequential priming probes the
connection between two different concepts. In such a case, participants might be exposed, for
example, to either harsh or kind facial expressions, and then probed for how generously they
might behave under certain conditions (Bargh & Chartrand, 2000; Friedman, 2013). And lastly,
repetition priming “refers to the change in responding to a word or an object as a result of a
previous encounter with that same item” (Henik & Carr, 2002, Inhibition).
Apart from the priming techniques mentioned above, there are further distinctions in the
literature, but as the various methods (e.g., semantic, mindset, sequential) are seldom
distinguished in biopsychological research, they will not be considered here. Rather, in many
priming studies the specific conditioning method (e.g., evaluative, or conceptual, etc.) is not
labeled but simply referred to as priming. Most importantly, for the purpose of this paper, what
all of these methods “have in common is a concern with the unintended consequences of an
environmental event on subsequent thoughts, feelings, goals, and behaviors” (Bargh &
Chartrand, 2000, p. 317). For clarity, and to adhere to a standard that can apply across all
research sectors, priming is the preferred term herein.
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In the last two decades, pioneering work on priming has been advanced by research in
mindsets and creativity (Bargh, 2016; Moskowitz, 2009; Friedman, 2013), which will be
considered in the section on mindsets. Organizational psychology, too, has contributed findings
on the use of primes such as “photographs, music, artifacts and scents . . . [to] promote desired
behaviors that are aligned with organizational strategy” (Friedman, 2013, p. 561). Although the
majority of psychological research in priming has reportedly been for marketing purposes
(Karremans et al., 2006), the robust findings therein contributed to a growing interest in priming
for health (Smarandescu & Shimp, 2015).
Given that priming effects can interact with autobiographical memory, it is
understandable that priming opportunities––particularly when concerning health––should be
selected based on the characteristics and needs of the individual (Hine & Tsushima, 2018;
Sliwinski & Elkins, 2013). Bearing this out, in many investigations, a null effect is found when
the goal or prime is not syntonic with the individual’s predisposition, or value system (Sheeran et
al., 2012). For example, individuals who are not hungry are less influenced by food related
primes (Bargh, 2016). As in operant conditioning, “persuasive messages can motivate behavior
change, but only if people are receptive” (Kang et al., 2018, Abstract, para. 2). This is one reason
some find priming unsuitable to large scale interventions (e.g., populations); while others, such
as Papies (2016), advocate priming to encourage healthy food selection and exercise in
communities at large.
A review of priming’s relatively recent history also reveals the complexity and variability
of personal processes, such as memory and perception, that may affect one’s sensitivity to a
prime. Although priming’s potential to influence behavior is undisputed by researchers, the
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mechanisms by which it operates, and variations in defining terms are intensely debated, as the
next section will show.
A Defining Problem: Variations in Terminology
Having considered a brief history of priming, and the nature of memory, it is important to
note that various disciplines, and even experts within a discipline, define the nuances of priming
in various ways. This understanding establishes a framework for the preferred terminology
herein and provides the necessary groundwork to explore priming in a more inclusive, and
interdisciplinary manner. For example, in cognitive and experimental psychology automaticity
research involves the study of the way individuals may automatically perceive themselves,
others, situations and events, whereas priming research is “more concerned with effects of the
current situational context and how these environmental features cause the average individual to
think, feel, and behave differently than otherwise” (Bargh & Chartrand, 2000, p. 312).
Despite this distinction, automaticity and priming techniques are often applied
interchangeably for practical reasons. As a result, even Bargh and Chartrand (2000) acknowledge
that “automatic processing is . . . a grab-bag of the various types of processing that are
considered not conscious” (p. 314). Furthermore, the term nonconscious priming generally
applies to participants who are unaware of the effects of a prime, but there are exceptions.
Moskowitz & Gesundheit (2009), for example, caution that while implicit priming can occur
without awareness, it can also occur “despite awareness of some component(s) of the process”
(p. 207). Since implicit priming may, therefore, occur through both nonconscious and conscious
components, for the purpose of this paper the term priming is preferred, but is not distinguished
from automaticity.
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There is significant disagreement over what constitutes a subliminal or supraliminal
prime. Using an example from Cohn et al. (2014), an individual exposed to the word cancer may
decline the offer of a cigarette––in which case, the word “cancer” could, by some, be considered
subliminal, while others argue that because the prime was not flashed below the threshold of
awareness it is supraliminal (i.e., above the threshold of awareness). To illustrate the
disagreement, in one well-publicized case, investment bankers were offered money if a coin toss
resulted in more heads than tails (2014). The experimental group, having been uniquely primed
by discussing their identity as bank employees, was found to have cheated significantly more on
the coin toss than the control group who had simply chatted about their hobbies. According to
Bargh (2016), “whenever the participant can accurately report afterwards on the experimental
hypothesis, this is not ‘priming’ as the term has been used in psychology over the past 40 years”
(p. 49). Since the bankers were unaware of the prime (e.g., conversation) and its effect on
cheating, the prime and its portended effects could be considered subliminal, or outside the realm
of consciousness.
Others disagree, arguing that if an individual is aware of the prime at all, but not its
purported effects, it is still considered to be a supraliminal prime (Friedman, 2013; Elgendi et al.,
2018). This means the person cannot be aware even of “the presence of the priming stimuli”
(Bargh, 2016, p. 49) for the prime to be considered subliminal. According to Bargh, this
definition is problematic for several reasons:
it is not the historical definition of ‘unconscious’ as used by Darwin, Freud, and others, to
whom it meant effects of (supraliminal) stimuli of which the person was not aware; it is
overly restrictive and implies (alas, to many younger students and researchers in our
field) that as long as a person is consciously aware of the primes they are also aware of
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and intend any influence of the primes (because these are other qualities traditionally
associated with ‘conscious’ processing, and worst of all, it conflates ‘unconscious’ with
‘processing very weak and brief stimuli’ and of ‘conscious’ with ‘processing strong and
long lasting stimuli’ . . . in many priming studies, for example, individuals are
consciously aware of the prime, but are nonetheless unaware of the ways in which the
prime affects their subsequent cognition, affect, or behavior. (Bargh, 2016, p. 49)
Emblematic of the interplay between the subliminal and supraliminal, “some studies showed that
placebo hypoalgesia and nocebo hyperalgesia that had been conditioned with supraliminally
presented cues (i.e., explicit conditioning) can be activated by subliminally presented cues”
(Brascher et al., 2018, Significance of Classical Conditioning, para. 2).
Yet, Bargh (2016) also argues that in subliminal priming the prime must be very brief,
immediately masked (i.e., hidden), and followed by a screening for awareness of the prime. Such
research can be particularly complex, gauged through electroencephalographic and eye
movement tracking, along with other computer assisted programs, where words are occluded
(i.e., masked), and input is flashed outside of the visual field (Elgendi et al., 2018; Friedman,
2013). Cognitive psychology studies, for example, “often include very short experimental
observation periods (milliseconds) to understand the impact of a brief exposure on an
individual’s decision-making when exposed to a subsequent stimulus” (Elgendi et al., 2018, p.
2). It should be noted, though, that the goal in masking––to reduce conscious awareness of
primes (Bussche et al., 2013)––is often to study the role of the subconscious or isolate a
particular feature of the subliminal process:
One point of criticism regarding prevalent models concerns the classification of
physiological processes into being either conscious or unconscious. Evidence suggests
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that it is conceivable that most, if not all, bodily functions, including perception and
behavior, have ‘unconscious’ (i.e., outside a person’s awareness; cf., e.g., blindsight and
implicit operant conditioning and ‘conscious’ (i.e., verbally represented) portions.
(Bascher et al., 2018, Significance of Classical Conditioning, para. 4).
Understandably then, not all priming investigations make use of this structure. Health
priming is not always concerned with isolating a particular aspect of the unconscious, and so it
may be argued that the greater effect, the better. Consider, for example, that adjustments in
micro-environments, such as workplaces, have been shown to influence health behavior, and
even outcome (Friedman, 2013), in which there is little point in occluding the prime, or making
it brief. Environmental and organizational priming research, for example, has contributed to a
choice architecture (e.g., design that supports the decisions or choices being made in a particular
context), that leverages the environment––including web design––for marketing purposes or
health and well-being choice promotion (Thorndike et al., 2012; Shafir et al., 2012; Thaler et al.,
2012).
The effects extend to healthcare architecture. For example, when abstract art was
replaced with photographic art, there was a significant reduction in white coat hypertension
(Harper et al., 2017; Hollands, 2016). Therefore, the distinction between the two types of
priming––subliminal and supraliminal, as described above––has become blurred, and subliminal
is frequently used in both contexts. As a result, many advocate that research “on implicit
conditioning should be expanded and diversified,” by more inclusive classification of
“physiological processes into being either conscious or unconscious” (Brascher et al., 2016,
Significance of Classical Conditioning, para 4).
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Conflicting definitions and standards are indicative of the recent emergence of health
priming and the lack of an established framework to contextualize appropriate terms and
conditions according to the category, or goal, of the research. In fact, some environmental health
priming research is not even referenced as priming (Thorndike et al., 2012), perhaps due to the
associated arguments. Yet, studies using a variety of health-related primes, both explicit (i.e.,
indicating that one is aware of either the nature of the research or of the potential effects of the
prime) and implicit, have documented effects on blood pressure, blood sugar, and even memory
(Wegesin et al., 2004). In health priming, therefore, such distinctions may hold less relevance
than in other sectors such as experimental and applied psychology.
Bearing this out, Friedman (201) explains that environmental cues can help achieve a
synchronous alignment between conscious and unconscious motivation, for greater effect. In
fact, multiple studies show that by deliberately increasing the strength of a prime at the conscious
level, attitude, and performance improved, exceeding subliminal priming, conscious attitudinal,
and goal setting (Friedman, 2013; Moskowitz, 2009). Similarly, in some cases conscious and
unconscious primes have demonstrated “identical perceptual strength . . . but the effects for
conscious trials were significantly stronger” (Bussche et al., 2013, p. 1). By way of example, in
research on social anxiety, only individuals consciously aware of the prime benefited from the
intervention (Maoz et al., 2013). In another investigation, null results were found when priming
was subliminally presented, but not when consciously presented (Akram et al., 2018). Papies
(2016) argues that the emphasis in priming should simply be on processes other than those
requiring an intentional focus, regardless of whether one is aware of the prime or not.
Two more conceptual conflicts must be acknowledged briefly before concluding this
section. When defining top-down processing in the previous section, it was assumed that the
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term was consistently used in the same way by all; when, in fact, this too, represents a revolving
door depending on the researcher. Gaspelin and Luck (2017) complain about the inconsistency of
critical terminology within priming research, noting that top-down mechanisms (i.e., responses
conditioned by context, experience, and expectations) have been conflated with voluntary or
intentional, and even volitional. Sheeran et al. conflate these ideas in precisely this manner,
stating that bottom-up processing can lead to relatively effortless, “automatic bottom-up control”
(Sheeran et al., 2013, p. 462). Since the literature references ‘automatic’ processing both ways
(top-down and bottom-up) it:
highlights a broad problem in attention capture [i.e., priming] research: The terms used to
describe attentional control are often poorly defined, and much current debate seems to
be related to the meaning of words. To move forward . . . we must agree on what terms
such as ‘top-down’ and ‘bottom-up’ actually mean. (Gaspelin & Luck, 2018, p. 1)
Using an analogy of the color blue, Gaspelin and Luck (2018) argue that if two groups
disagree on what the color means the debate will continue forever until a common definition of
blue is agreed upon. It was tempting to overlook the debate entirely; the author of this paper
found conflicting definitions, and multiple instances of the terms being used in contrary contexts,
but as the two constructs (top-down and bottom-up processing––referring most often to sensory
input) are so commonly referenced in psychological priming investigations, inclusion is
warranted. However, since the terms seldom appear in psychobiological investigations, and
rather than burden this paper unnecessarily, they will not be referenced further. The point at hand
is the consensus that––whatever the phrase––priming is a response of automaticity, requiring less
conscious processing than strictly cognitive methods.
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A final point of dissention is that not all researchers agree that “implicit measures reveal
the same processes,” (Blair et al., 2001, Discussion of Experiments 4 and 5, para. 3). Put another
way, while research on nonconscious processing has taken on significant importance and made
great gains, the mechanisms involved in implicit and explicit processing are debated. Sheeran et
al. (2013) argue that the time and energy lost in debate could better focus on interventions
targeting implicit processes to “maximize behavior change efforts” (p. 468), concluding that
implicit attitudes are important predictors of health behaviors and should be investigated as
interventions. In line with Sheeran et al. (2013), Shashkevich (2017) posits that the focus should
be on interventions, that “deliberately harness [the prime, or the placebo effect] to improve
health care” (para. 5).
Therefore, studying the effects of explicit and implicit primes, in tandem with any
placebo elements (discussed in the following section), is well within the bounds of clinical
research aiming for a therapeutic application. With that in mind, this paper rests from further
references to problematic terminology. So, it stands: a call for clarity among researchers, and
across disciplines, would do much to advance the field and the interpretation of results. In the
meantime, dissecting the meaning of key terms prior to evaluating a stated conclusion in priming
research is critical.
In sum, Hollands et al. (2013) argue that the lack of conceptual clarity, as indicated
throughout this section, is a limiting factor in advancing priming research. To study the impact of
priming on physical health and concomitant well-being a researcher must bridge, not only the
varying vocabulary of different disciplines, but also reach beneath the surface to comprehend the
various ways researchers, often within the same field, use key concepts, which affect
interpretation. What researchers appear to agree on, though, is the power of priming, in that,
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“once activated, a primed goal operates like a conscious goal” (Friedman, 2013, p. 549).
Harnessing that potential are studies documenting physiological change in response to
environmental cues, both explicit and implicit. Rather than argue for definitions the focus is to
investigate priming’s effects on physical health, attitudes, and well-being. Therefore, unless
otherwise indicated, priming refers to the implicit or explicit utilization of primes, whether one is
aware of the effects, be it attitudinal, behavioral, or physiological.
Since gains in priming research have been slow to trickle down into the
psychophysiological model, only recently gaining traction in the health sciences (Elgendi et al.,
2018), the intersection of priming and health can be explored via the placebo response, covered
in the next section.
Placebo and Nocebo: To Deceive or Not to Deceive
While priming in psychological research, as mentioned in the previous section, can
involve eye tracking and electroencephalogram (EEG), in medical arenas functional magnetic
resonance imaging (fMRI), positron emission tomography (PET), serological measures, and
neural imaging studies, to name a few, investigate the placebo effect. A placebo is a chemically
inactive mechanism––which includes beliefs such as the meaning an individual ascribes to their
illness as well as the social context––that produce measurable, physiological change (Eaves et
al., 2016; Shashkevich, 2017). Likewise, the nocebo effect can be elicited when a
disadvantageous process or outcome is suggested which produces a measurable change for the
worse (Phillips & Pagnini, 2016).
Most often, both the positive and negative effects are collectively termed placebo.
Placebo responses “are catalyzed by and pertain to a broad range of human experience, from
changes in the meaning an individual ascribes to their illness to evolutionarily patterned and
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deeply embodied responses to conditioned action (such as the taking of a pill),” (Eaves et al.,
2016, p. 2). Their power is so well-documented that famed placebo researcher, Fabrizio
Benedetti, writes:
Placebos are not inert substances, as thus far believed. They are made of words and
rituals, symbols, and meanings, and all these elements are active in shaping the patient’s
brain . . . The placebo [is the] administration within a set of sensory and social stimuli
that tell the patient that a beneficial treatment is being given. (Benedetti et al., 2011, p.
339)
In a biomedical context, priming and placebo research are two parts of the same whole,
and research can include both overlapping constructs in various applications (Rosen et al., 2017).
Due to the general separation of psychological and medical research, however, placebo research
is seldom integrated in psychological priming studies. Yet, this psychobiological phenomenon is
inclusive of words, symbols, beliefs and other recognized primes. Crum et al. (2017) argue that
in everyday medical practice psychological forces of healing––which by definition include
environmental cues––underlie virtually every treatment effect.
Consider, for example, Parkinson’s disease. In Benedetti’s lab at the University of Turin,
when a patient is primed with an active pharmaceutical that is then withdrawn, and substituted
with saline (i.e., placebo), the treatment response is equally effective (Benedetti et al., 2011).
Typically, such investigations are geared toward establishing a purely psychological disposition,
or isolating the results of a medication; therefore, placebo related effects need to be as controlled
as possible. Thus, the goal in most medical research is to correct for the placebo effect, as in
most psychological research it is to obscure the prime.
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This poses a tangle for health priming research. Sliwinski and Elkins (2013) argue that,
although research studies attempt to minimize placebo and/or priming effects, “in clinical
practice there may be significant benefits in enhancing placebo effects” (p. 1). This recognition
reflects a dichotomy in health priming for two reasons. For one, most of the priming/placebo
literature reflects research rather than a clinical perspective; and second, deception in clinical
practice is unethical. Standard disclosure and consent forms, required in research with human
subjects, can pose unique problems, as well. Priming researcher, Ellen Langer, for example,
often couples an implied salutary effect (i.e., placebo)––or even a nocebo effect in some cases––
with an explicit or implicit prime for added effect (Fatemi, 2016; Payne et al., 2016). Yet,
verbiage on a consent form can be a double-edged sword. Langer argues that when subjects sign
a form acknowledging, for example, that there are no known benefits from participating in a
particular research project, it is, in effect a nocebo (Gierson, 2014).
So, is deception necessary in placebo research? Benedetti (2016) argues that the placebo
effect demands unconscious or subliminal buy-in to be effective, as opposed to willful and
intentional usage. Others disagree. Based on numerous investigations, Sliwinski and Elkins
(2013) contend that a placebo, or nocebo effect, can be achieved without deception. Recent
research has explored the potential for placebos in reducing the required dose of a medication––
lowering costs and inhibiting harmful side effects (Doering & Rief, 2012). Through a
conditioned response, placebo-controlled dose reduction (PCDR), also termed dose-extending
placebos, subjects have successfully been able to significantly reduce prescription medication
when knowingly alternating a placebo with the active medication. Results have been impressive:
reducing immunosuppressants in renal transplant (Kirchhof et al., 2018), and successfully
reducing opioids by utilizing “open-label dose-extending placebos” (Belcher et al., 2019,
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Abstract, para. 1). In view of compelling evidence, Colloca and Howick (2018) argue that not
only is deception unnecessary to produce effects, but that “at least some of the ethical barriers to
their clinical use [can be bypassed] . . . Future large scale, pragmatic trials should investigate the
potential of open-label and dose-extending placebos to improve outcomes and reduce side
effects” (p. 15).
Crum et al. argue that while a randomized clinical trial is considered the gold standard in
medicine, what the current model:
obscures is that, in the practice of medicine, the psychological and social elements
underlying placebo effects remain an influence in active treatment. Indeed, medical
diagnoses and treatments are never isolated from patient mindsets . . . Rather than being
incidental to treatment, these psychological and social elements play crucial roles in
determining clinical outcomes. (Crum, 2017, p. 1)
Likewise, placebo researcher, Kaptchuk, finds a placebo does not have to be delivered
below the threshold of awareness to have an effect, and is operational in patient encounters,
knowingly or unknowingly (Feinberg, 2013). The suggestive implications in hypnosis and
guided imagery, when aligned with a patient’s purpose or goal, are considered by some to be a
type of nondeceptive placebo (2013). Contextual effects, then, need not be entirely unconscious
to be effective (Kaplan & Epstein, 2012).
An example like PCDR, above, speaks to the potential value of marrying a conscious
goal to a prime, in a deliberate, intentional way. Although perhaps rare in research circles, the
idea of coupling a prime and a conscious goal may hold health benefits. Even Benedetti
acknowledges that the study of the “placebo effect can actually be viewed as a melting pot of
concepts and ideas for neuroscience. Indeed, there exists not a single but many placebo effects,
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with different mechanisms and in different systems, medical conditions, and therapeutic
interventions” (Benedetti et al., 2011, p. 1).
Widening the net may capture more therapeutic benefits, expanding the practical
application of priming and placebo with “far reaching consequences for health and well-being”
(Fatemi, 2016, p. xix). Likewise, Sliwinski and Elkins (2013) argue that “if treatment outcomes
are improved due to placebo effects, then it is in the client’s best interest if his or her therapist
attempts to maximize these effects” (p. 3). Although the fabric of our medical system is threaded
with Cartesian dualism, the call for a more integrated approach “to health that merges our
thoughts and emotions, [through] . . . context is paramount, in particular for its priming effect”
(Phillips & Pagnini, 2016, p. 174). Unfortunately, placebo research is seldom referenced in
priming literature, which reduces the health priming knowledge base––if such a thing existed––
considerably.
The sources cited in this section explore the connections between priming and placebo
research, as related to health, in conditioned responses. While the mechanism behind the effects
may be debated, their power is not. Throughout the literature, placebo is used just like a prime––
knowingly and unknowingly, consciously, and non-consciously––depending upon the preference
of the researcher, and the goal of the study. Although correcting for the prime (i.e., placebo)
might be standard procedure, it may not be necessary in investigations designed for clinical
application (Crum, 2017). While this paper does not attempt to discuss the complexities of
placebo research, it acknowledges the limited scope pertaining to clinical use. With that in mind,
a cueing intervention is gaining traction in both research and clinical practice that may open
unique opportunities for health priming research. This will be considered in the following
section.
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Attention Bias Modification
When introducing the question of priming and its potential impact on health and wellbeing, this paper emphasized that an individual’s response to a prime or placebo was dependent
on the goal or desire of the person (Cristea et al., 2016). Meta-analyses underscore the value of a
personalized approach, “revealing stronger behavior priming effects when the primes correspond
to an important or currently active goal of the individual” (Bargh, 2016, p. 49; Friedman, 2013).
A spate of recent findings in models that seek to retrain implicit responses (i.e., ingrained
habitual responses) to achieve an active goal, are intriguing.
Of these, Attention Bias Modification (ABM), based on principles of operant
conditioning, holds potential for health goals and behavior. Attention biases have been described
as unconscious processes that cause individuals to automatically focus their attention on certain
cues in their environment (Zhang et al., 2018). Techniques using environmental cueing or
priming to inhibit temptation, or strengthen a long-term goal, consciously or unconsciously, have
been referred to as ABM (Moskowitz, 2009; Wryobeck & Chen, 2003; Papies, 2016; Sheeran et
al., 2013).
The treatment goal in ABM is to affect implicit cognition by reducing one’s attention to
an alluring, but undesirable stimulus, thereby weakening a previously conditioned response
(Sheeran et al., 2013). This is believed to occur by “attempting to change which cognitive
structures get activated by specific situations” (Papies, 2016, p. 9), and by improving working
memory, a construct that refers to executive abilities, semantic access, and cognitive control
functions (Sheeran et al., 2013). In addictions, for example, an undesirable stimulus can harness
one’s attention, increasing the likelihood of succumbing (Field et al., 2014). In disrupting the
automatic focus, meta-analyses have found ABM to be effective in the treatment of substance
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disorders (Cristea et al., 2016), dietary change (Zhang et al., 2018), insomnia (Akram et al.,
2018), and sleep quality (Milkins et al., 2016); while similar methods are reportedly used to
boost measures of mood, quality of life, as well as strength and stamina in aging (Akram et al.,
2018; Lancee et al., 2017).
To illustrate, not long after reading a journal article on ABM, a client contacted me for
help with alcohol use after his oncologist warned that it would inhibit the efficacy of
chemotherapy. Aside from some binge drinking in college, Mark did not over drink. But since
his doctor’s prohibition, alcohol use increased. Each day he and his wife would have one last
drink before pouring the remainder down the sink. The next day, Mark would drive to the liquor
store for another “last drink,” and the cycle continued.
After discussing ABM methods, a series of cues were devised to interrupt the pattern. For
example, in the front seat of his car, where he would put the liquor, Mark placed a copy of his
favorite inspirational biography. On the island in the kitchen, where the bottle was typically set,
he added a flowering plant. Mark also purchased new glassware to be used only for sparkling
water, or nonalcoholic beverage. In the pantry, below eye level, he pasted a magazine picture of
a very ill elderly man and added a picture of a wine bottle. At eye level, he placed a picture of a
healthy figure running on the beach and to this was added an appealing photo of sparkling water.
Other ABM examples considered were red and green dots––since we are culturally conditioned
to respond to red (i.e., stop) and green (i.e., go), to attach to desirable and undesirable substances
(Thorndike et al., 2012). Mark felt this was unnecessary since the sparkling water was already in
a green bottle, and he no longer had alcohol in the house. Other adjustments were made to his
routine, but these illustrate how Mark’s goal was coupled with explicit priming. The first week
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after making these adjustments he only purchased and drank alcohol on two occasions. Twomonths later he reported he had only imbibed three or four times on social occasions.
Admittedly, this is a simple case, but it speaks to the topic question in interesting ways. It
appears that Mark’s motivation, and personal participation in the ABM process, were key factors
in his success. In sophisticated ABM investigations the prime is often obscured, as in
computerized models, but research in clinical application is less common. That Mark’s
collaboration on the cueing would be considered explicit does not change the fact that, once in
place, the symbols chosen “require[d] minimal conscious engagement” (Holland et al., 2016,
Discussion, para. 2). Since goals and motivations are indicators of what we notice or pay
attention to in any given environment, not everyone would be expected to respond similarly to
the same stimulus, and so a self-selection process seems reasonable (Bargh, 2016). Although
Field et al. (2014) found insufficient evidence to use ABM in addiction, others disagree. For
example, after reviewing:
several attentional bias programs, including the alcohol attention control training program
. . . [Cox et al] reported that the attention bias program is efficacious for re-training
attentional bias, reducing craving, and enhancing self-efficacy and perceived self-control
in a sample of harmful drinkers. (Zhang et al., 2018, pp. 1-2)
Papies (2016) posits that priming via ABM can be suitable for larger scale applications
within communities, such as grocery stores and markets, “to improve the nonconscious
regulation of health behavior” (p. 6). Although not termed “ABM,” a choice architecture study at
Massachusetts General Hospital, red and green labels were attached to healthy and non-healthy
foods, prompting a significant uptick in the consumption of healthy food (Thorndike et al.,
2012). The effects extend to health architecture, including hospital design which has been shown
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to influence patient outcome including recovery rates (Rappleye, 2017). Might similar
strategies––art and design––be employed in the homes of individuals recovering from surgery, or
those with chronic conditions? Although there is a growing body of evidence supporting health
architecture, a search did not uncover similar research-based findings for home use, which could
be pursued in another project.
Without arguing for large scale applications, Bargh (2016) contends that the effectiveness
of priming interventions depend upon which goals and outcomes are important to the individual
(2016). By way of example, in one investigation, individuals who felt their self-worth threatened
by certain primes––feeling shamed by negative messaging around weight or diet––were able to
ignore the prime toward healthy eating. Later, these individuals, when primed via compassion
meditation, responded more positively––without shame––to health behavior messaging (Kang et
al., 2018). Although the authors conclude that meditation training, as a conditioning process, can
affect attitude and subsequently behavior, Sheeran et al. (2012) reports that many findings in
attentional bias related to behavioral change are suggestive rather than conclusive, but its effect
on implicit motivation is pronounced. In either case, the suggestion that motivation can be
impacted by priming is key, which may offer a less effortful path to desired change.
Despite ABM documentation in anxiety, depression, and addiction research, “few studies
have assessed the impact of evaluative conditioning [used in ABM] on health-related attitudes
and behavior” (Sheeran et al., p. 463). Further, considering the lack of cross-sectional dialogue
among disciplines, it would be challenging to make a comprehensive assessment. For example,
placebo work and investigations in choice architecture (Thorndike et al., 2012) do not appear to
be referenced in ABM literature––and ABM literature is not necessarily included in priming or
placebo––likely due to variations in terms, and long-standing disciplinary divisions.
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In concluding this discussion, weighted evidence suggests that the methodology can be
effective in promoting implicit motivation in health behaviors, most notably when the prime
supports a valued goal. Given “that situational cues play a crucial role in health behaviour”
(Papies, 2016, p. 4), ABM offers untapped potential for future research. Although priming
interventions have been shown to influence mindsets (e.g., attitudes), none of these studies
appear to be included in the priming meta-analyses covered thus far. With that in mind, the
following section explores how mindset functions as placebo––a potent medicinal prime.
Mindset As Medicine
Positive traits and states (i.e., inclusive of mindsets) associated with greater overall health
and lower all-cause mortality are not fixed in time, but malleable (DuPont, 2020), shown to
impact decision making and activate health goals (Sheeran et al., 2013). The downstream effects
of mindsets on well-being and physical health (Van Tongeren & Burnette, 2018; Levy, 2009),
has recently captivated the attention of researchers and lay persons alike.
Simply put, mindsets incorporate beliefs and “organize the way people ascribe meaning
to events” (Van Tongeren & Burnette, 2018, p. 101) which can be activated by subtle
environmental cues impacting outcome in medical treatment (Girgis et al., 2018; Savary et al.,
2014). Whether or not one’s beliefs are grounded in fact has little bearing on the physiological
effects. Crum & Zuckerman (2017) argue that beliefs or mindsets:
are not inconsequential . . . [but] . . . profoundly affect health and well-being . . .
Research shows that mindset or expectations to heal, similar to placebos, can trigger
specific neurobiological correlates including the immune, cardiovascular, and
neuroendocrine systems. In fact, placebos are driven in large part by the mindset that the
pill is effective. Although less widely studied growth mindsets are also proving to be
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critical in health care. In one study involving . . . adolescents with type 1 diabetes, those
who believed that their health could be changed had lower mean hemoglobin A1C . . .
[While more] research is needed, what is clear is that instilling a growth mindset in
patients about their belief in the capacity to change is an important precursor to health
and healing . . . (p. 1)
For good or for ill, expectations about health have been found to be “self-fulfilling
prophecies” (Levy, 2009, p. 334). Considering that priming cuts both ways––as in the placebo
and nocebo effect discussed previously––effects can be pronounced. For example, when
participants rated a series of health-related words, they later reported an increased number of
health problems (Bargh & Chartrand, 2000). In another cueing study, when participants were
instructed to develop colds while primed with videos of people sneezing and coughing laboratory
evidence indicated immune system activation as typically seen in a viral pattern, although no
virus had been introduced (Fatemi, 2016). And recently, the act of DNA testing alone elicited a
nocebo effect, inducing physiological change (Lynam, 2018). Since placebo can be a “device for
changing mindsets” (Phillips & Pagnini, 2016, p. 179), there is reason to promote placebo-driven
primes that allow people to influence the “context of their own illness” (p. 179).
In testament to these findings, a longitudinal clinical trial at Stanford University (2020) is
currently recruiting patients to investigate the effect of mindset on cancer (Zion et al. 2019).
Developing evidence-based strategies to facilitate a constructive view of a medical condition
could be lifesaving. Petrie et al. (2018) explain that:
[t]he patient’s illness model strongly influences how the individual copes with his or her
condition and studies have shown that illness perceptions are related to a range [of] health
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outcomes, including functioning, the use of health care, adherence to treatment, and even
mortality. (p. 37)
That mindsets can affect physiological processes is intriguing, but that such appear
malleable, argues for targeted interventions aimed at instilling adaptive mindsets (Zion, 2019)
and overturning harmful stereotypes. By way of example, Crum et al. (2013) found associated
physical effects based on whether one believed stress to be enhancing or debilitating. Similarly,
Van Tongeren and Burnette (2018) note that positive mindsets could be cultivated with attendant
improvements in well-being, concomitant to physical health.
Belief systems “therefore may be strengthened or minimized, by the patient’s broader
mindsets about the nature of health and his or her ability and efficacy to change” (Crum &
Zuckerman, 2017, p. 1). An interesting example can be found in a randomized, double-blind
study that used three different priming questionnaires when probing for pain in a chronic pain
population. Those answering a positively phrased questionnaire reported less functional
disability than either the neutral, or the negatively primed (Claessen et al., 2015).
Similarly, the riveting effects of catastrophic news and eye-popping headlines exerts its
own toll on mind and body. The widespread media coverage of the SARS-CoV2 pandemic is
concerning to health psychologists, as the amount and type of media exposure has been found to
operate as a prime, significantly impacting emotional well-being and physical health over time
(Garfin, Silver & Holman, 2020). Whether through subtle societal cues, or attention-grabbing
headlines, positive and negative primes have been shown to reduce and increase anxiety,
respectively (Gibbons, 2009).
Likewise, when highly stressed individuals were primed with information about the
upside of stress––such as “stress is energizing”––both immunity and cognitive function
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improved (Crum & Zuckerman, 2017). The opportunity to reduce stress and/or depression via
priming may have far reaching effects on health. Some of the most well-publicized priming
research, geared toward health and well-being, is led by Ellen Langer, revealing that even “small
increases in control of one’s surroundings [are] associated with increases in longevity” (Fatemi,
2016, p. xviii). Novel approaches to priming, instituted by Langer, have been shown to influence
biomarkers such as weight, blood sugar, viral loading, and visual acuity. For example, in Type 2
diabetes, manipulating the perception of time––by using clocks that ran either fast or slow while
participants completed simple tasks––found that blood sugar levels follow perceived rather than
actual time (Grierson, 2014; Park et al., 2016).
In one creative investigation, overweight chambermaids instructed to interpret their work
as “exercise” rather than “labor,” not only lost weight but blood pressure dropped an average of
ten percent; while the control group––who were not primed––had no change (Crum & Langer,
2007; Crum & Liebowitz, 2017; Spiegel, 2008). All of which suggests that manipulating the
“context of a situation may supply much promise to maintaining and improving our health”
(Phillips & Pagnini, p. 173):
Although more research is needed on the value and limitations of such mindsets for
specific diseases, what is clear is that simply being more thoughtful about the words used
in diagnoses and recommendations may be just as important as the treatment delivered.
(Crum & Zuckerman, 2017, p. 1)
As promising as such evidence may be, Hollands et al. (2016) argue that while
interventions targeting non-conscious processes may be more effective than conscious methods
in changing health behavior, they remain largely untested due to the “lack of a practicable
conceptual framework that can be applied to better describe and assess these interventions”
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(Abstract). Arguing for more than a conceptual framework, Papies champions a paradigm shift.
Contending that low compliance in achieving health related goals, “points to significant
nonintentional influences on behavior,” she advocates retiring the theory of planned behavior
altogether in order “to increase the focus on automatic processes” (Papies, 2016, p. 3).
While it is beyond the scope of this paper to discuss the mechanisms involved––
particularly, as new findings continue to be debated (Dionigi, 2015; Levy, 2009), this section
addressed the research project directly by reviewing the downstream effects of mindsets.
Although more research is needed, the cited literature illustrates how mindsets, and/or placebo,
function as primes, promoting or hindering physical health and well-being.
These concepts are broadly applicable throughout the lifespan. Although aging is not a
disease, Niraula et al. (2017) contend that an increase in lifespan is insufficient unless
accompanied by good health. Therefore, the next section offers an overview of priming effects
related to aging.
Embodied Stereotypes in Health & Aging
The measurable effects of mindset on aging are illustrated in multiple investigations
linking primes to healthier food selection and an increase in exercise (Hine & Tsushima, 2018;
Hollands et al., 2016). As discussed in the previous section, mindsets or stereotypes can be
reinforced throughout life, assimilated unconsciously and “activated automatically by subtle
contextual cues” (Marques et al., 2014, p. 399). Particularly compelling is a spate of research
linking attitude more strongly to longevity than any other factor (McLachlan, 2020). Functional
and serological measures––once considered to be influenced only by physical interventions such
as diet and exercise and set apart from attitudes and beliefs––reveal the direct effects of subtle
attitudes and beliefs on biomarkers of aging (Phillips & Pagnini, 2016).
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Of these subtle influences, self-perception (i.e., self-concept) has been shown to have a
measurable effect on the aging process. In a study of more than a thousand individuals, strong
correlations were found between negative self-perceptions of aging and poor physical health
(Sargent-Cox et al., 2012). Meta-analyses reveal that negative age stereotypes are associated
with a decline in physical function and health (Levy et al., 2012; Levy, 2009; Levy, Slade &
Kasl, 2002; Meisner, 2012). In a review of the literature, Levy et al. (2018) conclude that
“considerable research has found that positive age beliefs predict better cognitive performance,
whereas negative age beliefs predict worse cognitive performance” (Introduction, para. 2).
As witnessed thus far, terms such as beliefs, self-perception, mindset, and stereotypes are
used somewhat interchangeably depending on the context, disciplinary division, and preference
of the researcher. When stereotypes become embodied, they are knowingly or unknowingly
applied to oneself as self-perceptions that can predict functional health over time (Levy et al.,
2000; Levy, 2009; Sargent-Cox et al., 2012). Emphasizing the impact of priming, these implicit
expectations are believed to operate psychologically, behaviorally, and physiologically (Levy,
2009). Although seemingly subtle, such embedded mindsets have been found to have profound
effects, directly impacting even the will to live (Marques et al., 2014). Negative age stereotyping
can unknowingly (i.e., non-consciously) develop when young, contributing to a significant
elevation of cardiovascular events in following decades (Levy et al., 2009). Levy et al. (2014)
explain:
when individuals recognize through environmental cues that they have entered old-age,
the age stereotypes that were applied to others acquire personal resonance, and thus
become self-perceptions of aging, which can be activated by subsequent exposure to
these cues; in turn, physical outcomes can then be impacted. (p. 4)
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It appears, then, that “when older individuals apply negative age stereotypes to
themselves, they can adversely influence a wide range of outcomes” (Levy et al., 2009, p. 1).
Negative age beliefs may lead to a higher subjective age, which has been shown to correlate with
cognitive impairments and even dementia (Stephan et al., 2018). Such negative self-concepts
may result in chronic activation of the autonomic nervous system with far-reaching effects
including morbidity and mortality (Levy et al., 2000; 2009; Moser et al., 2011):
Mounting evidence points to a causal link between the primed profile of the aged brain
and vulnerability to secondary insults, including infections and psychological stress.
Conversely, psychological stress may also induce aging-like sensitization of microglia
and increase reactivity to secondary challenges. (Niraula et al., 2017, p. 1)
Adding to the weight of evidence, a meta-analysis revealed that negative priming affected
health behaviors of older individuals (Meisner, 2012). When faced with a health threat, the belief
that aging is associated with physical losses reduced health supporting behaviors (Wurm, et al.,
2013).
Turning to positive expectations, Wurm et al. (2013) cite a cluster of studies that strongly
associate positive self-perceptions with health and life satisfaction. A positive age mindset has
been shown to promote longevity and have a protective effect on multiple physiological factors
including the cardiovascular stress response and recovery from severe disability (Levy et al.,
2014; Levy et al., 2012; Levy et al., 2009). Longitudinal data from three studies following nearly
13,000 people for 20 years found a lower subjective age to be correlated to increased lifespan
(Stephen et al., 2018). Specifically, positive self-beliefs associated with the aging process have
been found to promote memory (Wryobeck & Chen, 2003) and protect against dementia, even
among carriers of the APOE4 gene variant associated with an increased risk of Alzheimer’s
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disease (Levy et al., 2018). So compelling are the findings, researchers concluded that negative
age beliefs are an independent risk factor for dementia (Levy, et al., 2019).
Once embedded, though, are negative age beliefs malleable? To answer that question,
using pre-and post-physical and psychological measures, Levy et al. (2014) primed one-hundred
older individuals with either positive or negative age-related concepts over a period of several
weeks. Utilizing a masked intervention (i.e., words flashed below the threshold of awareness,
such as spry, wise or frail) and mental imagery (e.g., imagine a healthy senior), among those
positively primed, not only did their self-perception of aging improve significantly, but the
measurable gains in physical function––strength, gait, balance, speed of walking––were greater
than “the outcome of a six-month exercise program” (2014, pp. 11, 12).
Explicit priming was also effective. An intriguing series of studies demonstrate that
mental imagery (i.e., a willful and intentional process) was effective in altering implicit gender
stereotypes (Blair et al., 2001). Subsequently, Levy et al. (2014) successfully applied the method
to overturning age-related biases. Addressing the potential, further investigations support the
claim that the harmful effects of negative age stereotyping can be overcome––and survival
outcomes improved––by subtly priming one’s environment (Marques et al., 2014). As a result,
Pagnini et al. (2019) argue that aging can be, at least partially, mentally construed.
For example, when the environment of seniors was primed to recollect a time of vitality
and effectiveness, vision, hearing, and cognitive function improved. Conversely, a negative
correlation was found among those who remained fixated on the past and longevity (Fatemi,
2016). Pagnini et al. (2019) emphasize the importance of studies like these that promote:
a change in perspective about ageing, from the narrow biomedical perspective to a more
open and mindful idea based on the psychology of possibility, [which] can actually

CAN HOPE BE PRIMED IN CHRONIC PAIN

64

improve older adults’ well-being. Challenging the dominant biomedical view, and
properly communicating it through various channels, will lead to change mindsets and
stereotypes related to the ageing condition. (p. 7)
Contrary to the prevailing biomedical model, aging does not appear to follow a fixed,
linear path, but operates as a multifaceted dynamic responsive to priming. Unfortunately, when it
comes to priming, as in life, susceptibility to the negativity bias (i.e., a survival mechanism that
promotes attention to danger, or negativity) appears to be pronounced. Attention toward words,
symbols, or images, even when subliminally presented, appears weighted toward the negative
(Nasrallah et al., 2009). If such findings can be generalized, it presents a worrisome prospect
considering the bias in certain societies toward aging and argues for more research on how to
efficiently overcome socio-culturally entrenched beliefs. It is noteworthy that the average age of
chronic pain participants in the study reviewed in this paper was 45-54, an age where
counteracting the downstream effects of hopelessness can be pivotal.
Criticism in the arena of mindset and aging most notably appears in reference to a famous
study, in which participants, after being negatively primed to age stereotypes, walked slower
when exiting the laboratory (Bargh et al., 1996). In an attempt to replicate the original findings,
Doyen and Klein (2012) noted the same slow pace after being negatively primed––but only when
experimenters believed participants would walk slower. The authors suggest:
that both priming and experimenters' expectations are instrumental in explaining the
walking speed effect. Further, debriefing was suggestive of awareness of the primes. We
conclude that unconscious behavioral priming is real, while real, involves mechanisms
different from those typically assumed to cause the effect. (Abstract section, para. 1)
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Aside from the intriguing response to researchers’ expectations, Doyen and Klein’s
(2012) investigation illustrates that there is little debate among experts as to whether priming is
“real,” but the contention is on the mechanisms involved. Their concluding statements (2012)
regarding whether there was an awareness of the prime, harks back to arguments as to what
constitutes subliminal priming. Studies like Doyen and Klein’s (2012) shine a light on the
purpose of most priming research: exploring the influence of the subconscious (i.e.,
distinguishing effects below the threshold of awareness) and the mechanics of priming––rather
than exploring methods in clinical application which is a primary focus of the study presented in
this dissertation.
Nevertheless, Doyen and Klein’s (2012) conclusion indicates that mindset priming can be
effective even when one is aware of the prime. Three brief examples bear this out. When groups
were implicitly and explicitly primed with positive age stereotypes, Levy et al. (2014) found the
most notable improvement in the implicitly primed group. Likewise, in a randomized trial
statistically significant improvements in physical function and positive self-perception of aging
were achieved through both implicit and explicit priming, but the effect of implicit priming was
greater (2014). On the other hand, when comparing subliminal (i.e., below the threshold of
awareness) with spoken or written words in influencing behavior, Falk et al. (2010; 2011) found
the explicit method (e.g., spoken or written) to be more effective.
Considering the evidence, priming offers untapped potential to assist an aging population,
but there is a considerable need for intervention studies “to support effective strategy use in older
adults with serious illness” (Wurm et al., 2013, p. 1088). Successful studies of this nature are
often conducted in institutional environments or costly specialized settings (Pagnini, et al.,
2019). Even Langer’s most compelling health priming interventions involved secluding
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participants in a completely different environment for at least several days and is not easily
replicated (Baltzell & McCarthy, 2016). The paucity of research employing feasible priming
methods in aging is surprising yet points to the need for studies like the one presented in this
paper (Wegesin et al., 2004).
In summary, a reduction in birth rates in Western cultures and an increased lifespan has
contributed to a rising elderly population with “significant health and socio-economic
implications” (Niraula et al., 2017, p. 2). There is, therefore, a critical need for interventions that
contribute to active aging, and increased functionality. Since negative self-perception of aging is
a risk factor in morbidity and mortality, this section examined how such embodied stereotypes,
or mindsets, can be disentangled via subtle cognitive manipulations, with attending physical
gains.
The average age of chronic pain participants in this study was 45-54, indicating the need
for priming methods that attenuate states such as hopelessness, that contribute to comorbidities in
a middle-aged population. Further research, investigating methods designed to increase agency
and positive self-perception, is warranted (Moser et al., 2011). The challenges and the
opportunities therein, are discussed in the concluding paragraphs.
Conclusion
Lasting behavioral change requires evidence-based interventions that foster a change of
implicit evaluations (Vanalest et al., 2016). Of these, priming has emerged as a dynamic
intervention to recalibrate implicit attitudes and activate health goals (2016; Papies, 2016).
Although the downstream effects (i.e., physiological enhancements) of positive mindsets and
self-efficacy beliefs are well-documented, there is a great need for studies with a clinical
application (Sheeran et al., 2013).

CAN HOPE BE PRIMED IN CHRONIC PAIN

67

However, given the sectarian nature of health priming research, a cross-sectional review
is challenging, but necessary to advance clinical application. Even in the face of robust findings
results are not widely distributed across disciplines. For example, Harvard University’s choice
architecture study (Thorndike et al., 2012) utilized standard ABM priming methods, but it is not
classified as such, nor does choice architecture appear in ABM searches. Likewise, there is little
placebo work in priming research, no doubt due to its biomedical foundations. And vice versa.
As a result, important findings are stacked into discrete silos, laden by defining debates within
disciplines. The net effect is a reduction of the fullness of a remarkable field of opportunity.
Cross-sectional dialogue is further hampered by the absence of an overarching rubric, and
a central, unified (i.e., standardized) vocabulary tying research sectors together. Without such an
integrated framework, the field of health priming could flounder. Indeed, it is hard to imagine
any field of discovery gaining significant traction without a standardized vocabulary. Should
such a framework be established, and definitions be ratified, cross-categorical research could be
integrated across disciplines permitting the field to flourish.
It is perhaps for these very reasons that the “effect of primes (i.e., incidental cues) on
human behavior has become controversial” (Payne et al., 2016, p. 1269). The need for larger
sample sizes is an ongoing criticism of social psychology’s research, including that on primes
(Freedland, 2020). While well-founded in some cases, it should be noted that due to disciplinary
divisions, such conclusions do not appear to take into consideration the wide body of placebo
work (e.g., PCDR), choice architecture (Shafir et al., 2012), as well as mindset, and attitudinal
investigations spanning continents and decades (Levy, 2009). No doubt the wide variations in
terminology, and lack of cohesion among research circles, are challenges to an inclusive,
interdisciplinary analysis.
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While it is beyond the scope of this chapter to debate these issues further, the consensus
of evidence across disciplines is that “automatic response triumphs over . . . conscious effort”
(Wryobeck & Chen, 2003, p. 106; Vanalest et al., 2016). Although the mechanisms are debated,
it is agreed that priming impacts health in profound ways (Sheeran et al., 2013). In the aggregate,
findings indicate that not only do expectations affect clinical results and physiology (Sliwinski &
Elkins, 2013; Friedman, 2013), but the subtle cueing of environmental features can measurably
impact “behavior, choices and actions” (Elgendi et al., 2018, p. 1). In sum, a “convergence of
study results describe how mindsets can affect the body” (Phillips & Pagnini, 2016, p. 179); so,
while various disciplines in psychology and medicine may differ over defining constructs, the
broader literature showcases the impact of nonconscious methods on health behavior with
striking physiological effects (Crum & Zuckerman, 2017; Papies, 2016).
In the high-stakes world of healthcare, priming can be a time saving and cost-effective
tool to advance well-being, as relatively small primes in one’s surroundings are associated with
health and longevity (Fatemi, 2016). Harnessing that potential is yet to be seen. Although our
understanding of nonconscious processes that affect beliefs and behavior “has strongly increased
over the past decades” (Papies, 2016, p. 2), authors in all sectors cite concern over the lack of
practical research for clinical use. Capitalizing on the untapped potential, Sheeran et al. (2013)
urge: “Research on nonconscious processes holds significant potential that can and should be
developed by health psychologists” (Conclusions section, para. 1).
How might this potential be realized? One possibility is through awareness––and choice.
Choice has been shown to be crucial to well-being (Fatemi, 2016), but one must first become
aware that there is a choice. Restoring the heuristic––the power of discovery––to the individual
by allowing them to explore their beliefs, and participate in constructing relevant primes, is one
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answer. But is it possible for individuals to achieve a more dynamic and flexible view of aging,
mindsets, and self-efficacy beliefs process by personally choosing, and utilizing subtle cues? The
available data from studies using conditioning (Wryobeck & Chen, 2003) and open-label placebo
(Belcher et al., 2019) suggest this may be the case. Scaffolding priming methods to promote
health, as in ABM, and using imagery to inculcate positive expectations and reduce harmful
stereotypes, are further methods to consider.
Since placebo can efficiently change mindsets, there is reason to promote placebo-driven
primes that allow people to become a “’guardian’ of one’s own health” (Phillips & Pagnini,
2016, p. 179). Although seemingly subtle, such embedded mindsets have been found to have
profound effects, directly impacting even the will to live (Marques et al., 2014). Therefore, Crum
and Zuckerman (2017) propose that priming methods be implemented at the primary care level
in all physician/patient interactions.
Scaffolding priming methods in healthcare can include visual, verbal, and written
materials. Brief exposure to a primed health questionnaire in a chronic pain sample, resulting in
an improvement in quality of life, suggests that it is possible and practical (Claessen et al., 2015).
Claessen et al.’s (2015) study, coupled with the strong need for clinical application, inspired this
research project. Further inspiration came from Long et al.’s (2020) longitudinal study on hope.
When related to agency, hope was associated with hypoalgesia, a reduced risk of chronic illness,
lower all-cause mortality (Long et al., 2020) and enhanced motivation (Jaremka et al., 2014).
Although “a positive attitude is probably the first step needed to engage individuals with
chronic musculoskeletal (MSK) pain in self-management strategies,” it is rarely researched in
clinical application (Rondon-Ramos et al., 2020, p. 2). In contrast, a hopeless or “malignant
mindset can cast a shadow over the lived experience of the patient” (Zion et al., 2019, p. 3),

CAN HOPE BE PRIMED IN CHRONIC PAIN

70

interfering in actively managing one’s own medical care and healthcare goals. But mindsets are
malleable with “significant downstream impacts” (Zion et al., 2019, p. 2). How, then, to
condition the actionable quality of hope, despite the psychological and social burden of chronic
pain? Likewise, it appears that hope, too, as related to agency, is seldom studied in chronic pain
(Eaves et al., 2016; France et al., 2020; Long et al., 2020), and there is little extant literature on
priming hope, particularly in chronic pain (Katsimigos et al., 2021).
To contribute to the literature, therefore, this investigation addressed the following:
Could a positively primed pain tutorial have a salutary effect on hope, as related to agency? In
other words, can hope be primed in chronic pain? Since pain is recognized “as a
multidimensional phenomenon that incorporates sensory, affective, behavioral, and physiological
levels that can all be accessed on aware and unaware levels” (Brascher et al., 2018, Significance
of Classical Conditioning, para. 4), does hope impact the perception of pain? Further, the trait of
stress-hardiness has been associated with greater resistance to illness but has been rarely studied
in trauma and pain (France et al., 2020). Is hardiness related to hope and/or pain? If so, what is
the relationship among hope, the adaptive state of hardiness, and pain? To best address these
guiding questions a pre- post-test experimental design (i.e., randomized intervention study) was
utilized and is outlined in the following chapter.
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CHAPTER THREE: METHODS & PROCEDURES
This pre- and post-test intervention study, with two randomized parallel groups, was
designed to explore whether hope can be primed in individuals with chronic pain. This chapter
presents an overview of the design, as well as the rationale for the methods and instruments
selected. The process for participant recruitment, the setting, privacy procedures and descriptive
statistics of the sample are also given, before concluding with a review of the delimitations and
limitations of the study, and a chapter summary.
Overview of the Methods
When testing whether a practice, substance or idea makes a difference in results or
outcome measures, experimental designs (i.e., intervention studies) are generally preferred
(Creswell, 2012). As the goal of the research was to investigate the effect of a primed PNE
tutorial on hope and pain, an experimental, pre-and post-test intervention was conducted to
determine whether the critical quality of hope could be primed in a chronic pain population.
Although PNE is coded for reimbursement via Medicare, the researcher was unable to locate
studies investigating its impact on hope. Further, there is little extant literature on priming hope,
particularly in chronic pain (Eaves et al., 2016; Long et al., 2020), making a quantitative
investigation the design of choice. Not only did this method allow for a clear assessment of
effects (i.e., versus qualitative approaches), the design also eliminated the risk of investigator
bias and/or influence by administering all scales anonymously via a web link.
Although Claessen’s (2015) study on priming in chronic pain utilized positive, neutral,
and negative primes in three respective groups, in this study, even the neutral tutorial was written
in a supportive way to avoid a negative prime (e.g., increasing distress), as indicated in the
application to the Institutional Review Board (IRB).
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To evaluate the intervention’s effect on hope and pain, two parallel, independent groups
were surveyed via web-based software (i.e., Survey Monkey). All participants completed the
Five-Item Pain inventory, the Hope scale, and the Adapted Hardiness scale. Approximately fifty
percent of participants received the hope manipulation (i.e., primed PNE tutorial), and fiftypercent received a more neutral pain educational tutorial, forming a control group. After
reviewing either the primed or neutral tutorial, both groups again completed the four-item Hope
scale and rated pain at the present moment on a scale from 0 – 10. For a copy of each instrument,
please see Appendices C, D and E respectively. After data collection for these two parallel
groups were completed (n = 122), a third group (n = 32) was added to investigate whether the
hardiness scale functioned as a prime (i.e., elevated hope).
Three analyses were carried out in the Primed and Neutral groups. In the first analysis,
the effect of the intervention was isolated by controlling for the baseline measure of hope and
calculating the difference. In a second analysis, the outcome of pain was assessed in the same
manner. These analyses allowed the researcher to carry out two different types of comparisons:
(a) pre- and post-test (i.e., intervention) measurements, and (b) two distinct groups (e.g., a
primed manipulation vs. a control manipulation). As a result, it was possible to detect whether
the intervention had an impact on hope and/or pain.
The survey also collected additional information on pain and stress-hardiness, not only to
characterize this significant factor in the subject sample, but to perform a correlational analysis
to examine the associations among stress-hardiness, typical pain throughout the last year, and
hope.
This design was selected to address the following research questions: Does exposure to a
positively primed Pain Neuroscience Educational (PNE) tutorial promote hope in respondents
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experiencing chronic pain? Does exposure to a primed PNE tutorial influence the experience of
pain as perceived in the present moment? And, does hope impact pain, as perceived at the
present moment? This inquiry also measured the trait factor of stress-hardiness in participants,
which allowed the researcher to examine the relationship among hardiness, pain perception and
the experience of hope.
Instrumentation
Standardized scales, noted for their reliability and validity, were selected for their
potential to address the research questions while strengthening the methodology. Short-form
scales were preferred, and in some cases adapted, to reduce negative priming and survey
completion time. The scales selected are as follows: the Five-Item Pain inventory, the Hope
scale, and the Adapted Short-form Hardiness scale. A copy of each instrument, with instructions
and scoring, can be found in the Appendices. The primed intervention and neutral tutorial are
discussed under the section titled, The Neutral and Primed Tutorials. For clarity, the instruments
are first discussed individually and then collectively, as to their appropriateness and
measurement characteristics.
The Five-Item Pain Inventory
To establish the nature of an individual’s perception of pain (i.e., severity) and its effects
(i.e., interference), the first scale administered to participants in this study is the Five-Item Pain
inventory, based on the Brief Pain inventory (BPI) Short-form developed by MD Anderson
Cancer Center, and widely used in pain treatment centers. The original BPI Short-form is a 13item (Yes, No, numerical rating scale and 0-10 Likert scale) self-report instrument that has been
validated and shown to be reliable over time in terms of pain, as well as functional ability or
disability (Correll, 2007; Jelsness-Jorgensen, et al., 2016). Its internal consistency as measured
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by Chronbach’s alpha, ranges from .80 to .92. The test-retest reliability is highest for short-term
pain and typical pain ratings (.93 to .78). Test-retest reliability for current (i.e., “now”) pain
ratings is lower (.59) due to the changing nature of pain (Cleeland, 1991).
In addition to its validity and reliability, this pain scale was selected to gauge the severity
of pain and examine any post-intervention effect. It was adapted for the purpose of this study in
several ways. For example, in the paper and pencil version participants circle the number that
best answers the question; however, in the online adaptation, individuals clicked on the number
indicating the best answer. Additionally, the standard paper and pencil version includes a
diagram on which individuals shade in the areas where they experience pain. Since the area
affected by pain (e.g., neck, arm, leg, etc.) was not being evaluated in this investigation, this item
was eliminated from the survey. Likewise, an open-ended question asking that respondents list
their medications and pain treatments was also excluded, as these were not being assessed in this
study.
Redundant questions that could unnecessarily fatigue participants were also removed,
leaving five questions assessing current pain, typical pain throughout the last year, and pain
interference in three domains: general activity, walking and life enjoyment. Although even
shorter pain scales have been utilized effectively (France et al., 2020) it was determined that the
Five-Item Pain inventory was not so long that participants would feel fatigued but
comprehensive enough to allow for reflection on the nature of pain and its effect(s) on daily life.
The adapted version of the BPI Short-form––The Five-Item Pain inventory––can be
found in Appendix D.
The Hope Scale
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Although there are other hope/hopelessness scales from which to choose (Beck et al.,
1974; Everson et al., 1996), Long et al.’s (2020) adaptation uniquely reflects the
conceptualization of hope, as distinguished from optimism, pertinent to this investigation.
Evidence supporting the relationship between optimism and the experience of chronic pain is a
relatively recent one. According to Goodin & Bulls (2013), prior to the year 2000, research
focused primarily on negative psychological constructs, as opposed to positive traits and states.
Although there are multiple dimensions to optimism which are yet to be fully understood, in the
aggregate, dispositional optimism has been found to be a significant predictor of diverse physical
health outcomes (Scheier & Carver, 2018), contributing to reduced pain sensitivity and enhanced
physical recovery (Goodin & Bulls, 2013). Recently, functional neuroimaging studies indicate
that the cortical regions responsible for pain processing are also involved in generating optimism,
supporting a possible neuroprotective relationship between optimism and the sensory experience
of pain (2013).
An impediment to evaluating the effects of hope and/or optimism is that the two are
frequently conflated (Goodin & Bulls, 2013). For example, individuals scoring high on optimism
have been found to use approach rather than avoidant coping strategies when faced with
setbacks, as exhibited by determination and commitment toward a desired goal (2013). This
relates more directly to agency (i.e., hope), in contrast to optimism, which relates to “generalized
outcome expectancies” (2013, p. 2) “that the future will be good (which may be with or without
reasons)” (Long et al., 2020, p. 2). Positive expectations are not necessarily accompanied by
acting on one’s behalf, or perseverance in the face of obstacles (2020). For example, while
nurturing positive beliefs about one’s future (i.e., optimism) has been shown to facilitate
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contentment, it has also been associated with poor achievement (Kappes & Oettingen, 2011), and
lack of preparedness against risks (Tenney et al., 2015).
Although it seems obvious that positive thinking is quite different than acting in one’s
best interest, optimism and hope are frequently conflated in the literature (Long et al., 2020). It is
possible, then, that the approach coping facet of optimism (Goodin & Bulls, 2013) relates more
strongly with hope, as related to agency, and stress-hardiness, than positive expectations for the
future. Conceivably, extant research purportedly evaluating optimism may have been, in fact,
evaluating hope. In recognition of these disparities, Long et al. (2020) reverse coded items
derived from Everson et al. (1996) and Beck et al.’s (1974) measures to construct a scale of hope
rather than hopelessness. The self-report scale consists of four statements rated on a six-point
scale from one (Strongly Disagree) to six (Strongly Agree). Long et al. (2020) explain:
We reverse-coded the scale to construct a hope instead of hopelessness scale for three
reasons. First, HRS [Health and Retirement Study] is not a clinical or psychiatric
population, and as a result, levels of ‘hopelessness’ were relatively low. Even in the
tertile with the highest hopelessness scores, the median response was to slightly disagree
with all four items. Second, reverse wording of the questions strongly aligned with a
widely accepted, empirical conceptualization of hope as a positive motivational state
directing perseverance towards goals and pathways . . . As a result, we reverse-coded the
four items and then averaged them together to construct our hope scale (e.g., It is possible
for me to reach goals; the future seems hopeful to me; I do expect to get what I really
want; There is use in trying, etc.). (Long et al., 2020, p. 1)
While empirical evidence supports the health promoting effects of hope––both mentally
and physically––some Hope scales (Everson et al., 1996; Beck et al., 1974) could be gauging a
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lack of depressive symptoms rather than the actionable effect of hope on agency, or perseverance
toward goals (Long et al., 2020). As noted, the chronic pain population is not necessarily a
psychiatric one, which further argues for the use of this revised scale.
Seeing that the adapted Hope scale (Long et al., 2020) captures this distinct aspect of
hope it was the preferred measure in this study. For ease of comparison, Appendix C includes the
original items derived from Everson et al. (1996) and Beck et al. (1974) along with the revised
scale used in this investigation.
The Short-form Hardiness Scale
The concept of stress resistance, or hardiness, as a protective personality trait that is
stable over time was established by Kobasa (1979). While high numbers on the Rahe and
Holmes Life Event Checklist proved predictive of serious illness, individuals scoring high in
hardiness did not become seriously ill. Hardiness is more discreetly defined than the broad
construct of resilience, which is conceptualized in multiple ways by numerous researchers
(Zerach et al., 2020). Stress-hardiness encompasses three interrelated domains, colloquially
known as the three C’s for: control––a sense of self-mastery, commitment––to the self,
connection with others, and an ability to find meaning in life, and challenge––seeing change as
an opportunity rather than a threat.
Although the construct has been empirically demonstrated to be a moderator in illness
(Gebhardt et al., 2001), the relationship between stress-hardiness and chronic pain is seldom
studied (Zerach et al., 2020). Exploring and clarifying this relationship was a goal of this study.
Unfortunately, among hardiness scales, there is no gold standard (Windle et al., 2011), as
instruments measure varying properties or attributes of stress-hardiness, and few have strong
test-retest reliability. For example, some hardiness or resilience scales have been found to
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measure either an individual’s ability to bounce back or seek support from outside sources,
neither of which adequately captures the nature of hardiness as defined by Kobasa (1979). In
contrast, the Short-form Hardiness scale (Sinclair et al., 2003), based on Bartone’s (1991) earlier
work, captures an individual’s capacity to take personal responsibility (i.e., control) despite
challenges, as indicated by the three domains of control, commitment, and challenge.
Chronbach’s alpha, or coefficient alpha, measures the reliability of a particular
instrument when items are scored as continuous variables; ratings above .70 indicate an
instrument’s ability to accurately assess what it claims to measure. After reviewing a number of
hardiness scales, the Short-form Hardiness scale was found to have good overall internal
consistency (Chronbach alpha = .83), but test-retest reliability across various populations has
been difficult to establish for this instrument (Sinclair et al. 2013). However, since it is based on
the Dispositional Resilience scale (DRS), which has a coefficient alpha of .78 across numerous
populations (Bartone, 2007), it was selected for this study, as the DRS is more relevant for
language groups other than English (Bartone, 2013).
The Short-form Hardiness scale contains 18-items, rated on a five-point scale from one
(Definitely False) to six (Definitely True). This instrument evaluates six subscales: control or
self-efficacy; powerlessness and/or fatalism; commitment, which is defined as being interested in
and fully engaged with life; alienation, which refers to a sense of meaninglessness and isolation;
challenge, which is the “tendency to view stressors as challenges rather than threats;” and
rigidity which is gauged by a lack of flexibility and resistance to change. (Sinclair et al., 2003, p.
11).
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The internal reliability (i.e., Chronbach’s alpha) of each the six subscales is as follows:
Control (.79); Powerlessness (.93); Commitment (.79); Alienation (.88); Challenge (.77); and
Rigidity (.66) (Sinclair et al., 2003, p. 13).
For the purpose of this investigation, two items on the hardiness scale were reverse coded
to avoid a negative prime (Brascher et al., 2018). For example, the statement, “Sometimes, life
seems meaningless to me” was replaced with, “Despite challenges, life seems meaningful to
me.” The statement, “I often feel alienated from the people around me,” was changed to, “I often
feel connected to the people around me.” The Hardiness scale Short-form was also abbreviated
by eliminating non-scored items (i.e., fillers) and redundant items to reduce unnecessary survey
fatigue. The facets measured by the survey remain intact; for example, of the ten items, three
measure the facet of commitment, three examine control, and two evaluate challenge. The two
alienation measures were reverse coded to evaluate connection, as mentioned above. The
Adapted Hardiness scale can be seen in Appendix E.
The Neutral & Primed Tutorials
The primed 219-word PNE tutorial (see Appendix F) was modeled after PNE concepts
reflecting advances in the neuroscience of pain (Ashar et al., 2021). In designing the primed
tutorial, every effort was made to present the essential, but potentially disruptive data, in a
supportive way (Knowles et al., 2015). Even so, it was conceivable that the primed PNE could
have created conflict for some (see Appendix F). Although viewing the medical system as a final
authority on pain reduction increases the risk of hopelessness, being confronted with a different
perspective could lead to feelings of disillusionment, and/or anger, either at the authority (i.e.,
conflict of authority), or the source of the conflicting information (Stockdale, 2019). Since the
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effect of a positively primed PNE was unknown, this possibility was acknowledged in the IRB
application.
The experimental, hope-manipulation group (n = 68) reviewed the primed tutorial. Later,
when findings were analyzed and it was determined that both groups (i.e., primed and neutral)
were similar in all respects, a third group was recruited (n = 32) and exposed to the hope
manipulation, but without the hardiness scale in case the positively worded instrument served as
a prime. Therefore, 100-participants were exposed to the primed tutorial (i.e., 68 in the original
group and 32 in the primed without hardiness group).
The control group (n = 54), on the other hand, reviewed a relatively neutral, 219-word
tutorial on pain which was supportively written to avoid the nocebo effect (Brascher et al., 2018)
(See Appendix F). The development of a neutral tutorial presented a challenge, as a strictly
neutral topic (e.g., organic gardening) selects against a pain focus and would not enable an
adequate comparison of the two groups as the experimental group (i.e., hope manipulation) was
required to focus on pain throughout the survey. An organic gardening tutorial, by way of
example, side steps that condition, limiting the analysis of any potential effect of the primed
intervention. It also introduces another variable: distraction from pain, thereby obfuscating the
objective of the study. Nor could the neutral tutorial include negative pain conceptualizations and
risk inducing a nocebo effect. Thus, both groups were exposed to information on pain but in
somewhat different ways––one in a primed capacity and one in a relatively neutral condition. In
this condition, by requiring all subjects to focus on pain (N = 154), results are more applicable to
clinical practice or participating in PNE.
Participants: Recruitment, Consent & Privacy
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According to Freedland (2020) most pilot studies are underpowered, yielding null results
and “halting work on promising and unpromising interventions alike” (2020, p. 851). To avoid
this pitfall and draw meaningful conclusions from the data, an a priori power analysis was
performed during the planning stages of this study.
Typically, the standard deviation between groups is necessary to estimate a sample size
for adequate power. Since the adapted Hope scale is a novel instrument––used once in an
epidemiological study (Long et al., 2020) of 12,998 people, correlating hope with physical
function, pain, and morbidity––there was no empirical precedent upon which to calculate a
sample size to ensure adequate power. Without an available precedent to compare the hope
difference and pain difference as outcomes in the experimental and control groups, Cohen’s
(1988) Power Table was consulted. Assuming a medium effect size, with alpha probability of .05
and .10, it was established that each group needed either 36 or 38 participants respectively (i.e.,
at least 75 participants total, and upwards of 200 total assuming a small effect size). Initially, 168
were recruited and 122 qualified. Later, a third arm was recruited. In total, more than 200
participated and 154 qualified (e.g., incomplete surveys were eliminated).
Upon approval by the IRB, the survey and website were constructed according to design
principles shown to increase participation and accurate test-taking (Oppenheimer et al., 2012;
Regmi et al., 2016). The web page provided clear and easy to understand information about the
study, an embedded link to the survey, and a button to download the relaxation audio gift. As
noted previously, the title of the website and recruitment announcement differed from that of the
study, since disclosing the topic of hope could alter perception and be counterproductive (see
Appendix A). Recruitment of adults experiencing chronic pain for at least one-year, began in
May and concluded in July of 2021.
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To maximize participation, the web link was posted on social media and sent to email
subscribers, associates, colleagues, physicians, physical therapists, and chiropractors so that
interested and qualified individuals could anonymously take the survey (i.e., snowballing).
Numerous online facilitators of pain groups were contacted but permission to post was denied by
all. Although medical clinics have limited the use of in-office brochures due to SARS-CoV-2,
permission was granted to place cards with a QR code linking to the study in the waiting areas of
a general practitioner, two private physical therapy offices, a hospital pain clinic, and two
chiropractic offices. The researcher was not present so there was no interviewer bias, and
respondents chose when and where to participate.
As an incentive a 30-minute relaxation audio was offered to participants. To ensure
anonymity, the audio was embedded on the website and configured in such a way that it could be
downloaded without being tracked, and available regardless of survey completion. To further
protect participants and ensure anonymity, the survey was administered online, and no identifiers
or email addresses were collected. The software, Survey Monkey, allowed the researcher to
deselect the capturing of email addresses, which was enabled and tested prior to recruitment to
ensure anonymity throughout data collection. In other words, personal data were not collected at
any point in the process so that survey responses could not be identified with any personal
information. The deidentified survey responses will be stored in an Excel file for 5-years and
then deleted.
An informed consent was provided prior to taking the survey (see Appendix B). To
ensure anonymity, signatures were rendered unnecessary as participants were unable to move
forward in the survey without indicating consent by clicking “next.” As required by the IRB, the
informed consent stated that individuals may stop their participation at any point; additionally,
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by eliminating the presence of an administrator there was no pressure to continue if taking the
survey became uncomfortable.
Although it routinely happens during medical visits, answering questions about one’s
experience of pain could be distressing. Specific efforts were taken to reduce this type of stress.
For example, questions about pain were kept to a minimum by reducing MD Anderson’s 13-item
Short-form Pain inventory to five-questions (see Appendix D). Likewise, an abbreviated version
of The Short-form Hardiness scale was reduced to ten items and reverse coded to further
minimize stress and negative priming. Further, every effort was made to present pain information
in a non-threatening way in both tutorials (see Appendix F).
During this process, only two respondents contacted the researcher with questions. Via
email, one individual reported difficulty answering the survey questions as they inquired about
pain in the present, yet her experience with chronic pain was in the past. The response given was
that the experience of chronic pain needed to be current to participate. A second respondent left a
voice message stating she had completed the survey and asked that I return her call to discuss the
study, which I did. Even though these two participants identified themselves to the researcher, no
identifying information connected survey results to the individuals.
The Setting
The setting for the study was a designated website, so that participants could privately
complete the survey at a convenient time and place. A link to the survey was embedded in the
web page and the Likert scale questionnaires, instruments, and consent were tested for clarity
and ease of use by friends and family members of the researcher, prior to data collection. As
indicated in the above section, the survey was administered online, and the data collection
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process ensured anonymity at every step. No email addresses were captured by the system, and
the process was equal for all.
Since identifiers were not collected the researcher was unable to contact participants with
a summary of results. However, all participants were invited to contact the researcher via email
or phone to discuss any part of the study.
Survey Participants
Eligibility was established by indicating the participant was at least 18-years of age and
had experienced chronic pain for a minimum of one-year. The web page introducing the survey
stated these two requirements, and after clicking “take survey,” participants indicated consent
and then clicked “yes” or “no” to the two qualifiers (i.e., at least 18-years of age and whether
they have experienced chronic pain for at least one-year). 163-respondents were randomized to
either a primed or neutral survey group. Of these, 41 either did not meet the requirement for
chronic pain and/or had incomplete responses; therefore, all corresponding data for these 41respondents was eliminated. Of the 122 remaining qualified respondents, 54 and 68-individuals
participated in the neutral and primed group, respectively. After analyzing results, the decision
was made to recruit a third group. After securing permission from the IRB, and following
procedures outlined in this chapter, 41 additional respondents were recruited. Of these, nine were
eliminated as they either did not meet the requirement for chronic pain or had incomplete
responses. The rationale for this third group of 32-participants will be discussed in the following
chapter; however, all processes and methods are as described here.
Age range options for participants to click on were: 1 (18-24); 2 (25-34); 3 (35-44); 4
(45-54); 5 (55-64); 6 (65-74); 7 (75 and up). The mean age of the 68-participants in the Primed
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group was 4.98, indicating the 45-54 age group. The average age of the 54 qualified respondents
in the Neutral group was 4.74, indicating the same 45-54 age group.
Gender and Country of Origin were not listed with multiple choice options, so
participants wrote in their selection. In the Primed group of 68-participants, 53 were Female, 14
were Male and one was listed as “a gender.” Out of 54 qualified respondents in the Neutral
group, two chose not to answer, one listed “nonbinary,” nine wrote in male and 42 female,
including “cisgender” and “female assigned at birth.”
64-participants in the Primed group listed the United States as their country of origin, one
the United Kingdom, one Israel, one South Africa and one Brazil. In the Neutral group, two
chose not to answer, one respondent was from Canada, one from Guyana and the remaining 50
indicated the United States as their country of origin.
The typical pain rating throughout the last year for the Primed group was 6.17, rated on a
scale from 0 to 10. In the Neutral group, the typical pain throughout the past year was 5.57 in a
range of 1-10.
As befitting randomization, the two groups are well-matched in age, gender, country of
origin, and the level of typical pain experienced throughout the last year.
Procedure
The procedure for participants was as follows: On the designated website,
www.UnderstandingPainStudy.com, participants clicked on the link provided and established
qualifiers (i.e., age and chronic pain duration of at least one-year). After reading the consent
form, participants selected “continue” to agree to the terms of participation (see Appendix B).
After consenting, a brief demographic survey was completed (e.g., age, gender, country of
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origin), and individuals could download an incentive gift, a 30-minute relaxation audio using
psychoacoustics.
After completing the above section, administration of the first wave of instruments began.
Participants completed the Five-Item Pain inventory (see Appendix D), the four-item Hope scale
(see Appendix C), and the 10-item Adapted Hardiness scale (see Appendix E).
The experimental group reviewed a primed PNE tutorial of 219-words, while the control
group was exposed to a relatively neutral pain tutorial, with the same word count. See Appendix
F to compare the two tutorials. After reviewing either the primed or traditional tutorial, post-test
measures began. Participants completed the four-item Hope scale again and rated the level of
pain or discomfort in the present moment on a scale of 0-10.
Data Collection Procedures & Tools
Data collection began when target participation goals were reached. After 84-participants
completed the survey using the Primed tutorial, data was collected and uploaded into Excel and
IBM Statistical Package for the Social Sciences (SPSS). The Primed tutorial was then replaced
with the Neutral (i.e., control) tutorial. After 77-participants completed the neutral survey, data
was collected and uploaded into Excel and SPSS software.
In SPSS, incomplete questionnaires, and unqualified participants (e.g., did not have
chronic pain for more than one-year) were eliminated from both datasets. The result was that 68
and 54 qualified participants completed the primed and neutral surveys, respectively. One
participant in the Primed group skipped a hardiness item “Life is Meaningful,” so 999 was
entered into SPSS to identify missing data. In this case, since only the single hardiness item was
skipped, data from this individual was included. There were no other incomplete cells or items in
the data set of 122-participants.
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After descriptive statistics were completed, mean scores were calculated on the Five-Item
Pain inventory, the Hope scale, and the Adapted Hardiness scale. The difference between preand post-test measures on hope and pain in the present were calculated and evaluated for
statistical significance. Paired tests, both parametric and non-parametric were conducted and
correlational analyses among hope, pain and hardiness were performed. The analysis of each and
corresponding measures, will be discussed in the following chapter. The delimitations and
limitations of this study are discussed in the following section.
Delimitations/Limitations of the Study
Although chronic pain is defined as ongoing for at least six-months, this study limits
participation to adults experiencing chronic pain for at least one-year, ruling out the experience
of those whose pain is of a shorter duration. Further, completion of the online survey required
access to a computer or cellular device. While libraries, prior to SARS-CoV2 provided computer
access, these were not fully available at the time individuals took the online survey, therefore the
sample is skewed toward English speaking individuals with access to technology.
Medical histories were not included in this study, as the perception of chronic pain and its
relationship to hope was the primary focus, versus the type of chronic pain and comorbidities.
Suggestions for future research could include relevant medical histories that could be analyzed
and correlated to hope and pain perception; however, MD Anderson found such data to be of
little help in analyzing pain (MD Anderson’s Brief Pain Inventory Guide).
A future investigation could assess and control for short-term versus chronic use of
analgesics, which could potentially impact outcome. In this investigation, however, pain
medication was not assessed as participants self-identified as suffering chronic pain, indicating
that––with or without medication––the pain condition had not been successfully treated but was
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intractable or on-going. Furthermore, although a diagnosis of chronic pain is established at sixmonths duration, participation required at least one-year of chronic pain. Presumably by then
pain pathways would be sensitized and operational even if the underlying cause was treated,
contributing to the identification with “chronic” pain. The perception, then, of chronic pain and
its relationship to hope was the focus regardless of analgesic use.
Moreover, this investigation did not assess the difference in hope utilizing a negatively
primed chronic pain group, as did Claessen (2016). In general, standard biomedical
questionnaires and tutorials are considered to be potential negative primes (2016), and since the
control tutorial attempted to be neutral, it was constructed to err on the positive to avoid harm.
Therefore, a delimitation of this study is that the neutral tutorial could also have functioned as a
positive prime. Future research could include a negatively primed tutorial (2016) for comparison.
While every effort was made to avoid a negative prime in terms of hopelessness or pain,
it was acknowledged in the IRB application that the Hope scale could function as a positive
prime. Rather than risking a nocebo effect (i.e., negative prime,), and because of the unique
attributes of Long et al.’s (2020) revised scale (e.g., discussed in the instrumentation section), the
positively worded instrument was preferred. Therefore, as discussed in Chapter Five, the positive
Hope scale may have had an effect beyond the intervention itself.
In a similar way, the Adapted Hardiness scale, could have primed individuals toward
hope. Although the hope difference was not correlated with hardiness, to correct for the
possibility that it served as a prime, a third group was recruited (n = 32), and this scale removed.
The results will be discussed in the following chapter, but it appears that the Adapted Hardiness
scale did not function as a prime.
Limitations
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It should be assumed that “systematic differences may be present between subjects who
choose to respond to a survey compared to those who do not” (Oppenheimer et al., 2012, Bias,
para. 3). Due to the effect of hopelessness on motivation (Jaremka et al., 2014), it is possible that
the self-selection process and a response bias could incline individuals toward hope and
openness to taking the survey, resulting in a group skewed toward hope.
On the other hand, it could be that high functioning individuals with chronic pain were
not inclined to spend time taking the survey biasing the sample toward more debilitated
individuals. A larger sample could also enable adequate power allowing for multiple groups
(e.g., negative prime, neutral, etc.) and reflect a greater age range.
Summary
This chapter presented an overview of the study design, methodology, and rationale for
each as related to the primary research questions. The strengths of this investigation are sample
size, randomization, relatively standardized instrumentation, and a unique priming method. A
pre- and post-test experimental design (i.e., intervention study) consisting of two randomized
parallel groups, was selected to best answer the primary research questions, and contribute to a
nuanced understanding of the relationship among chronic pain, stress-hardiness, and hope. The
process for participant recruitment, the setting, privacy procedures and descriptive statistics of
the sample were also covered in this chapter, before concluding with a review of the
delimitations and limitations of the study.
In brief, the researcher designed a website incorporating survey software in an embedded
click-to-answer, pre- and post-test survey, tested for ease of use across multiple devices (e.g.,
cell phones, tablets, computers). All procedures and methods ensured anonymity throughout the
process. The validity and reliability, and any adaptations, of each instrument were also presented
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in this chapter. The order of instrumentation was structured to best answer the research
questions. In the pre-test, participants of both groups respond to questions about the nature of
their pain and its effect on daily activities immediately prior to completing the Hope scale. A
measurement of self-mastery, the Adapted Hardiness scale follows the Hope scale. After the
Hardiness scale, 84-respondents were exposed to the hope manipulation, and 79-respondents to
the control manipulation. Post-test measures assessed hope again and rated and pain in the
present moment. Of the 163-respondents, 122 qualified participants completed the survey. After
analyzing results, a third group of 41was recruited, 32 qualified and completed a primed survey
without the Hardiness scale.
Data for all three groups was uploaded to Excel and SPSS for analysis. A detailed
description of the process and the findings is discussed in the following chapter.
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CHAPTER FOUR: RESULTS
This study examined whether a primed tutorial could raise hope in a chronic pain sample.
A pre-test and post-test, hope manipulation v. control manipulation (i.e., experimental design),
was selected to answer the guiding research questions. Chapter Three detailed the methods and
processes utilized as participants completed a survey incorporating the Hope scale, the Five-Item
Pain inventory, and the Adapted Hardiness scale prior to reviewing either a primed or neutral
tutorial on pain. Following the intervention, participants completed the Hope scale again and
rated pain at the present moment on a scale of 0-10. This chapter describes the procedures used
to analyze data that address the guiding research questions and concludes with a summary of key
findings.
Data Analysis Procedures
A power analysis was performed during the planning stages of this study to create a
sampling goal so that a medium effect size would be captured by Cohen’s d with alpha
probability set at 0.05. A post-hoc power analysis confirmed that the sample size (N = 154)
provided sufficient statistical power in tests within and between subjects at 0.972 and 1.0,
respectively, to detect a medium effect, p = 0.05 (Cohen, 1988; Lenth, 2001).
Version 27 of the Statistical Package for the Social Sciences, or SPSS, developed by
IBM, was used for each analysis. A brief description of, and the rationale for selecting, each test
statistic, is presented in this chapter with a focus on how the analysis answers the research
questions.
The data consists of survey results of pre-test and post-measures of hope and pain at the
present moment, level of typical pain experienced throughout the past year, and the trait of
stress-hardiness. The analysis is organized by test-statistic, beginning with descriptive statistics
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that calculate measures of central tendency for facets of pain and overall hardiness and any
tendency toward skewness or kurtosis as measured by Shapiro-Wilk.
To answer the first three research questions (i.e., whether exposure to a positively primed
PNE tutorial promotes hope, influences the perception of pain at the present moment, and
whether hope impacts the experience of pain), paired tests were performed to establish whether
the intervention had an effect and if the effect reached the level of statistical significance.
Inferential statistics––in this case paired t-tests (i.e., dependent sample t-test) and Wilcoxon
Signed-Rank Tests––address these questions. By calculating the difference between the means of
the dependent variables of hope and pain the results are compared and examined for statistical
significance. After determining that the difference in hope scores reached statistical significance,
a complementary test––Cohen’s d––was used to calculate the size or magnitude of the effect.
Benchmarks established by Cohen (1988) for this purpose are discussed in that section.
The next inferential statistic explores the trait of stress-hardiness in this sample,
investigating the relationship among this factor, pain perception, and the experience of hope. To
examine the strength or magnitude of a relationship between two continuous variables, and
whether its direction is positive or negative, a value between -1 and +1 is calculated, known as
the correlation coefficient. In this study, a bivariate correlation––Pearson’s Correlation
Coefficient––calculated the strength of the relationship between hope and pain at the present
moment (before and after), between hardiness and hope, and between typical pain experienced
throughout the past year and hardiness.
Therefore, each test statistic helps answer the guiding research questions. In this chapter,
descriptive statistics are presented first, followed by parametric and nonparametric paired tests,
and concludes with correlational analyses. Since this is a pre-and post-test intervention study
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utilizing two parallel groups, any given test statistic will be analyzed and immediately contrasted
with the other group for clarity of comparison, and to best answer the guiding questions. In all
analyses, the Primed group data are summarized first and then compared with the Neutral (i.e.,
control) group. Therefore, to compare and contrast findings, this chapter is organized by the
particular analysis being conducted rather than presenting the full data analysis for the Primed
and Neutral groups in two different sections.
Sample Description
The recruitment announcement invited adults experiencing chronic pain (e.g., chronic
migraine, etc.) for at least one-year to participate in an online survey titled “understanding pain.”
The web link was posted on social media and sent to email subscribers, associates, colleagues,
physicians, physical therapists, and chiropractors (i.e., snowballing). Permission was granted to
place cards with a QR code linking to the study in the waiting areas of a general practitioner, two
private physical therapy offices, a hospital pain clinic, and two chiropractic offices. An incentive
was a 30-minute relaxation audio available via a link that could be accessed upon qualifying to
participate.
In the initial analysis, out of 161 respondents 122 met the inclusion criteria and
completed all measures. A third group was later recruited (n = 32) which, for clarity, will be
discussed at the relevant juncture. Of the 122 initial subjects, 54 and 68-individuals were
randomly assigned to two interventions, the Primed tutorial group, and the Neutral tutorial group,
respectively. Age, gender, country of origin, and typical pain experienced throughout the year
are summarized below for each group.
Age
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The age range options on the survey were: 1 (18-24); 2 (25-34); 3 (35-44); 4 (45-54); 5
(55-64); 6 (65-74); 7 (75 and up). The mean age category of the 68 qualified respondents in the
Primed group is 4.98, corresponding to the 45-54 age group. This is similar to the mean age (i.e.,
4.74) of the 54 qualified respondents in the Neutral group, placing them in the same 45-54 age
group.
Gender and Country of Origin
Gender and country of origin were write-in items (i.e., not multiple choice). In the Primed
group of 68-participants, 53 were female, 14 were male and one was listed as “a gender.” 64
participants listed their country of origin as the United States, one the United Kingdom, one
Israel, one South Africa, and one indicated Brazil. Out of 54 qualified respondents in the Neutral
group, nine indicated gender as male, 42 wrote in female, two chose not to answer, and one listed
“nonbinary.” Fifty indicated the United States as their country of origin, two chose not to answer,
one wrote in Canada, and one Guyana.
Mean of Typical Pain & Hardiness
The Five-item Pain inventory assessed pain in five areas. The pre-test and post-test
variable (i.e., dependent variable) was pain experienced at the present moment. On the other
hand, the typical pain rating throughout the year was assessed as an independent variable prior to
the intervention, with 0 being no pain at all and 10 being the highest ever. The mean of typical
pain rating (i.e., throughout the last year) for the Primed group was 6.17, and the mean of typical
pain for the Neutral group was 5.57.
Hardiness was scored as the mean of ten items on a five-point scale with one being false,
and five being true. Mean hardiness is 3.87 for the Primed group and 4.00 for the Neutral group.
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Both skewness and kurtosis describe the shape of a distribution, with values between -1.0
and 1.0 representative of a normal curve. Skewness assesses the symmetry of the distribution
while kurtosis describes the impact of outliers and whether the distribution is too peaked or too
flat.
The Primed sample did not appear skewed on either variable, as the mean of typical pain
throughout the year and the mean of hardiness are -0.398 and -0.625 respectively. Kurtosis was
not significant as the means of typical pain and of hardiness are -0.041 and -0.167 accordingly.
Similarly, the Neutral group reflects a normal distribution for typical pain with skewness
of 0.084, which is not greater than 1.0 and not less than -1.0. Hardiness, however, was skewed
outside the value of -1.0 at -1.052, and kurtosis was somewhat elevated at 1.08 (i.e., leptokurtic)
resulting in a peaked distribution. Therefore, the tendency toward hardiness in this group is
somewhat more pronounced than in the Primed group.
Summary of Descriptive Characteristics
The majority of participants in the Primed (n = 68) and Neutral (n = 54) groups were
female (i.e., approximately 80%), between 45-54 years of age, listing the United States as
country of origin (98%). The independent variables of typical pain throughout the year and
hardiness were comparatively assessed as they describe each group’s distribution. The mean
hardiness score is 3.87 for the Primed group and 4.00 for the Neutral group. Subjects rated
typical pain experienced throughout the past year at five-to-six in a range of 0-10. Both samples
reflect a relatively normal distribution on the experience of typical pain, and both groups tend
toward higher levels of stress hardiness, the trait being more pronounced in the Neutral group. In
both groups, the highest-rated value on the ten-item Adapted Hardiness scale is “life seems
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meaningful to me,” and the lowest score in both samples was “stressful life events are
opportunities to grow.”
Therefore, Primed (n = 68) and Neutral (n = 54) groups exhibited homogeneity in terms
of age, gender, country of origin, typical pain, and hardiness profile, indicating successful
randomization. There were no significant outliers, and most data approximated the normal
distribution, although for the Neutral group the trait of hardiness was skewed at -1.052, and
kurtosis was somewhat elevated at 1.08 (i.e., leptokurtic) reflecting a greater tendency toward
hardiness than seen in the Primed group.
To compare the outcome measures of pain (i.e., at the present moment) and hope, before
and after the intervention, paired t-tests, and the Wilcoxon Signed-Rank Test were performed
and are discussed below, while correlations between hardiness, hope, and pain will be discussed
in the section on correlations.
Normality Assumptions & Paired Tests
To answer the primary guiding research questions, (i.e., can hope be primed, does hope
influence the perception of pain at the present moment, and does hope impact the experience of
pain?), it was necessary to establish whether the intervention had an effect. In brief, prior to the
intervention, participants completed the Hope scale, the Five-Item Pain inventory, and the
Adapted Hardiness scale. The hope measure is the mean of four items, rated on a scale from one
to six, and the pain scale is a five-item self-report measure assessing pain from 0-10. Baseline
evaluations for hope and pain at the present moment (i.e., discomfort now) were performed prior
to and following the intervention as a post-test evaluation. As noted previously, the pre-test also
included a ten-item, five-point scale assessing stress hardiness.
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A paired t-test compares the mean scores of two items or dependent variables that are
measured twice as in the case of before and after testing. Since the data set contains two
measurements, pre-test and post-test for every participant, a paired test was the appropriate test
statistic. Paired tests are available for both parametric and nonparametric data. The parametric
paired t-test (i.e., dependent sample t-test) procedure makes several assumptions about the
differences between two paired sets of values (e.g., pre-test and post-test outcomes); namely, the
sample must be random, the dependent variable continuous, the difference in the means
approximates a normal distribution, and outcomes do not contain significant outliers.
The normality assumption of a t-test assumes that the means of the different samples are
normally distributed (i.e., not that the population is normally distributed), so the findings are
statistically more likely to extend to a broader population. In general, when non-normal
distributions contain a sufficient number of samples the assumption of the t-test requirement is
considered to be satisfied. However, it is argued that this assumption only applies in samples
over 300, and even then, cannot be presumed (Kim & Park, 2019; Mohd & Khairani, 2020). At
122, the sample is considered to be of medium size, as it is greater than 50 but less than 300
(Mohd & Khairani, 2020). Although the sample population in this study, by some standards,
could be considered large enough to rely on paired t-test data alone, to ratify and clarify findings
as much as possible, a test of normality was also performed.
While t-tests are robust even when used in score distributions that violate normality,
additional test-statistics were performed to further evaluate the data. The Shapiro-Wilk test of
skewness and kurtosis is recommended for samples of less than 300 (Mohd & Khairani, 2020),
and was set at the .001 level to detect even subtle deviations. In the Primed group, skewness is
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minimal at 0.157, while kurtosis is elevated at 3.041. On the other hand, skewness and kurtosis
in the Neutral group were 2.089 and 8.127, respectively.
Although George and Mallery (2010) define skewness and kurtosis as within +/-2, Hair et
al. (2010) finds +/- 7 an acceptable range for kurtosis. Statistician Nicholas Cox (2010) argues
that varying values are not only misleading, but that stringent limits for skewness and kurtosis
may distort results, “impart[ing] bias to estimation and, in extreme cases, imply[ing] that no
sample could bear exact witness to its parent distribution” (p. 482). Cox finds “kurtosis . . . even
more enigmatic [than skewness]: some authors write of kurtosis as peakedness and some write of
it as tail weight, but the skeptical interpretation that kurtosis is whatever kurtosis measures is the
only totally safe story” (p. 483).
Even so, Mohd and Khairani (2020) argue that when normality is assumed rather than
established, “interpretation and inference may not be reliable,” (p. 689). Therefore, in an
abundance of caution this paper assumes a level of kurtosis according to testing via ShapiroWilk. According to the +/- 2 limit for skewness, with a stringent setting at the .001 level, the
Neutral sample is slightly skewed. Kurtosis, however, is high at +/-8. In a review of the
literature, Mohd and Khairani (2020) note that “normality is important when skewness or outliers
affect correlation or significant value statistical analysis,” while kurtosis may “not have much
effect on most statistical analysis” (p. 691).
In summary, t-tests are robust measures even when normality in score distributions has
been violated. Nevertheless, the Shapiro-Wilk test for skewness and kurtosis was performed in
both data sets. In the Primed group, skewness was minimal at 0.157, while kurtosis was elevated
at 3.041. On the other hand, skewness and kurtosis in the Neutral group were 2.089 and 8.127,
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respectively. Since normality cannot be assured, both parametric and nonparametric paired tests
were conducted; the findings are discussed below, beginning with the Primed group.
Paired T-Tests: The Primed Group
After establishing a baseline for scores of hope and pain, 68-subjects were exposed to a
primed pain tutorial (i.e., the hope manipulation), and again took the four-item Hope scale and
rated pain at the present moment (i.e., now). A before and after measurement of each participant
was taken on a scale where 6 = high hope and 1 = low hope, and 0-10 indicated the level of pain
experienced at the present moment. Accordingly, a paired t-test was performed to calculate the
difference between the means of the dependent variables of hope and pain at the present moment,
before and after the intervention.
Before the intervention the mean of hope was 4.319 (HopeT1) and after was 4.672
(HopeT2). The mean of pain at the present moment (i.e., pain now), before the intervention, was
6.0 and after 5.89. The differences in the mean of hope (i.e., HopeT1, HopeT2), before and after,
and discomfort at the present moment, before and after, can be seen in the paired sample t-tests
in Table 1. The difference in the mean scores of hope, before and after the intervention, is
significant at the 0.001 level, while the difference in pain was not statistically significant, p =
0.57.
After determining that the difference in hope scores reached statistical significance,
Cohen’s d was used to calculate the size or magnitude of the effect. Benchmarks established by
Cohen (1988) for this purpose are reported as small (.2), medium (.5), and large (.8) effect sizes.
Since the post-test score for hope (i.e., HopeT2) is greater, subtracting it from the pre-test score
(i.e., HopeT1) yields a positive value for Cohen’s d, as the point estimate indicates a medium
effect size at 0.425.

CAN HOPE BE PRIMED IN CHRONIC PAIN

100

Wilcoxon Signed-Rank Test: Primed Group
Although parametric tests have greater power, that is, greater ability to detect differences,
nonparametric tests are not dependent upon assumptions of normality and were performed as
complementary measures considering the slight skewness and kurtosis of the control group (Kim
& Park, 2019). The Wilcoxon Signed-Rank Test compares the sum of the positive ranks or
outcomes with the sum of the negative. According to this test measure, the median of differences
in the Primed group indicates the increase in hope is significant at the 0.001 level (alpha set at
0.05), rejecting the null hypothesis. There was no pre-test and post-test difference in pain. These
results confirm the paired t-test findings discussed above, rejecting the null hypothesis (i.e., that
there is no significant difference in pre-and post-test scores).
Paired T-Tests: Neutral Group
The same statistical analyses, described above, were performed on the Neutral group’s
data. After establishing a baseline for hope and pain at the present moment (i.e., now), 54subjects were exposed to a neutral pain tutorial and again took the Hope scale and rated pain at
the present moment (i.e., now). In other words, a before and after measurement for each
participant was taken on a four-item scale where six represents high hope and one represents low
hope, and rated pain or discomfort experienced at the present moment (i.e., now) from 0-10, both
before and after reading the neutral tutorial.
The mean of hope before the intervention was 4.578, and after was 4.995. The mean of
pain experienced at the present moment of the pre-test was 5.185 and after 5.055. As in the
Primed group, the paired t-test found no statistical pre- post-difference in pain; however, the
difference in hope was, again, significant at the .001 level. After determining that the difference
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in hope scores reached statistical significance, Cohen’s d was used to calculate the magnitude of
the effect. According to Cohen’s d there is a moderate effect size at 0.546.
As performed on the Primed group sample, the Wilcoxon Signed-Rank Test finds the
median difference of pre- and post-test hope scores to be significant at the 0.001 level (alpha set
at 0.05), and no difference in pain.
Results of Paired Tests: Summary—and Rationale for a Third Group
Two of the research questions guiding this pilot study were: Does exposure to a
positively primed Pain Neuroscience Educational (PNE) tutorial promote hope in respondents
experiencing chronic pain? And does exposure to a positively primed PNE tutorial influence the
experience of pain as perceived at the present moment? In both samples, paired tests
demonstrated that only the dependent variable of hope changed from one analysis to the next.
The difference in pain scores did not reach the level of significance in either group. In both the
Primed and Neutral groups, the Wilcoxon Signed-Rank Test and the paired t-test found
statistically significant differences between the pre-and post-test hope scores at the 0.001 level,
with medium effect sizes, p = 0.05. The Primed tutorial (i.e., hope manipulation) did not perform
better than the Neutral tutorial (i.e., control manipulation). The third question probed whether
hope impacts the perception of pain at the moment (i.e., now). The uptick in hope across both
groups did not correspond with a reduction in pain now (i.e., at the present moment).
These results indicate that while hope increased during the survey process, it could not be
established whether the effect was due to the tutorials, the positively phrased hardiness scale, the
repetition effect, or a combination. As a result, a third group was recruited in an attempt to
isolate and clarify the findings.
Paired T-Test Results: A Third Group is Surveyed
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Since hope increased significantly throughout the survey process for both groups, the
decision was made to reduce the number of variables by removing the positively phrased
hardiness scale in case it was serving as a prime, while keeping all other measures. Although
both tutorials raised hope, the Neutral group had a slightly greater effect size, so the decision was
made to use the Primed tutorial to better isolate any hope effects of the hardiness scale. Fortyone individuals responded and results were uploaded into SPSS. Of these, three respondents did
not qualify, and six did not complete the survey, so the scores of the remaining 32 were
evaluated in SPSS.
This sample includes 23 females and nine males; and aside from a participant citing
Canada as country of origin, all others listed their country of origin as the United States. As in
the Primed and Neutral groups, the mean age was 4.6 which corresponds to the same 45-54 age
group. The mean of typical pain throughout the past year was 6.18.
For statistical purposes, as in the other two groups, a test of normality was performed on
the difference in hope scores, pre-test and post-test. According to the Shapiro-Wilk Test of
Normality, this sample was normally distributed with skewness of 0.862 and kurtosis of 0.545;
therefore, a paired t-test was performed. As in the Primed and Neutral groups, there was no
difference in pain, as pre-test and post-test scores for pain at the present moment (i.e., pain now)
did not reach statistical significance at 0.165. However, the difference in hope––as in the other
two groups––was significant at the 0.001 level, with a medium effect size at 0.67 (Cohen’s d)––
which is somewhat greater than the other two groups.
Although effect sizes have been reported, it should be noted that after adjusting for the
pre-intervention hope scores, an Analysis of Covariance did not find a statistically significant
difference in post-intervention hope between the three groups, p = 0.660.
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In summary, and for ease of comparison, Table 1 compares the paired t-tests results of
hope, before and after, and effect sizes of all three groups. Pain ratings did not change in any
group, but in all three groups the change in hope was significant at the 0.001 level. In the Primed
group (n = 68) the effect size was 0.425, in the Neutral group (n = 54) Cohen’s d was 0.546, and
in the Primed Without Hardiness group (n = 32) it was 0.672. Although the effect size appears
greater in the Primed Without Hardiness group, an Analysis of Covariance (i.e., ANCOVA) did
not find a significant difference between groups, p = 0.660.
The final research query involves the potential relationships among the variables of hope,
pain, and hardiness in this sample population. The next section of this chapter examines these
findings.
Relationships: Pearson’s Correlation Coefficient
To better characterize the sample chronic pain population, this inquiry also measured the
trait factor of stress-hardiness to examine the relationship between this factor and the outcomes
of pain perception and the experience of hope.
Bivariate correlation analysis determines the strength and direction, whether positive or
negative, of the relationship between two continuous variables; in this case, between hope and
hardiness, hope and pain, and between pain and hardiness. A bivariate analysis can be
descriptive or inferential, but in both cases, it is used to examine the relationship between two
variables. Pearson’s bivariate correlation coefficient assumes a linear relationship between
variables, best confirmed by a scatterplot.
In a scatterplot, each point represents the intersection of two variables, and the line
indicates the correlative (i.e., not causal) nature of the relationship and its direction. Although a
non-linear relationship is possible, a scatterplot confirmed a linear relationship between the two
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variables of hope and hardiness, indicating Pearson’s bivariate correlation coefficient to be the
appropriate test statistic for this evaluation, which will be discussed in more detail later in this
section.
The analysis of the correlation between hope and hardiness should be distinguished from
the hope difference. The trait of hardiness does not explain the difference in hope––pre-test and
post-test Hope scales––in the Primed and Neutral groups, as it was barely significant at the 0.07
and 0.24 levels accordingly (e.g., a strong correlation is +/- 0.50 and 1.0). Likewise, there was no
pre-test and post-test difference in pain, therefore, no statistically significant relationship with
hardiness in this particular test statistic.
However, Pearson’s Correlation Coefficient demonstrates a significant and strong
correlative relationship between hardiness and hope in the Primed and Neutral groups. In the
Primed group, the before measure, HopeT1 (i.e., time 1), is strongly correlated with hardiness at
0.73, as is HopeT2 (i.e., time 2), at 0.72, p = 0.01 level. Likewise, a significant correlation was
found between hardiness and hope in the Neutral group, which became stronger post-test, as
indicated by Pearson’s Correlation Coefficient for HopeT1 (i.e., before) and HopeT2 (i.e., after)
at 0.58 and 0.83, respectively, p = 0.01 level. On the other hand, there is no meaningful
relationship between pain now, before and after, and hardiness, r = 0.09 and 0.20, p = 0.05.
Although there was no difference between the baseline measure for pain at the present
and the post-test measure in either group, the researcher wanted to know if there was a
relationship between typical pain experienced throughout one year (i.e., as opposed to pain at the
present moment) and hardiness. Pain throughout the year was assessed only once in the pre-test,
prior to being exposed to either the hope intervention or the control intervention, or the Adapted
Hardiness scale.
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In the Primed group, Pearson’s Correlation Coefficient found the relationship between
hardiness and an individual’s typical pain level to be significant at the 0.01 level, and moderately
correlated at -0.32, indicating an inverse relationship: As hardiness levels rise, typical pain
experienced throughout the year decreased (i.e., an upper left to lower right pattern on the
scatterplot). Moderate correlation is established between 0.30 and 0.49. The relationship was
weaker in the Neutral group but still statistically significant, r = -0.29, p = 0.05, confirming an
inverse correlation between hardiness and typical pain.
Therefore, typical pain experienced throughout the year (i.e., as opposed to pain at the
present, measured before and after) appears to be moderately and inversely correlated with
hardiness in the Neutral and Primed groups (n = 122). A linear relationship between these two
variables was established by a scatter plot confirming that Pearson’s Correlation Coefficient was
an appropriate test statistic to examine the strength and direction of the two continuous variables,
hardiness, and typical pain throughout the year.
A correlation analysis was also performed to gauge the association between typical pain
throughout the past year and hope. In both the Neutral and Primed groups (n = 122), the
correlation was significant at the 0.01 level, indicating a moderate inverse relationship (-0.41 for
the Primed group and -0.44 for the Neutral group) between pain and hope. In contrast, no
significant correlation between hope and typical pain throughout the last year was found in the
Primed Without Hardiness group (n = 32), r = 0.037.
Summary of Correlations
The final guiding query concerned the relationships among the traits of stress-hardiness,
hope, and pain. Pearson’s Correlation Coefficient found hope to be strongly correlated with
hardiness in the Primed and Neutral groups at -0.73 and -0.83 respectively, and significant at the
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0.01 level. As hope rose, hardiness did as well. Hardiness and pain were significant at the 0.05
level with a correlation of -0.29 in the Neutral group, with a more moderate correlation between
hardiness and pain at -0.32, significant at the 0.01 level, in the Primed group. There was,
however, a stronger, inverse relationship between typical pain and hope (using the pre-test
measure of HopeT1), significant in the Primed and Neutral groups at the .01 level, r = -0.41 and 0.449 respectively.
A striking difference was observed in the third group (n = 32), where–-unlike the other
two groups––no correlation between hope and pain was found. Since hardiness was not assessed
in this group, the pre-test hope score was correlated with typical pain throughout the past year
and no relationship between the two was found in this group as evidenced by Pearson’s
Correlation Coefficient, r = 0.037.
Summary
This study was constructed to understand the effect of a priming intervention designed to
instill hope and to explore the relationship between hope and the perception of pain. This chapter
reported the findings of several analyses carried out on the primary sample of 122. After
examining the results, a revised survey was constructed, and an additional 32 qualified
participants were recruited (N = 154). This chapter was organized by test statistics for ease of
comparison between groups.
There were no significant demographic or descriptive differences between the Primed (n
= 68), Neutral (n = 54), and Primed Without Hardiness (n = 32) groups. Likewise, the Primed
and Neutral groups (n = 122) scored similarly on the variables of hope, pain, and stresshardiness. As a result of these analyses, the randomization of the experiment appears successful.
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A central guiding question was whether hope can be primed via brief, written
communication in respondents experiencing chronic pain. Further questions were: Does
exposure to a positively primed PNE tutorial influence the experience of pain (i.e., as perceived
at the present moment)? Does hope impact the experience of pain as perceived at the present
moment (i.e., now)? And finally, what is the relationship between hope, pain, and the trait of
stress-hardiness?
To answer these questions paired tests and correlational analyses were performed. Paired
t-tests were conducted to compare means between the pre-test and post-test samples, but due to
the presence of kurtosis, a nonparametric test, the Wilcoxon Signed-Test was also performed as a
supplemental statistic. Neither paired test demonstrated a significant difference between the two
groups in the pre-test and post-test scores for the dependent variable of pain; however, both the
Primed and Neutral groups showed a significant gain in hope at the 0.001 level, with a medium
effect size. Therefore, hope did not change as a result of the primed intervention, but it did
change in both conditions (i.e., the hope manipulation and the control manipulation) throughout
the process of taking the survey. The gain in hope, across both samples, did not affect pain as
perceived at the moment.
To define the variable potentially responsible for raising hope, a third survey was
developed, and 32 qualified participants were recruited. This new survey eliminated the
hardiness scale in case it was serving as a prime. The sample proved to be normally distributed,
and similar to the other two groups demographically. Furthermore, the mean of hope “before” in
all three groups is comparable: Primed group, M = 4.31, Neutral group, M = 4.57, and Primed
Without Hardiness, M = 4.42. A paired t-test found the hope difference in the third group to be
significant at the .001 level, but with a somewhat greater effect size than the other two groups

CAN HOPE BE PRIMED IN CHRONIC PAIN

108

(i.e., r = 0.672, compared with 0.546 for the Neutral group and 0.425 for the Primed). As shown
in Table 1, the increase in hope was statistically significant, with medium effect sizes, in all three
groups, with the greatest effect size in the Primed Without Hardiness group. Nevertheless, an
Analysis of Covariance did not find a statistically significant difference between groups, p =
0.660.
To better characterize the sample population, this inquiry also measured the trait factor of
stress-hardiness in participants in the Neutral and Primed groups. This approach allowed the
researcher to examine the relationship of this factor and the outcomes of pain perception and the
experience of hope, via Pearson’s Correlation Coefficient. In both groups, there was a strong
correlation between hope and hardiness, an inverse medium correlation between pain and
hardiness, and an inverse medium correlation between hope and pain.
In terms of correlations, an exception was found in the Primed Without Hardiness group
where hope and pain were not correlated, r = 0.037. In other respects, the three groups are quite
similar, but the lack of correlation in this particular sample (n = 32) is notable.
Having presented the findings in this chapter, the final section will discuss the strengths
and limitations of the project, conclusions that can be drawn in light of existing literature, and
future directions for research.
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CHAPTER FIVE: DISCUSSION
As methodological details and the results of the experiment were covered in Chapters
Three and Four, this final chapter interprets the findings in view of existing literature with an
emphasis on implications for future research and clinical application. The first section of this
chapter supports the rationale for this study in view of gaps in health priming literature, while the
following section interprets the results according to each guiding research question. A discussion
of the limitations and delimitations of the study follows, with a focus on how these may be
addressed by future research. The final section highlights conclusions that can be drawn from the
findings, how the project contributes to the literature, directions for future research and
implications for clinical practice.
The Rationale: Addressing Gaps in Priming Literature
While the downstream effects of mindsets and self-efficacy beliefs are widely
recognized, effective intervention tools are lacking (Papies, 2016). This pre- and post-test
experiment, consisting of two randomized parallel groups, was designed in response to a
collective call for research in nonconscious processes aimed at clinical application (Sheeran et
al., 2013). Therefore, this study contributes to cross-categorical research with a goal of
improving outcome.
Chronic pain, affecting more than fifteen percent of the world population and twenty
percent of the US population, was selected as the target condition. In the aggregate, biomedical
treatment for chronic pain is burdened by poor outcomes. When pain becomes chronic, “it can
lead to dramatically reduced quality of life, depression and suicide, insomnia, lowered immune
function, changes in eating patterns, impaired cognitive function, maladaptive stress responses,”
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and other long-term deleterious effects (2015, p. 23). Even so, chronic pain is seldom studied in
clinical practice (Brascher et al., 2018).
More recently, findings in pain perception contributed to the development of pain
neuroscience education (PNE) as a treatment for chronic pain, coded for reimbursement by
Medicare. Although adaptive mindsets are critical, according to Rondon-Ramos et al. (2020), the
first trial to evaluate PNE in modulating self-efficacy beliefs in chronic pain was conducted in
2020. Furthermore, this researcher was unable to locate studies investigating its impact on hope.
Self-efficacy beliefs and adaptive mindsets––including the actionable quality of hope––are
recognized as essential to the attainment of valued goals (2020), and while these may be
addressed in PNE as part of a biopsychosocial program, long-term effects and adherence have
proved disappointing (Wood & Hendrick, 2018).
Priming methods, on the other hand, are purported to be more effective than purely
conscious methods in recalibrating mindset, attitudes, beliefs, and health behavior (Elgendi et al.,
2018; Papies, 2016; Sheeran et al., 2013; Wryobeck & Chen, 2003). Since priming does not
appear to have been investigated in PNE, and attitudes and beliefs correlate strongly with wellbeing and health outcomes (Coughlin, 2006; Van Tongeren & Bernette, 2018), this research
project also addresses a gap in clinical pain education research.
Additionally, there is little extant literature on priming hope, particularly in chronic pain.
Hope––while well-represented in depression literature––is seldom studied in physical health
outcomes and chronic pain despite its association with reduced morbidity and all-cause mortality
(Long et al., 2020). Notwithstanding its determining role, hope is seldom studied in expectancy,
priming and placebo research (Eaves et al., 2016). Claessen et al. (2016), for example,
encouraged the study of “positively phrased words and concepts [that] can prime and coach

CAN HOPE BE PRIMED IN CHRONIC PAIN

111

patients to be less ill for a given pathophysiology” (p. 54), inspiring this investigation to explore
the feasibility of priming hope in chronic pain conditions. A primary guiding research question,
then, was whether hope could be primed in chronic pain, a population particularly vulnerable to
loss of hope (Kerns et al., 2014).
And finally, although resiliency measures are commonly studied, the trait of stresshardiness has been found to be supportive of mental and physical health and is seldom
investigated in pain conditions (France et al., 2020; Zerach, et al., 2020). Consequently, this
project supports the call for targeted interventions that evaluate stress-hardiness in chronic pain
populations.
Summary of Findings
A pre- and post-test intervention study consisting of two randomized parallel groups,
hope manipulation v. control manipulation, was selected to investigate the primary research
questions: Can hope can be primed via brief, written communication in respondents experiencing
chronic pain? Does exposure to a positively primed PNE tutorial influence the experience of pain
(i.e., as perceived at the present moment)? Does hope impact the experience of pain as perceived
at the present moment? And finally, what is the relationship between hope, pain, and the trait of
stress-hardiness?
To avoid the common pitfall of underpowered pilot studies (Freedland, 2020), an a priori
power analysis indicated a sample of at least 75 was needed to detect a medium effect size
between 0.3-0.5 (Cohen’s d) with alpha set at 0.05. A post-hoc power analysis confirmed that the
sample size (N = 154) provided sufficient statistical power in tests within and between subjects at
0.972 and 1.0 respectively, to detect a medium effect, p = 0.05 (Cohen, 1988; Lenth, 2001).

CAN HOPE BE PRIMED IN CHRONIC PAIN

112

Since the social context and an experimenter’s expectations can influence the placebo
response, this investigation eliminated the risk of investigator bias and/or influence by
administering all scales anonymously via a web link, and there was no physical interaction
between researcher and participants. Participants were also unaware of the prime and the purpose
of the study. After being exposed to the pain scale, a baseline of hope was established. Then, 122
of the 154-participants also completed a hardiness scale. Next, all participants (N = 154) focused
on pain related material (i.e., the pain condition), either in the form of a relatively neutral pain
tutorial or a primed PNE, before completing the Hope scale again (i.e., post-test) and rating pain
at the present moment (i.e., now).
To answer the guiding research questions paired t-tests and correlational analyses were
performed. Paired tests (N = 154) demonstrated a significant gain in hope at the 0.001 level, with
a medium effect size at 0.425, 0.546 and 0.672 for the Primed, Neutral and Primed Without
Hardiness groups, respectively, as shown in Table 1. The increased effect size in the third group
could be due to the smaller sample, as an Analysis of Covariance did not find a statistically
significant difference between the three groups, p = 0.660. Accordingly, it can be assumed that
variations between groups are likely insignificant. Therefore, there was a statistically significant
gain in hope in both conditions (i.e., the hope manipulation and the control manipulation)
throughout the process of taking the survey, with and without the hardiness scale (N = 154).
Pain––as perceived at the moment––did not change as a result of the tutorials, nor did the gain in
hope as seen across all samples, affect pain as perceived at the moment.
Statistically significant correlations were found among hope, hardiness and typical pain
experienced throughout the year. A moderate, inverse correlation between hope and typical pain
was seen in the Primed and Neutral groups (n = 122) at the 0.01 level, r = -0.41, -0.449, p = .05.
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An exception was found in the Primed Without Hardiness group (n = 32) where hope and pain
were not correlated, r = 0.037. An inverse correlation between hardiness and typical pain
throughout the past year was statistically significant at the 0.01 and 0.05 levels for both the
Primed and Neutral groups, accordingly, and moderately correlated at -0.32 and -0.29, p = 0.05,
respectively (Cohen’s d). Moreover, there was a strong correlative relationship between
hardiness and hope in both groups (n = 122) at 0.73 and 0.83 respectively, p = 0.05. Although
elevated hope was more closely correlated with pain reduction than hardiness, the trait of
hardiness is similar in that stress-hardy individuals seek to take responsibility for their behavior
and attitudes via challenge, commitment, and control (Zerach et al., 2020).
Interpretation of Findings
In addition to the above, detailed descriptions of the experimental design (i.e., pre-test
and post-test hope manipulation v. control manipulation) and outcome measures can be found in
Chapters Three and Four. In sum, paired tests investigated the primary research questions, while
further conclusions were derived from correlational analyses. The sections that follow present
the conclusions drawn from those results. While the guiding research questions are interrelated,
the findings and associated contributions for each are considered individually prior to being
discussed collectively in the concluding section.
The First Guiding Question: Priming Hope
The first guiding research question was: Does exposure to a positively primed PNE
tutorial promote hope in respondents experiencing chronic pain (i.e., can hope be primed via
brief, written communication among participants experiencing chronic pain)? The results suggest
that hope can be primed in chronic pain, however, the mechanism for the effect is not clear. In all
three arms (N = 154), Neutral, Primed and Primed Without Hardiness, the differences in the
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mean scores of hope, before and after the intervention, were significant at the 0.001 level with
medium effect sizes as seen in Table 1.
There are several possible explanations for the notable gain in hope exhibited by all
groups. The most obvious is that great care was taken to avoid the nocebo effect (Brascher et al.,
2018) when constructing the Neutral tutorial. Although the Neutral tutorial did not feature new
findings in pain science, nor provide a specific reference to hope, it did validate the pain
experience and offer supportive language for communicating the unique nature of pain
perception. A neutral tutorial on a different topic (e.g., organic gardening) selects against a pain
focus and would not enable an adequate comparison of the two groups, as the experimental
group (i.e., hope manipulation) was required to focus on pain throughout the survey. Were the
control group to be exposed to a non-pain related topic, any subsequent change in hope could be
attributed to the distraction. By requiring all subjects to focus on pain, conditions are consistent
across groups and results are potentially more applicable to clinical practice, in that, patients are
focused on pain when seeking treatment or participating in PNE. It is conceivable then, that this
relatively neutral educational piece increased hope among participants.
The possibility that the positively phrased hardiness scale functioned as a prime was
addressed by recruiting a third group. Since hope increased significantly throughout the survey
process for both the Neutral and Primed groups (n = 122), a third group (n = 32) was exposed to
the Primed tutorial but without the hardiness scale, while keeping all other measures. The
significant gain in hope, at the 0.001 level, demonstrated by this third group––coupled with a
moderate effect size––verified that the hardiness scale did not serve as a prime. The conclusions
that can be drawn from the addition of the third group is that the hardiness scale did not increase
hope, nor was the Neutral tutorial more effective than the Primed tutorial.
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So, if the increase in hope was not due to the hardiness scale, nor to a notable advantage
of either the Neutral or Primed tutorial, what other explanation is there? In the final analysis,
there is another intriguing possibility to consider: repetition priming (Henik & Carr, 2002,
Inhibition). In this study, the repetition of the Hope scale (i.e., baseline and post-intervention)
could have elevated hope independently of the tutorials or had an additive effect, particularly
since two of the positive phrases were in the first person (e.g., it is possible for me to reach goals;
the future seems hopeful to me).
The increase in hope over such a short period of time, however, is notable for another
reason: it underscores the malleability of hope and the potential effect(s) of even brief exposure
to words––whether through the Hope scale, educational tutorials, or a combination of the two
(Claessen et al., 2016; Crum & Zuckerman, 2017; Zion et al., 2019), even while focusing on pain
and related sequelae.
In sum, to answer the initial research question––can hope be primed in chronic pain––the
answer is yes. However, the mechanism for this effect is not clear. All groups experienced a
statistically significant gain in hope. While it is possible that both the Primed and Neutral
tutorials served as primes, the repetition of the Hope scale could have promoted hope
independently or interacted in an additive manner with the tutorials. Future research, with a
much larger sample, could distill results by administering the Hope scale before and after
standard pain questionnaires at routine screenings in treatment centers, thereby isolating any
effects.
Having explored whether hope can be primed, what of pain? Was pain at the moment
affected by the Hope scale or the tutorials? Guiding research questions related to pain perception
are discussed in the following section.
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The Second & Third Guiding Questions: Pain Perception
An analysis of the remaining guiding research questions revealed additional contributions
to priming literature. “While the majority of studies on placebo hypoalgesia and nocebo
hyperalgesia examined healthy participants, only few investigated pain patients and even less
focused on clinical pain” (Brascher et al., 2018). By gauging pain at the present, two interrelated
guiding questions were evaluated: whether exposure to a primed PNE tutorial influenced pain as
perceived at the present moment, and if an elevation in hope corresponded to a perceived
difference in pain. Paired t-tests showed pain at the present moment (i.e., now) did not change in
this study. Neither the Primed tutorial (n = 100), the Neutral tutorial (n = 54) nor the hardiness
scale (n = 122) acted as an intervention in pain. Further, the notable increase in hope across all
groups (N = 154) was not correlated to outcomes in pain perception at the present.
In brief, these findings are in line with classical conditioning in placebo research,
wherein, pain relief accompanies implicit cues and verbal suggestions (i.e., spoken or written)
(Brascher et al., 2018)––which was not the case in this study to avoid interference in the
evaluation of hope. Put another way, priming/placebo effects are “related to the broader concept
of expectancy . . . [in that] positive expectancy means the outcome is positively influenced and
negative expectancy means the outcome is negatively influenced” (Claessen et al., 2016, p. 48).
In this investigation there was no explicit or implicit suggestion that the intervention would
affect pain. Before exploring the reasons for this design choice further, a primary question must
be addressed: Is pain malleable in the moment?
Pain research indicates the answer is, yes. Verbal suggestion appears highly effective for
acute procedural as well as chronic pain even after open-label placebo administration (Brascher
et al., 2018). Equivalent results are also seen in nocebo pain responses. In one study, patients
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“primed with pain-related questions with a negative connotation showed an increased pain rating
compared with the control group” (Claessen et al., 2016, p. 54). Conversely, in Claessen et al.’s
(2016) investigation, positively primed subjects experienced a gain in functional mobility but not
a reduction in pain. In part, this could be attributed to repeated therapy failure––common in
chronic pain––that “might lead to weakened placebo or persistent nocebo effects potentially
contributing to the maintenance of chronic pain” (Brascher et al., 2018, Clinical Context, para.
5). In terms of PNE, a systemic review and meta-analysis found that it produced statistically
significant but clinically small improvements in pain (Clarke et al., 2011).
Such contrasting findings contribute to the notion, supported by pain science, that
perception (i.e., interpretation) drives the sensate experience. Pain, like pleasure, becomes part of
the neural network and emotional memory circuitry of the brain reflecting “moment-to-moment
shifts in value judgments regarding the self and regarding the relationship between the self and
the environment” (Baliki & Apkarian, 2015, p. 9). To clarify the role of perception in pain,
Baliki & Apkarian (2015) cite the example of a ballerina applying 50 kg of weight on a 1 cm
area of skin. In purely biological terms the weight should be excruciating, yet the actual
experience is gratifying. Although pain perception is reported to be highly malleable in the
moment, “pain and negative moods are envisioned as a continuum of aversive behavioral
learning, which enhance survival by protecting against threats . . . [in which] the limbic brain
plays a critical role” (Baliki & Apkarian, 2015, p. 1). It is conceivable, then, that an increase in a
positive emotion like hope could have imparted a measure of pain relief in the here-and-now
(i.e., at the present moment) among participants in this project, particularly since “conditioned
placebo and nocebo effects in pain [can occur independently] of explicit expectation” (Brascher
et al., 2018, Clinical Context, para. 5).
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In this study, to better isolate the hope effect, there was no suggestion that the
intervention (i.e., exposure to the tutorial) would affect pain at the present, nor was there an
implicit or hidden cue implying pain would decrease. There are three primary reasons the study
was constructed without priming for pain relief. If, for example, hypoalgesia primes were
included––and pain decreased and hope elevated––the results could be incorrectly conflated, in
that a reduction in pain contributed to gains in hope. Without this interference hope was
effectively isolated––its rise due to either the tutorials, the Hope scale, or a combination of the
two. Secondly, as it stands, there is an existing body of evidence that supports the verbal (i.e.,
written) effect of priming (i.e., placebo) on pain––but not on hope. The study’s design, therefore,
provides a unique contribution to priming research.
The third reason is that the primed tutorial was designed to reflect the PNE model by
implying that new learning and skills can lead to pain relief. Had it contained an implicit or
explicit cue suggesting pain would be reduced at that very moment, it would not have mirrored
PNE content. Since the tutorial was not primed for hypoalgesia effects, the researcher was able
to explore whether a reduction in pain would accompany the information, and/or any elevation of
hope. Future research could explore implicit and explicit hypoalgesia primes in PNE. In clinical
practice, hypoalgesia priming may be further enhanced when suggested by the treating physician
and allied health professionals (Crum & Zuckerman, 2017).
This investigation also measured a trait seldom studied in chronic pain (Zerach et al.,
2020): the factor of stress-hardiness. The correlations among hardiness, pain perception and the
experience of hope will be discussed in the following section.
Correlations: Hope, Stress-hardiness & the Experience of Pain
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This study incorporated correlational analyses that contribute to an understanding of the
relationship among chronic pain, stress-hardiness, and hope. As discussed in the previous
section, there were no pre-test post-test differences in pain at the present moment, but the
researcher also wanted to know if there was a relationship between the pre-test measure of hope
and typical pain throughout the past year (i.e., as opposed to pain at the present moment). Indeed,
in both the Neutral and Primed groups (n = 122), the correlation was significant at the 0.01 level,
with a moderate inverse relationship, r = -0.44, -0.41 respectively, p = 0.05, in that, as hope
increased the experience of typical pain decreased. The association between hope and pain
perception is not surprising considering the “remarkable overlap between the brain structures . . .
affected by pain chronification and pathological negative moods” such as hopelessness (Baliki &
Apkarian, 2015, p. 39). It may be, then, that the mindset of hope, as related to agency, is
protective, with downstream effects contributing to pro-health behaviors that moderate pain
perception.
Surprisingly, however, the third group (n = 32) did not demonstrate a correlation between
hope and pain on average, r = 0.037. It could be reasoned that since this group was not exposed
to the hardiness scale it interfered in some fashion. This was not the case, however, as typical
pain throughout the past year was correlated with the pretest measure of hope in the primary
groups (n = 122), prior to the administration of the hardiness scale. Without definitive data to
explain the difference in the third group, apart from its smaller size (n = 32), a much larger
sample could better clarify the relationship.
While attitudinal measures such as “positive affect, pain acceptance, optimism and hope”
(France et al., 2020) have been associated with improved outcomes, the protective characteristics
of stress-hardiness are seldom studied in chronic pain. The unique facets of this
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multidimensional disposition––commitment, control and challenge––distinguish hardiness from
other resilience measures (Zerach et al., 2020); therefore, exploring this trait was a goal of this
investigation.
In this study, the relationship between hardiness and typical pain throughout the past year
was statistically significant at the .01 level and inversely correlated at -0.32 and -0.29, p = 0.05
for the Primed and Neutral groups, respectively. In other words, as hardiness levels increase, the
level of typical pain decreases. Moreover, there was a strong correlative relationship between
hardiness and hope for the Primed group, r = 0. 73, p = 0.05. The Neutral group’s pre-hope score
was moderately correlated with hardiness at 0.58 and the post-hope score strongly correlated at
0.83 (i.e., Cohen’s d). Although hope was more inversely correlated with pain than hardiness,
the trait of hardiness is similar in that stress-hardy individuals take responsibility for their
behavior and attitudes (Zerach et al., 2020). As a notable aside, to date this is the first study
comparing and contrasting Long et al.’s (2020) revised Hope scale with the trait of stresshardiness. The correlation between the two indicates that this unique scale captures a vital aspect
of agency.
In some studies, adaptive states (e.g., resilience) have been shown to foster adherence to
health behaviors despite intense and prolonged pain (France et al., 2020). While such states
promote a higher quality of life, in a review of the literature France et al., (2020) did not find an
association between adaptive states and pain reduction. In this investigation, however, the
actionable quality of hope was moderately correlated with lower levels of pain throughout the
year, echoing longitudinal findings (Long et al., 2020; Rondon-Ramos et al., 2020), and strongly
correlated with hardiness. The variability could be due to several factors, including discrepancies
within resilience measures, as noted in the discussion of optimism and hardiness in Chapter
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Three. Further, adaptive states––while clearly beneficial––do not necessarily imply that one
finds meaning in difficult or challenging circumstances (i.e., hardiness). It is beyond the scope of
this paper to contend with such conflicting findings, but they offer a rich opportunity for future
research.
Nevertheless, capitalizing on the association between hope and hardiness could offer
promising results in clinical practice. While short-term gains of PNE have been encouraging,
long-term adherence has been poor (Wood & Hendrick, 2018). As hardiness and hope were
moderately but significantly correlated with pain reduction over time, could targeted hardiness
training, as suggested by France et al. (2020), yield––not only a measure of pain relief––but
improved adherence to biopsychosocial and PNE programming? Likewise, would hope priming
in chronic pain contribute to gains in hardiness over time? These questions cannot be answered
with the current data but could be pursued more directly in another project.
In conclusion, the study design and its findings highlight both the malleability of hope
and its correlation with pain reduction and the trait of hardiness over time. As “hope has rarely
been considered in discussions of expectancy and the placebo response” (Eaves et al., 2016, p.
3), this investigation addresses gaps in health priming and chronic pain literature. To further
contribute to the field, the limitations, and delimitations of the investigation, and how these may
be addressed by future research, will be discussed in the following section.
Limitations, Delimitations & Future Research
It is important to note several factors that limit the generalization of findings to broad
pain populations. This study, for example, limited participation to adults experiencing chronic
pain for at least one-year and does not capture the experience of younger patients, those whose
pain is of a shorter duration, nor individuals who have recovered from chronic pain. Further, the
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self-selection bias assumes that “systematic differences may be present between subjects who
choose to respond to a survey compared to those who do not” (Oppenheimer et al., 2012, Bias
section, para. 3). The effect of hopelessness on motivation (Jaremka et al., 2014) is an additional
factor which could indicate that individuals inclined toward hope were more likely to participate.
On the other hand, it could be that high functioning individuals with chronic pain were
unwilling to spend time taking the survey, biasing the sample toward more debilitated
individuals. By way of example, a Reddit chronic pain community with more than 50,000
members advertises: “For the broken, malfunctioning, pained people of the world and their
friends/family. Got pain? This is the place to be. Bitching, complaining, whining, and otherwise
venting about your condition is encouraged” (https://www.reddit.com/r/ChronicPain/). Since the
study was accessed online, individuals inclined to participate in this type of forum could have
been surveyed as well.
Moreover, survey participation required access to a computer or smart phone, therefore, it
may or may not have captured a variety of demographic contexts. Although libraries, prior to the
SARS-CoV2 pandemic, provided computer access, these were not widely available at the time of
survey completion. Therefore, the sample is skewed toward English speaking individuals who
have access to technology. Future research could correct for this by implementing a similar
investigation at various pain clinics that provide electronic or paper versions.
Additional research with a much larger sample could correct for some of these
limitations. For example, while the sample in this study was mostly female (70-80%)––mirroring
the prevalence in the chronic pain population––a pain center may treat more men who could be
surveyed. Pain clinics and treatment centers are ideal environments to implement novel priming
methods and collect relevant data. Greater collaboration between researchers and physicians
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could further cost-effective data collection contributing to enhanced clinical application and
improved outcomes. A database of cross-over studies like this one (i.e., inclusive of
psychological priming and medical placebo) could incentivize collaboration and spark ingenuity.
Since this study gauged the perception of chronic pain and its relationship to hope, the
influence of comprehensive health status and pain medication was not accounted for. Future
research could include relevant medical data that could be analyzed and correlated to hope and
pain perception.
With an objective to do no harm, a delimitation of this investigation is that it did not
assess the difference in hope utilizing a negative prime. Brascher et al. (2018) explain, “due to
ethical constraints, nocebo hyperalgesia cannot be investigated as rigorously as placebo
hypoalgesia in clinical samples” (Clinical Context, para.5). Nevertheless, catastrophic pain
statements were used by Claessen et al. (2016) as a negative prime. Pain catastrophizing is
“empirically associated with greater disease severity, disability and poorer treatment outcomes”
(Farris et al., 2020, p. 928). As such, scales and health questionnaires in clinical practice could
unintentionally operate as negative primes, therefore a protective stance is clearly warranted.
Additionally, to control for Type I errors rigorous alpha levels were adopted and
therefore may have increased the likelihood of Type II errors, particularly given the study’s
relatively small sample size (N = 154). Future research could focus on designing low-cost
priming studies in clinical settings with hundreds if not thousands of subjects, thereby increasing
power, reproducibility, and a greater store of knowledge from which to draw.
Finally, although the gain in hope was statistically significant, it is unknown how long the
influence of hope priming lasts. Primes have been shown, though, to remain operational even
when expectancy was extinguished. Put another way, when the prime or the placebo was
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revealed as inert, the effects persisted (Brascher et al., 2018). Further priming research is needed
to explore and clarify this issue, but clinical practice could scaffold primes in web pages, health
questionnaires and through verbal discourse.
In summation, a pre- and post-test experimental design (i.e., intervention study)
consisting of two randomized parallel groups, was selected to best answer the primary research
questions, and contribute to a nuanced understanding of the relationship among chronic pain,
pain education, hardiness, and hope. Utilizing a much larger sample from a pain clinic could
correct for some of the limitations discussed. Suggestions for future research include assessing
the hope difference utilizing a negative prime and designing low-cost priming studies with
improved methodology (i.e., power) in clinical settings.
Conclusions: Implications for Research & Clinical Practice
This pre- and post-intervention study suggests that unconscious exposure can prime or
condition implicit attitudes apart from conscious goal setting, supporting the utilization of
positive primes in clinical practice.
While positive traits and mindsets are associated with greater overall health and lower
all-cause mortality, their malleability (DuPont, 2020) underscores the relevance of attitudinal
interventions. Of these, nonconscious methods are believed superior to conscious deliberation
(Moskowitz, 2009; Papies, 2016). However, priming is not well-integrated among medical,
psychological, and behavioral sciences and most published studies call for more research aimed
at clinical application.
Classification conflicts, coupled with a striking lack of conceptual clarity in published
research, are limiting factors in advancing priming research (Hollands et al., 2013). As
Shashkevich (2017) and Sheeran et al. (2013) argue, the time and energy lost in debate could be
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spent focusing on developing effective priming interventions for health and well-being (Fatemi,
2016).
While substituting an inert substance for an active medical treatment (i.e., placebo) can
be ethically complex, utilizing verbal primes are less so. Primes are used regularly––if not
consciously––when physicians share positive expectations or provide encouraging findings about
a new treatment, but they can be classified as a placebo or a prime depending on the discipline.
This study suggests that the briefest of verbal conditioning may have significant effects on mood
(e.g., hope) and motivation (i.e., agency), and need not be cumbersome, complex and time
consuming to incorporate in clinical practice.
The same applies to disentangling expectations from conscious versus unconscious
conditioning effects. Although such distinctions are useful in psychological investigations
exploring the nature of the subconscious, they unnecessarily burden health priming research
(Brascher et al., 2018). While the mechanism behind priming/placebo may be debated, their
power is not. The results of this cross-sectional study align with a growing consensus that
restrictive classifications of conscious v. non-conscious priming (e.g., supraliminal, and
subliminal) and the sectarian nature of priming research (e.g., medical placebo v. psychological
primes) hinder an inclusive meta-analysis, reduce growth in the field and limit opportunities for
clinical application.
Accordingly, this paper focused on the clinical application of conditioning elements,
thereby defining priming in broad terms. Even so, participants had no expectation that hope was
being manipulated, nor that it could increase; hence, this study would be considered a subliminal
(i.e., nonconscious) priming investigation by most, and a supraliminal investigation by some.
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Such restrictive distinctions could artificially limit search results, impinge on cross-sectional
dialogue, and stymie the development of novel applications of priming in clinical settings.
As noted, this author was unable to locate studies on priming hope in chronic pain.
Consequently, this study addresses an important demand since hope, according to Eaves et al.
(2016), has its own distinct biovalue including stakeholders such as the biomedical research
sector and patient advocacy groups. It can be argued that any biovalue should first be realized in
medical care where the overarching imperative to do no harm recognizes that depletion of hope
is toxic to the organism. Since words and their context function as primes, they play a critical
role in chronic pain and other diseases (Brascher et al., 2018).
Pain-related beliefs are predictive of quality of life (France et al., 2020), thereby
warranting feasible intervention strategies that target implicit beliefs and activate health goals
(Papies, 2016; Vanaelst et al., 2016). Underscoring the potential, positive mindsets have topdown effects (i.e., physiological enhancements), contributing to a reduction in co-morbidities
associated with chronic pain (DuPont et al., 2020). The weight of evidence notwithstanding, it
bears repeating that despite a relatively robust literature on pain and placebo dynamics, little has
been done in a clinical setting (Brascher et al., 2018). Therefore, this study also helps fills a gap
by highlighting both the malleability of hope and its correlation with pain reduction over time.
This investigation also explored the relationship among hope, pain, and stress-hardiness.
The results align with findings that show “self-efficacy beliefs are associated with less physical
impairment and pain intensity in people with chronic pain” (Rondon-Ramos et al., 2020, p.1). To
gain further insight on the relationship between stress-hardiness and hope, as well as the apparent
alliance between the hardiness measure and Long et al.’s (2020) revised Hope scale, future
research is needed, with a much larger sample.
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Beyond these constructs, however, the evidence suggests a need for optimized education
and targeted strategies that foster hope and advance stress-hardiness in health care. One of the
challenges facing clinicians is the need for practical and economical delivery methods
(Freedland, 2020). Given the potent downstream effects of mindsets, repeated exposure to
primed materials, in paper and online, relieve the burden of time stress on medical professionals.
A scaffolding of methods need not be complex. Cost effective surveys can contribute to
the development of more effective communication tools (e.g., tutorials and questionnaires) and
priming opportunities. Claessen et al., 2016, argue that health can be improved “by consistently
using positive language and concepts in medical care” (p. 48). As illustrated by this study,
priming methods that recalibrate maladaptive beliefs and disruptive mindsets can be cost
effective, with minimal risk, and should be expanded.
Pain clinics and treatment centers are ideal environments to implement novel priming
methods and collect relevant data. Greater collaboration between researchers and physicians
could further cost-effective data collection contributing to enhanced clinical application and
improved outcomes. A database of cross-over studies like this one (i.e., inclusive of
psychological priming and medical placebo) could incentivize further collaboration and spark
ingenuity.
It is hoped that this study will highlight the feasibility and potential of priming strategies
and encourage the use of similar platforms (e.g., medical questionnaires and web-based surveys)
to deliver primed material in clinical settings.
Summary
Priming “affects all aspects of human behavior” (Claessen et al., 2016, p. 48), yet has
only recently gained traction in the health sciences (Elgendi et al., 2018). In response to a
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collective call to action by many of the sources cited herein, the results of this pre- and postrandomized intervention study, and associated literature, argue that unconscious exposure can
prime or condition implicit attitudes apart from conscious goal setting with the potential to
improve outcomes (Zion et al., 2019).
Hence, the findings suggest that hope, as related to agency, can be strengthened via
priming, although the mechanism for the effect is not clear. Whether through the tutorials, the
repetition of the Hope scale or an additive effect of both, this study indicates that the briefest of
verbal conditioning (i.e., written or spoken) may have significant effects on mood (i.g., hope)
and motivation (i.e., agency), and need not be cumbersome or time consuming to incorporate in
clinical practice.
By addressing gaps in subliminal priming literature, as well as stress-hardiness and pain,
this investigation highlights the potential for high fidelity, economical and time saving priming
opportunities in clinical practice––not only in the pain population––but in the wide arena of
health care. Claessen et al.’s (2016) forward thinking study utilizing a primed health
questionnaire inspired this project, and it is hoped this study will contribute to the development
of a diversified approach to priming research in clinical settings. Until then, there is clear
evidence for health care practitioners to use language, spoken and written, that closes the gap
between research and clinical application by leveraging targeted interventions aimed at instilling
positive mindsets.
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Appendix A

Recruitment Announcement
Chronic Pain Study: Help researchers understand your pain.
Anonymity protected. Please forward/share.
Your participation is meaningful! By means of a brief (10-15-minutes) online questionnaire you
can help researchers at Lesley University learn more about the relationship between pain and
well-being. No names or personal identifiers are collected.
If you have questions about taking the survey or would like to discuss the study and its findings
afterward, please feel free to contact Brenda Stockdale.
Thank you for helping advance our understanding of pain!
Brenda Stockdale, PhD cand., Lesley University
P: 678-393-0066 E: Brenda.stockdale@gmail.com
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Appendix B

Online Consent Form
You are invited to participate in a research project titled “Understanding the Relationship
Between Chronic Pain and Well-being.” By means of a brief (10-15minutes) online
questionnaire you can help researchers at Lesley University learn more about the relationship
between pain and well-being.
The online questionnaire consists of 29-click-to-answer questions and reading a few paragraphs.
- Former knowledge about pain and well-being is not necessary.
- Participation is strictly anonymous.
- You are free to choose not to participate in the research and to discontinue your
participation in the research at any time by quitting the survey.
- No risks have been identified by taking the survey, apart from any feelings that arise from
answering multiple choice questions about the experience of pain.
- There is no reward for participating apart from the free 30-minute audio download.
- No names or identifying details are collected by the researchers.
- If any problem in connection to the research arises, you can contact the researchers: Brenda
Stockdale at 678-393-0066 or brenda.stockdale@gmail.com and/or Ulas Kaplan, EdD, Associate
Professor at Lesley University at ukaplan@lesley.edu.
There is a Standing Committee for Human Subjects in Research at Lesley University to which
complaints or problems concerning any research project may, and should, be reported if they
arise. Contact the Committee Chairperson at irb@lesley.edu
Participation in this online questionnaire by clicking "next" will constitute consent.
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Appendix C

The Hope Scale
Derived and adapted from Everson et al. (1996) and Beck et al. (1974) by Long et al.
(2020). Permission for use granted.
The Hope Scale consists of four statements rated from 1 to 6 (strongly disagree to strongly
agree):
1.

It is possible for me to reach goals.

2.

The future seems hopeful to me.

3.

I do expect to get what I really want.

4.

There is use in trying.

The statements below were reverse coded (Long et al., 2020) (see above) in order to construct a
hope, rather than hopelessness scale. This was done for a few reasons, one of which was to align
with the “empirical conceptualization of hope as a positive motivational state directing
perseverance towards goals” (Long et al., 2020, p 2). Another was to avoid the negatively
phrased scale that can indicate depression.
1.

I feel it is impossible for me to reach the goals that I would like to strive for.

2.

The future seems hopeless to me and I can’t believe that things are changing for the
better.

3.

I don’t expect to get what I really want.

4.

There’s no use in really trying to get something I want because I probably won’t get it.

The negatively worded items 1, 3 and 4 implicitly reference agency and item 2 references hope
itself.
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Appendix D

Five-Item Pain Inventory
Adapted version of the Brief Pain Inventory (Short Form)
For more information on the original Short-form Hardiness Scale:
https://apps.dtic.mil/dtic/tr/fulltext/u2/a562799.pdf
1.

Throughout our lives, most of us have had minor aches, sprains, and toothaches from

time to time. Other than these everyday kinds of pain, please indicate the number that best tells
how much discomfort you have right now. (0-10)
2.

Please indicate the one number that best describes your experience of pain on average.

(0-10)
3.

Please select the one number that describes how much pain interferes with your general

activity.
(Likert Scale: Does not Interfere to Completely Interferes, 0-10)
4.

Please select the one number that describes how much pain interferes with your ability to

walk. (Likert Scale: Does not Interfere to Completely Interferes, 0-10)
5.

Please select the one number that describes how much pain interferes with your

enjoyment of life. (Likert Scale: Does not Interfere to Completely Interferes, 0-10)
The original paper and pencil version of the Brief Pain Inventory (Short Form) can be found
here:
https://www.mdanderson.org/documents/Departments-and-Divisions/Symptom-Research/BPISF_English-24h_Original_SAMPLE.pdf
Permission for use granted by MD Anderson.
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Appendix E

Adapted Short-form Hardiness Scale (DRS-II, short-form)
Permission requested via email, September 26, 2020. Reduced from 18-items to 10.
Items that have been reverse coded are indicated by an asterisk.
Instructions: Each of these statements reflects ways people sometimes feel. Please carefully read
each statement and use the scale below to indicate the extent to which you feel each statement is
true.
1 = Definitely False 2 = Mostly False 3 = Don’t know 4 = Mostly True
5= Definitely True
1.

My successes are because of my effort and ability.

2.

I enjoy most things in life.

3.

Despite challenges, life seems meaningful to me. *

4.

I take a head-on approach to facing problems in my life.

5.

I feel confident I can handle just about any challenge.

6.

Most of my life gets spent doing things that are worthwhile.

7.

I often feel connected to the people around me. *

8.

I see really stressful events as opportunities to grow personally,

9.

My successes are related to the choices I make.

10.

Most days, life is really interesting.
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Appendix F

Neutral & Primed Tutorials
50% of Participants Receive the Neutral Tutorial (219-words): Control Group
There are several definitions for chronic pain, but pain is often classified as chronic when
it persists longer than six-months. Medically speaking, pain can be a protective signal. For
example, pain can quickly alert us to stop touching something hot. But if we happen to burn
ourselves, the pain can motivate us to apply cold water or other treatment.
This kind of pain may be relatively easy to describe to others. But other types of pain
may be challenging to put into words. That is because “pain is mediated by nerve fibers in your
body, and these nerve fibers have the job of sending pain signals to the brain . . . Once they find
their way to the brain, the brain acts to make you aware of the pain. Because every person’s body
is different, their nerve fibers and their brain can react differently to the same stimuli”
(www.Beaumont.org).
This understanding helps explain why some people experience more pain than others
even with the same condition or injury. Since everyone experiences pain differently, it can be
particularly difficult to describe our experience. Not only that, but we can even experience more
than one type of pain at the same time, making it even more complex to describe. *
*The quoted text is from Beaumont; other concepts are from WebMD.
50% of Participants Receive the Primed PNE (219-words): Intervention Group
Neuroscience offers new hope for chronic pain! For the first time, scientific evidence
(reported in the Journal of Pain, Journal of Neuroscience, Journal of the American Medical
Association, etc.) shows that we can experience relief without pills, injections, and surgeries.
Before and after results can even be seen in brain imaging studies.
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Inspired by the evidence, surgeons, neurologists, and pain specialists are teaming up to
educate physicians and patients in how to treat a major source of pain––the brain and nervous
system. These easy-to-apply methods target the specialized pain-sensing network in the brain
and help rewire the nervous system. This new approach helps the brain “unlearn” pain and has
been shown to be effective even when there is nerve, bone, and tissue damage.
As a result, these strategies are empowering thousands, providing significant
and measurable relief, while restoring hope and a valuable sense of control over one’s body and
life. *
* There are books and interactive websites written and developed by physicians that feature these
new findings, such as orthopedic spinal surgeon David Hanscom’s book, Back in Control (2017)
and the Curable app. There is also a growing network of medical centers (i.e., Mayo Clinic) and
insurers (i.e., Kaiser Permanente in California, United Health Group Research & Development),
utilizing these methods and bringing new hope to chronic pain.

